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ABSTRACT 
 Arabidopsis CRINKLY4 (ACR4) is a receptor-like kinase (RLK) that is required for 
the global development of the plant. In aerial tissues ACR4 promotes the differentiation of 
the outer, epidermal layer in the leaves and reproductive tissues. Loss of ACR4 function 
results in malformed, ‘crinkled’ leaves due to graft-like fusions of vegetative tissues.  
Underground, ACR4 is responsible for stem cell differentiation in the root tip and for the 
initiation of lateral roots.  Acr4 mutant plants show increased proliferation of stem cells and 
increase lateral root initiation sites.   ACR4 has architectural features analogous to receptor 
tyrosine kinases (RTK).  It includes an extracellular ligand binding domain, a transmembrane 
helix, and an intracellular kinase domain. The intracellular domain contains two subdomains, 
the juxtamembrane domain (JMD) and the C-terminal domain (CTD) which flank the core 
kinase domain (KD).  The Arabidopsis genome also encodes four homologs of ACR4, 
referred to as Arabidopsis CRINKLY4 Related (AtCRR) proteins, that contain equivalent 
architectural domains to ACR4 and have high sequence similarity.   Genetic and cell biology 
studies have suggested potential communication between members of the ACR4 gene family.  
However, a biochemical basis for receptor hetero-oligomerization among these family 
members has not been established.  An additional RLK, ABNORMAL LEAF SHAPE 2 
(ALE2), is involved in proper epidermal layer formation.  ALE2 is also known to 
synergistically enhance ACR4 kinase activity in vitro. Furthermore, the spatial expression of 
a transcription factor, WOX5, has been demonstrated to be regulated by ACR4 signaling.  
However, the precise signaling pathway(s) modulated by these RLKs and the molecular basis 
of their biological function remain to be determined.   
vi 
 Although significant advancements have been made in understanding the biological 
relevance of ACR4, little is known about the biochemical aspects of ACR4 signaling.  In this 
dissertation, we provide a fundamental biochemical analysis of the activation of the ACR4 
intracellular kinase domain. We have expressed and purified the intracellular domains of 
ACR4, the AtCRRs, and ALE2 as C-terminal fusions to the yeast SUMO protein.  We 
provide evidence for an intramolecular interaction mechanism between the ACR4 JMD and 
the amino-terminal region of the KD and demonstrate its potential role in the regulation of 
kinase activity.  Additionally, we provide evidence for an intermolecular interaction 
mechanism between ACR4 and the AtCRRs, and potential regulation of this interaction by 
the ACR4 JMD.  Lastly, we demonstrate that ACR4 can bind to the WOX5 transcription 
factor and phosphorylate it in vitro at four sites.
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CHAPTER 1.  GENERAL INTRODUCTION 
 
Introduction 
Higher organisms must maintain controlled equilibrium between cell proliferation 
and differentiation throughout development.  Failure to retain this balance results in 
developmental problems which lead to increased disease states and decreased survival.  
Utilization of cell-surface receptors to perceive external or internal signals is a widespread 
characteristic of all organisms.  Mammalian systems have acquired signal transduction 
mechanisms via the use of receptor tyrosine kinases (RTK) to regulate cellular processes 
such as proliferation, migration, differentiation, and cell-cycle control (1).  The use of RTKs 
allows the cell to perceive proper signaling cues and communicate their message 
intracellularly.  RTKs consist of an extracellular ligand binding domain, a single 
transmembrane helix, and an intracellular tyrosine kinase domain.  The general paradigm of 
RTK activation entails ligand binding to the extracellular domain of the receptor, followed by 
receptor oligomerization, and activation of the kinase domains by trans phosphorylation (2, 
3).  Activation of the intracellular kinase domain of the receptor initiates a coordinated signal 
transduction cascade involving cytoplasmic components that ultimately lead to regulation of 
gene transcription in the nucleus (1, 4). 
Dissimilar to animals, plants are inherently sessile organisms i.e. they are not free-
moving.  Their immobility prohibits them from escaping predation, mobilizing towards 
favorable conditions, or moving from hostile surroundings.  Therefore, plants have acquired 
the ability to recognize various stimuli and coordinate an appropriate response to their 
prevailing conditions.  In order to perceive and respond to both external and internal cues, 
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plants have developed extensive signaling mechanisms to help adapt to changing 
environments.  Similar to animals, plants make use of receptor-like kinases (RLK) in order 
perceive extracellular signals and transport the signal across the plasma membrane to 
regulate transcriptional activation in the nucleus.  Signal transduction via RLKs ultimately 
guides a host of cellular responses such as cell growth, proliferation, differentiation.  Thus, 
the ability for a plant to respond according to its environment, both internally and externally, 
drives the proper growth and development of the organism to ensure its survival. 
 
Dissertation Organization 
This dissertation is organized into six chapters.  Chapter 1 provides a literature review 
of the past and current knowledge of CRINKLY4 biology and signaling in plants.  Chapter 2 
has been published in the ACS journal, Biochemistry (5).  This article represents the in vitro 
biochemical characterization of the intracellular kinase domain of Arabidopsis CRINLY4 
(ACR4) and the identification of multiple autophosphorylation sites.  A manuscript 
describing the expression and purification of the intracellular domains of ACR4, the ACR4 
homologs, and ALE2 receptor-like kinases as C-terminal fusions to the yeast SUMO protein 
is outlined in Chapter 3.  This includes characterization of their autophosphorylation activity, 
oligomerization, and intrinsic fluorescence properties.  Additionally, the effect of Ala point 
mutations of the ACR4 autophosphorylation sites is examined.  Chapter 4 is a manuscript 
describing the autoregulatory role of the ACR4 juxtamembrane domain (JMD) on kinase 
autophosphorylation.  A potential intramolecular mechanism involving the JMD and the N-
lobe of the kinase domain has been established.  A manuscript outlined in Chapter 5 
examines and provides evidence for intermolecular interactions between the intracellular 
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domains of ACR4 and its homologs, the AtCRRs, and a transcription factor involved in stem 
cell differentiation.  Furthermore, evidence for an intermolecular mechanism in which the 
JMD of ACR4 modulates intermolecular contacts between the homologs is illustrated.  
Lastly, Chapter 6 is a general conclusion that draws together the work described in the 
previous chapters and outlines ideas for future research in the elucidation of the ACR4 




RLKs in plant development 
The Arabidopsis genome encodes over 600 RLKs with a large variety of putative 
extracellular ligand binding domains.  The RLK family is one of the largest and represents 
2.5% of the known coding sequences in Arabidopsis (6).  Furthermore, this family accounts 
for 60% of the total number of kinases encoded in Arabidopsis (7). The architectural features 
of the majority of RLKs consist of an extracellular ligand binding domain, a transmembrane 
spanning helix, and an intracellular kinase domain, similar to mammalian receptors.  The 
sequence diversity of the extracellular domains of the RLK family allows them to be further 
subdivided into 15 groups which share similar domain features common among animal 
RTKs.  The leucine-rich repeat (LRR) RLKs are the largest group within the family, 
containing more than 200 members (6).  The diversity of extracellular domains suggests 
plants are able to distinguish between a broad array of signaling molecules including 
hormones, peptides, pathogen recognition motifs, steroids, and small molecules (8-16).  
However, examples exist in which receptors lack an extracellular or intracellular region 
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which define their overall functionality at the cell surface (6, 17, 18).  RLKs are reasoned to 
act in a similar fashion to RTKs but, in contrast to the the RTKs, the kinase activity of the 
RLKs is predominantly via phosphorylation of serine/threonine residues, although evidence 
of tyrosine phosphorylation has emerged in more recent studies (19, 20).  A key way to 
regulate kinase activity is through activation loop phosphorylation.  Structural analyses 
comparing Ser/Thr and Tyr kinases has revealed differing mechanisms of activation loop 
stabilization via phosphorylated residue contacts with the N-lobe of the kinase.  The mode of 
contact differentiates the two classes of enzymes.  The phosphorylated residue(s) in Ser/Thr 
kinases make use of electrostatic contacts with basic residues in the N-lobe, whereas Tyr 
kinases primarily use cation-π interactions between a conserved Phe residue just C-terminal 
to the activation loop and the kinase N-lobe (21).  Nevertheless, there is remarkable structural 
conservation of kinase domains across the Ser/Thr and Tyr kinase families even though the 
activation loop regions are highly divergent in both conformation and sequence (Fig. 4).  
This exemplifies the evolutionary differences arising from kinase-specific activation and 
functionality (22). 
Insofar as very few of the RLKs have been characterized in detail at the molecular 
level, the biological functions of several RLKs involved in plant-pathogen interactions, 
defense and stress responses as well as in plant growth and development have emerged in 
recent times (6, 16, 23-25). These studies suggest that activation of the kinase domain elicits 
an amplification of the extracellular signal via recruitment of cytoplasmic downstream 
protein targets and their subsequent phosphorylation.  The phosphorylated effector proteins 
can then act to modulate transcriptional activity in the nucleus. 
5 
 
Plant embryo development begins when sperm cells from the pollen fertilize the cells 
of the female gametophyte (26).  During the early stages of embryogenesis two polar stem 
cell niches form to create the apical meristems of the developing shoot and root.  All new 
tissues and organs originate from these meristems to give rise to the aerial and underground 
portions of the plant (27, 28).  In the shoot apical meristem (SAM) a small population of 
pluripotent cells has the ability to differentiate into leaf and stem structures, but can be 
reprogrammed to form reproductive tissues.  In the root apical meristem (RAM), the 
pluripotent stem cell niche has the ability to form all tissues of the roots (27).  A small 
number of RLKs that modulate plant development have been studied extensively, namely the 
Brassinosteroid insensitive 1 (BRI1) and CLAVATA1 (CLV), and have shed light on receptor 
complex formation, ligand identification, and downstream signaling components.  They have 
provided valuable insight into the mechanistic aspects of the signal transduction events that 
regulate the proper growth of the plant. 
BRI1 is a LRR RLK that binds to a steroid hormone, brassinosteroid (BR), in the 
extracellular domain (29).  BRs are growth promoting hormones that influence cell division 
and elongation in the plant and can be regulated by environmental conditions such as light 
and temperature (30).  Loss of BRI1 function leads to a variety of plant defects ranging from 
dwarfism, to delayed senescence, to aberrant skotomorphogenesis when plants are grown in 
the dark (30-32).  BRI1 is constitutively expressed in all parts of the plant ranging from the 
root meristem to the apical meristem.  Although BRI1 is globally expressed in the plant, 
temporal regulation of the receptor occurs and is more actively expressed in younger tissues 
than mature tissues (33). 
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At the cell surface, BRI1 can form homo- or heterodimeric receptor complexes.  
Studies have shown that BRI1 has the capacity to form inactive homodimers in the absence 
of BR stimulation and that homodimerization is a mechanism of autoregulation (34, 35).  The 
formation of the homodimeric complex and the binding of kinase inhibitor BRI1 KINASE 
INHIBITOR 1 (BKI) (36) ensures BRI1 signaling is maintained in the inactive state.    In 
vivo demonstration in both yeast cells and Arabidopsis has provided confirmation that BRI1 
forms an active heterodimer with another LRR RLK, BRI1-Associated Receptor Kinase1 
(BAK1) (34, 37, 38).  Direct binding of BR (39) to the extracellular domain leads to 
activation and transphosphorylation of the intracellular kinase domains within the BRI-
BAK1 receptor complex (40) and levels of phosphorylation are directly associated with BR 
binding (41).  BR binding and establishment of the active BRI1-BAK1 receptor complex 
initiates an intracellular signaling cascade involving recruitment and activation of membrane-
localized kinases BSK1 and 2 (24), a protein phosphatase BSU1 (25, 42), the cytoplasmic 
kinase BIN2 (43), and transcription factors BZR1 and 2 (44-46).  Thus, like mammalian 
systems, plants use receptor mediated signaling cascades to moderate their own growth. 
A challenge in the developmental biology of all multicellular organisms is striking a 
balance between cell proliferation, specification, and differentiation.  In higher plants, new 
tissues and organs are produced post-embryonically from stem cell populations in the SAM 
and the RAM.  A meristem is defined as a formative region of cells that divide and 
differentiate into a number of tissues that eventually comprise the entire plant.  The 
boundaries of the meristem are classified by genetic, cellular, and molecular constraints as 
well as the ability of this zone to produce primordia which eventually give rise to the organs 
of the plant (47).  The SAM can be divided into three cell layers.  The L1 layer is the outer, 
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single-cell layer that gives rise to epidermal tissues by anticlinal cell division.  The L2 layer 
produces cells of the mesophyll and the L3 layer produces cell the make up the inner tissues 
of the stems and leaves (48).   Furthermore, the SAM can be divided into three radial sectors: 
the central zone (CZ), the peripheral zone (PZ), and the rib zone (RZ).  Cell division in the 
CZ is slow, whereas in the PZ it is rapid in order to produce all cells necessary for organ 
development (49).   The RZ harbors the Organizing Center (OC) which is the pool of 
pluripotent stem cells in the SAM (27).  These layers work in concert to maintain SAM 
homeostasis during the lifetime of the plant. Thus, all aerial organs are formed from 
differentiation of cells at the summit of the SAM. 
Multiple factors control cell proliferation and specification in the SAM.  Studies in 
Arabidopsis indicate that the balance between the antagonistic processes of stem cell renewal 
and organogenesis is maintained by a signal transduction process involving the CLV genes 
CLV1, CLV2, and CLV3 which are expressed in adjacent regions of the SAM and function in 
the same genetic pathway (50-54).   clv1, clv2, and clv3 loss-of-function mutants display 
abnormal phenotypes of shoot fasciation, enlarged meristems, and increased number of floral 
organs (48).  CLV1 is an LRR RLK that is expressed only in the central L3 layer of the SAM 
and CLV2 is an LRR RLK that is similar to CLV1 but lacking the kinase domain (55).   The 
CLV3 gene encodes a 78-amino acid precursor protein that is expressed only in the L1 and 
L2 layers.  Proteolytic processing of CLV3 releases the active 12-amino acid peptide ligand 
containing two post-translationally modified hydroxyproline residues (56, 57) that binds 
directly to the CLV1 ectodomain (58).  CLV1 and CLV2 have been shown to form an 
inactive disulfide linked heterodimeric complex in the absence of CLV3.  The CLV1/CLV2 
heterodimer can form a larger complex which includes a kinase associated protein 
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phosphatase (KAPP) and an ROP-GTPase which is dependent on CLV3 ligand binding 
directly to the CLV1 extracellular domain (58, 59).  CLV3 binding activates the intracellular 
kinase domain of CLV1 and initiates downstream signaling events ultimately leading to 
repression of the WUSCHEL (WUS) transcription factor.  WUS is expressed in the 
underlying OC of the meristem and functions to prevent stem cell differentiation.  Activation 
of the CLV signaling pathway leads to suppression of the WUS expression domain, thus 
inhibiting the WUS signal.  Inhibition of the WUS signal now promotes the differentiation of 
stem cells.  Thus, a feedback loop is generated in the SAM between opposing CLV3 and 
WUS signals to regulate stem cell proliferation and differentiation (60, 61). 
The CRINKLY4 gene and its role in plant development 
The maize CRINKLY4 (CR4) gene was first identified by transposon tagging as a 
putative receptor-like kinase encoding gene involved in the proper differentiation of 
epidermal tissues in the aerial organs of the plant.  It was observed that the loss of epidermal 
cell identity led to improper formation of the cuticle on the leaf surface and fusions between 
leaf tissues,  causing the leaves to be “crinkled” (62).  Genetic analyses confirmed the role of 
this gene in regulating epidermal cell specification and morphology primarily in the leaves 
and the kernel. Leaf epidermal cells of cr4 mutants showed irregular cell patterning, 
enlargement, and irregular shape compared to wild-type.  In some instances, cell proliferation 
was affected in mutant cr4 epidermal cell lines, leading to wart-like structures (62, 63).  This 
gave rise to the notion that CR4 was involved in a growth factor like signaling event within 
the plant.  Further studies have shown that CR4 behaves in a cell autonomous fashion.  
Genetic mosaic analysis revealed that the cr4 mutant phenotype could not be rescued by 
neighboring wild-type cells (64, 65).  This suggested that signaling cues from wild-type cells 
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could not be perceived or that cr4 mutant cells were unable to activate intracellular signaling 
networks to effect proper differentiation. 
Orthologs of CR4 have been identified in rice (OsCR4) and Arabidopsis (ACR4) (66, 
67). In addition, both rice and Arabidopsis contain homologous RLKs. In Arabidopsis, there 
are four Crinkly4 related proteins (CRRs) designated as AtCRR1, AtCRR2, AtCRR3 and 
AtCRK1, that share similar structural features with ACR4 (67), suggesting functional 
redundancy in dicot plants (67-69).  The ACR4 receptor-like kinase is primarily expressed in 
the outer cell layers of the developing plant.  In situ hybridization studies have shown ACR4 
transcripts to be localized to the protoderm in the early stages of embryo formation (66).  In 
later stages of embryogenesis, transcripts were located predominantly in the L1 layer at the 
tips of the cotyledons and in meristematic tissues in both the shoot and root apices.  Post 
germination, high transcript levels were found primarily in the epidermal tissues of the shoot, 
shoot apical meristem (SAM), and outer layers of flower and leaf primordia, and in the root 
tip (66, 68).  ACR4 protein expression patterns mirror RNA transcript localization.  In aerial 
organs, ACR4 is found in the L1 layer of the SAM, ovule integuments, and epidermal layer 
of the leaves (67-69).   In the roots, ACR4 expression is found in the quiescent center (QC), 
underlying columella cells, and flanking cells of the lateral root cap (68, 70, 71).  The global 
expression of ACR4 throughout the plant implicates its importance to the overall 
development of the plant. 
ACR4 has been described to have similar phenotypic effects as maize CR4.  In the 
leaves, alterations in epidermal cells could be observed as outgrowths of cells at the leaf tip 
and the lack of cuticle formation.  Loss of cuticle was observed by the presence of 
hydrophilic toluidine blue staining of underlying dermal tissues, indicating a deficiency in 
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epidermal cell establishment (69).  The reproductive organs of the plant displayed similar 
characteristics.  In the absence of ACR4, mutant plants have abnormalities in the 
organization of the L1 layer of ovule integuments and in the sepal margins.  Gross 
morphological characteristics could be distinguished when compared to wild-type tissues.  
Mutant plants showed irregular seed coat formation with unusual outgrowths and fusions to 
adjacent seeds.  Furthermore, affected seeds showed increased abortion rates most likely due 
to the morphological abnormalities derived from loss of functional ACR4 (68, 69). 
In the root apical meristem (RAM), all cells are derived from a population of 
undifferentiated initial cells surrounding a small pool of rarely dividing cells, designated the 
quiescent center (QC) (72).  Short-range signals from the QC maintain strict control of the 
stem cell population in the undifferentiated state.  Stem cell division gives rise to daughter 
cells that are distal to the quiescent center and the surrounding mature, differentiated cells 
then cue the daughter cell to differentiate into its appropriate cell type (73, 74).  ACR4 has 
been connected to two developmental processes within the RAM.  First, at the primary root 
tip, the gravity sensing, starch granule containing columella cells (CC) are born from a 
defined set of columella stem cells (CSC) situated just below the quiescent center.  CSC 
differentiation leads to a daughter cell that eventually differentiates into a CC given the 
proper signal by the underlying CCs (71, 73, 75, 76).  In the absence of functional ACR4, 
CSCs fail to differentiate into CCs, leading to a proliferation of CSCs and disorganization of 
CCs in the root tip (70, 71). 
A feedback loop has been proposed involving the CLE40 peptide, ACR4, and the 
WOX5 transcription factor in which ACR4 acts to perceive the CLE40 peptide and controls 
the expression pattern of WOX5, similar to the CLAVATA signaling mechanism in the SAM 
11 
 
(71).  CLE40 belongs to the CLAVATA3/ENDOSPERM SURROUNDING REGION (70) 
family of peptide hormones in plants.  The gene encodes an 80 amino acid precursor protein 
and contains the 14 amino acid CLE box sequence common to members of the CLE family 
(77, 78).  Exogenous application of the active, 14-amino acid CLE40 peptide to Arabidopsis 
roots is able to promote meristem consumption by promoting differentiation of CSCs into 
CCs (71, 79).  The WUSCHEL RELATED HOMEOBOX 5 (WOX5) belongs to the 14 
member WOX gene family of transcription factors in Arabidopsis and is solely expressed in 
the QC of the RAM (74, 80).  WOX5 contains a homeobox DNA binding domain and a 
stretch of sequence C-terminal of the homeodomain, termed the WUS box.  This sequence, in 
WUS, is required for stem cell maintenance and floral patterning (81, 82).  Interestingly, 
WOX5 and WUS can functionally replace each other in their respective meristems of the 
SAM or RAM, suggesting that these two transcription factors operate similarly in stem cell 
maintenance regardless of their location (74).  WOX5 functions antagonistically to CLE40 in 
that it promotes stem cell maintenance, whereas CLE40 encourages stem cell differentiation 
(71, 74).  Spatial expression of WOX5 is shifted toward the apical side of the QC when 
CLE40 peptide is exogenously applied to Arabidopsis roots.  Restriction of WOX5 
expression to this domain is presumably through ACR4 activation since application of the 
CLE40 peptide in the acr4 mutant background fails to differentiate CSCs to CCs in the root 
tip (71).  Thus, a postulated feedback mechanism has been proposed where CLE40 binds to 
ACR4 in the extracellular domain, activates the receptor, which in turn regulates WOX5 
influence inside the cell. 
In addition to stem cell maintenance in the RAM, ACR4 has been implicated in the 
initiation of lateral roots.  Coordinated signaling events within the root are needed to 
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commence lateral root formation.  During the initiation event, longitudinal pericycle cells 
develop characteristics of founder cells and undergo anticlinal, asymmetric cell division to 
produce daughter initial cells.  These initial cells then undergo another round of anticlinal, 
asymmetric division to produce two central cells.  In a final step, the latter divide periclinally 
to produce the site where the lateral root emerges from the primary root (70, 83).  ACR4 is 
required for the proper regulation of cell division during this process.  Loss of ACR4 results 
in increased division in the pericycle, fusion of lateral initials, and an increase in opposing 
lateral root initiation sites (70).  Additionally, double and triple mutants in which 
combinations of ACR4 and the ACR4 homologs have been knocked out displayed increased 
lateral root meristems.  Functional redundancy has been suggested in Arabidopsis due to 
ACR4 having four homologs with similar structural features (67, 70). 
The 901amino acid maize CR4 protein (Fig. 1) has a putative extracellular ligand 
binding domain, a single transmembrane helix, and an intracellular kinase domain, all 
architectural features similar to mammalian RTKs (62).  Orthologs in rice, OsCR4, and 
Arabidopsis ACR4, share the same features (66, 67).  The extracellular domain of CR4, a 
putative ligand binding domain, contains seven repeat regions approximately 39 amino acids 
in length, followed by three cysteine-rich regions similar to the tumor necrosis factor receptor 
ligand binding domain. However, a ligand has yet to be identified.  A single alpha helix 
spanning the membrane connects the extracellular domain to the intracellular, active 
serine/threonine kinase domain (62, 63, 67).  Studies utilizing truncation mutants lacking 
single/multiple domains of ACR4 in transgenic plants demonstrated that the extracellular 
domain is required for receptor function and turnover (84).  However, opinions differ on 
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whether or not the intracellular kinase domain is absolutely necessary for receptor function 
(69, 84). 
Fundamental functional analysis by biological and biochemical methods of the 
varying domains within ACR4 has provided some insight into the importance of these 
regions on receptor function.  The extracellular crinkly repeat domain is thought to fold into a 
β-propeller like structure that may be involved in protein-protein interactions (67, 84).  The 
structure of the crinkly repeat domain of ACR4 was determined by homology modeling to 
two crystal structures of 7-bladed propeller proteins, the β‐Lactamase inhibitor protein-II (85) 
and the Regulator of Chromosome Condensation protein (86).  The model showed conserved, 
regularly spaced Cysteine residues in the repeats were likely to contribute to structural 
stability in the oxidizing environment of the extracellular space (84).  In RTKs, evidence 
indicates that TM domains function in a dynamic fashion and have the intrinsic capacity to 
drive receptor dimerization (87, 88).  Thus, the propensity of the transmembrane (TM) 
helices of the CR4, ACR4, and ACR4 homologs (AtCRRs) to dimerize has been studied by a 
modified TOXCAT assay.  The TM domains of the receptors vary in their ability to 
homodimerize with AtCRR1 possessing the highest propensity to dimerize, whereas the 
ACR4 TM showed the lowest potential (89).  Further mutagenesis studies also demonstrated 
the important role of specific amino acids within the TM helix of CR4 and ACR4 that 
profoundly affected dimer formation (90).  The intracellular domain of ACR4 has been 
demonstrated to possess intrinsic kinase activity (67-69).  More recently, the biochemical 
properties of the ACR4 kinase domain have been extensively characterized in vitro with 
regard to autophosphorylation and its mechanism, preference for divalent metal ions, 
conformational and oligomerization properties (5).  This description also constitutes a major 
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chapter in this dissertation along with other significant descriptions on sub-domain regulation 
of kinase activity and protein-protein interactions among ACR4 and ACR4 homologs. 
Kinase domain structure and regulation 
Reversible phosphorylation is one of the primary post-translational modifications 
utilized by metazoans to communicate between cellular components in order to regulate cell 
growth, proliferation, and differentiation.  Uncontrolled phosphorylation events can lead to 
increased disease states of an organism and ultimately death if left unchecked.  Protein 
phosphorylation can alter protein conformation, modulate protein-protein interactions, 
control catalytic activity, and regulate subcellular localization of proteins (91).  
Communication using phosphorylation is regulated by protein kinases and phosphatases in 
order to preserve cellular homeostasis. 
A kinase is an enzyme that catalyzes the transfer of a phosphate group to a specified 
substrate.  For the majority of kinases, the γ-phosphate donor is a molecule of adenosine 
triphosphate (ATP) and phosphotransfer occurs on the hydroxyl groups of serine, threonine, 
and tyrosine residues (92).  The kinase catalytic domain comprises approximately 250-300 
amino acids and, based on numerous structural and biochemical studies, can be separated 
into 11 distinct subdomains that house roughly 10 highly conserved residues and/or motifs 
that contribute to the activity and stability of the molecule (93).  These subdomains and 
residues are depicted in Fig. 2 for the ACR4 kinase domain.  The kinase domain folds into a 
highly conserved structure with an N-terminal lobe that is comprised predominantly of β-
sheets and a C-terminal lobe that is mostly α-helical, as seen in the first crystal structures 
solved using the cyclic AMP-dependent kinase (94-96).  Fig. 3a shows the homology model 
for the ACR4 kinase domain.  The tertiary structure produced at the interface of the N and C-
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terminal domains creates a pocket that serves as the active site of the enzyme.  Conserved 
features (Fig. 2 and 4) include the Gly rich motif (P-loop) between β-strands 1 and 2 of the 
N-lobe which function to help bind and stabilize the α and β phosphates of the bound ATP 
molecule.  The essential Lys residue in β-strand 3 of the N lobe also helps to stabilize the α 
and β phosphates of ATP and forms a salt bridge with the invariant Glu residue in helix-C.  
The C-lobe of the kinases harbors a conserved HRD motif, termed the catalytic loop, in 
which the aspartic acid serves as the catalytic base during the phosphotransfer reaction and 
chelates a Mg2+ ion that bridges the α and γ phosphates.  Loss of this amino acid results in 
complete inactivity of the kinase. The activation loop of kinases is slightly downstream of the 
catalytic loop and located between two conserved DFG and APE motifs (DPE in ACR4) that 
serve as hinge points for activation loop movement.  The Asp in the DFG motif functions to 
chelate a Mg2+ ion that stabilizes the β and γ phosphates of ATP.  The APE motif serves a 
structural role in stabilizing the C-lobe (22, 93, 96).  These conserved features work to 
coordinate the efficient transfer of phosphate from ATP to the appropriate target. 
Phosphotransfer from ATP to the substrate occurs at the active site.  A molecule of 
ATP binds to the kinase domain in an orientation that stages the γ-phosphate for transfer to 
the substrate (Fig. 3b).  The adenine ring of ATP is buried in the hydrophobic cleft of the 
active site and the γ-phosphate is presented outwards toward the target molecule.   The 
reaction mechanism of phosphotransfer can occur by two possible extremes, an associative 
mechanism or a dissociative mechanism.  The associative mechanism, comparable to a Sn2 
reaction, implies that the hydroxyl group on the substrate undergoes nucleophilic attack on 
the γ-phosphate moiety, formation of a transition intermediate, followed by release of 
adenosine diphosphate (ADP) and the phosphorylated protein.  Whereas, the dissociative 
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mechanism, similar to a Sn1 reaction, involves expulsion of the γ-phosphate as a monomeric 
metaphosphate ion, followed by nucleophilic attack by the substrate hydroxyl group (97).  It 
is likely that the associative mechanism occurs during phosphotransfer of di- and triesters, 
while the dissociative mechanism takes place in phosphotransfer of monoesters (97, 98).  
Structural studies of protein kinases have revealed how the enzyme facilitates 
phosphotransfer using conserved residues lining the active site.  These residues help 
coordinate the ATP molecule and assist in stabilizing the transition state during the 
phosphotransfer reaction (99). 
Regulation of phosphorylation events is crucial to cellular signaling networks.  
Unfettered kinase activity can lead to different disease types including a multitude of cancers.  
These cancers arise from mutations within the kinase domains of many RTKs causing 
constitutive activation that drives uncontrolled signaling in the cell (100-102).  There are 
several mechanisms exploited by kinases to maintain tight regulation of their activity.  The 
activation loop of the kinase, ~20-35 residues, is a key regulatory element.  Most kinases are 
activated by one or more phosphorylations within the activation loop.  A subsequent 
conformational change occurs to remove inhibitory constraints imposed on the kinase.  Once 
phosphorylated, the activation loop can also serve as a docking site for kinase substrates 
(103).    The intracellular kinase domains of cell-surface receptor kinases are flanked by N 
and C-terminal regions that assist in modulating kinase activity.  The juxtamembrane domain 
(JMD) is the region between the inner membrane and the kinase domain and the C-terminal 
domain (CTD) is located downstream of the kinase domain.  In the absence of ligand, the 
JMD and CTD adopt a conformation that preserves the kinase in an inactive state (104).  For 
instance, the JMD of the KIT RTK binds directly to the N-terminal lobe of the kinase causing 
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inhibition as demonstrated by exogenous application of JMD peptides to KIT proteins in a 
kinase assay in vitro.  Furthermore, overexpression of the KIT JMD caused a reduction of 
KIT activity in vivo (105).   Evidence exists in the Eph receptor family in which the JMD 
adopts a conformation that binds to the N-lobe of the kinase and distorts a crucial salt bridge 
required for activity therefore inhibiting kinase activity.  Phosphorylation of two tyrosine 
residues in the JMD forces the domain into an alternate conformation, relieving its inhibitory 
effect (106, 107).  During receptor activation, residues within the JMD and CTD are 
phosphorylated, which drives a conformational change that opens up the molecule and 
relieves inhibition of kinase activity and allows for substrate binding (104).  Lastly, 
intermolecular interactions can take place between kinases and proteins that act as inhibitors.  
In the case of the TGFβ receptor (TβR-I), the kinase domain is kept in the inhibited state by 
the FKBP12 protein.  The JMD region of TβR-I contains a TTSGSGSG motif (GS motif) 
that binds the FKBP12 in the unphosphorylated state and represses kinase activity.  
Phosphorylation of multiple Ser and Thr residues in the GS motif is required for full kinase 
activity (108) and causes structural changes in the JMD that releases FKBP12 binding (109, 
110). 
Other components in epidermal cell fate 
The epidermal layer in plants helps regulate gas and nutrient exchange, maintain 
water, and provides a barrier against insect/pathogen attack.  The proper formation of the 
epidermis on multiple organs is necessary for the overall growth and development of the 
plant.  The protoderm originates at embryogenesis and it is still unclear how these cells are 
cued to differentiate into their final cell type (111).  A multitude of candidate genes have 
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been identified that engage in a variety of mechanisms to promote, specify, and maintain 
epidermal cell type. 
Maize DEK1 is a member of the calcium-dependent calpain proteinase superfamily 
and shares the highly conserved cysteine proteinase domain common among the family.  
DEK1 is a membrane bound protein that differs from mammalian calpains in the fact that it 
contains a large N-terminal domain.  This region contains 21 transmembrane passes and a 
300 amino acid extracellular loop, raising the possibility that this region plays a role in 
perceiving an extracellular signal and causes autolytic cleavage of the intracellular calpain 
domain to release from the membrane to transducer a signal inside the cell (112, 113).  The 
intracellular calpain domain contains a conserved catalytic triad common to cysteine 
proteinases (112, 114).  Enzymatic activity of the calpain domain is enhanced in the presence 
of Ca2+, however, Ca2+ is not a requirement for catalytic activity as seen with mammalian 
calpains, indicating that DEK1 may be regulated in some other manner (114).   DEK1 is 
mandatory for the maintenance of aleurone cell identity in the kernel during endosperm 
development.  However, DEK1 is not required for specification of aleurone cell fate and it is 
thought that CR4 perceives positional cues to prompt aleurone differentiation.  Loss of DEK1 
results in a reversion of aleurone cells to starchy endosperm, indicating DEK1 works 
separately from, but overlaps with CR4 to maintain aleurone identity (64, 112). 
A putative class E vacuolar sorting protein named SUPERNUMERARY LAYER1 
(SAL1) is another protein involved in epidermal differentiation and maintenance.  SAL1 is a 
negative regulator of epidermal cell differentiation, where loss of SAL1 function leads to 
multiple aleurone layers in the maize kernel and weak epidermal defects in vegetative tissues 
(115).  Sequence alignment of SAL1 shows similarity to the human CHMP1 gene which is 
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involved in vesicle trafficking of proteins targeted for proteasomal degradation, suggesting 
SAL1 may be involved in membrane protein turnover.  Interestingly, SAL1 has been shown 
to co-localize with DEK1 in cellular vesicles in maize, signifying its possible role in protein 
turnover (116). 
In Arabidopsis, a putative subtilisin-like protease, ABNORMAL LEAF SHAPE 1 
(ALE1), and a LRR RLK, ALE2, have also been implicated in epidermal development.  
During embryo and seedling development ale1 mutants show seedling lethality, loss of 
cuticle formation in the leaves, and the adherence of adjacent leaf tissues (117).  ALE1 
contains a N-terminal signal sequence for secretion into the extracellular space and may 
function to provide a peptide ligand for a cell-surface receptor such as ACR4.  Genetic 
analysis of ale1/acr4 double mutants showed a stronger mutant than either single mutant, 
suggesting that ALE1 and ACR4 act in separate but overlapping pathways (69).  The ALE2 
gene encodes a LRR RLK that has an active, intracellular kinase domain.  Both ACR4 and 
ALE2 have been shown to synergistically enhance phosphorylation in vitro (118).  ale2/acr4 
double mutants are phenotypically similar to the ale2 single mutant (118).  The epidermal 
phenotype analysis along with the phosphorylation enhancement suggests these two receptors 
may function in the same pathway. 
Overall, multiple modulators of epidermal specification and differentiation have been 
identified.  Individual components have been determined to be involved at various stages of 
communication in order to properly form and maintain epidermal cell type.  However, the 
exact molecular mechanisms of how these components function and their ability to 





Cellular signaling via cell-surface receptors is a highly regulated process across all 
organisms.  Loss of control in phosphorylation events can lead to a multitude of defects and 
diseases in an organism.  Receptor kinases are emerging as key components of growth and 
development in plants, as seen with the BRI1 and CLAVATA signaling pathways.  In recent 
years the ACR4 RLK has also emerged as an important player since it appears to be involved 
in the entire development of the plant as evidenced by its global role in the differentiation of 
both aerial and underground tissues.  A plethora of biological data has been amassed about 
the functional significance of the ACR4 RLK.  However, little information is known 
acknowledging the molecular mechanisms of how the receptor functions in putative ligand 
perception and receptor activation, the regulatory aspects of kinase activity, and the 
downstream components involved in ACR4 signaling.  Therefore, this dissertation begins to 
address the fundamental biochemical properties of ACR4 including its kinase activity, the 
role of the juxtamembrane domain on kinase activity, the recombinant expression of some of 
the homologs and other proteins implicated in epidermal cell fate specification and provides 
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CHAPTER 2.  IDENTIFICATION OF IN VITRO AUTOPHOSPHORYLATION 
SITES AND THE EFFECTS OF PHOSPHORYLATION ON THE ARABIDOPSIS 
CRINKLY4 (ACR4) RECEPTOR-LIKE KINASE INTRACELLULAR DOMAIN: 
INSIGHTS INTO CONFORMATION, OLIGOMERIZATION AND ACTIVITY 
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 Arabidopsis CRINKLY4 (ACR4) is a receptor-like kinase (RLK) that consists of an 
extracellular domain and an intracellular domain (ICD) with serine/threonine kinase activity.   
While genetic and cell biology experiments have demonstrated that ACR4 is important in 
cell fate specification and overall development of the plant, little is known about the 
biochemical properties of the kinase domain and the mechanisms that underlie the overall 
function of the receptor.  To complement in planta studies on the function of ACR4, we have 
expressed the ICD in Escherichia coli as a soluble C-terminal fusion to the N-utilization 
substance A (NusA) protein, purified the recombinant protein and characterized the 
enzymatic and conformational 
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properties.  The protein autophosphorylates via an intramolecular mechanism, prefers Mn2+ 
over Mg2+ as the divalent cation and displays typical Michaelis-Menten kinetics with respect 
to ATP with an apparent Km of 6.68 ± 1.62 M and Vmax of 193.8 ± 15.14 pmole/min/mg. 
Autophosphorylation is accompanied by a conformational change as demonstrated by 
circular dichroism, fluorescence spectroscopy and limited proteolysis with trypsin.  Analysis 
by nano-liquid chromatography mass spectrometry (nano-LC-MS) revealed 16 confirmed 
sites of phosphorylation at Ser and Thr residues. Sedimentation velocity and gel-filtration 
experiments indicate that the ICD has a propensity to oligomerize and that this property is 

















ACR4, Arabidopsis CRINKLY4; ALE2, ABNORMAL LEAF SHAPE 2; ATP, adenosine 
triphosphate; BRI1, Brassinosteroid insensitive 1; CR4, maize CRINKLY4; CD, circular 
dichroism; AtCRR, Arabidopsis CRINKLY4 related; CTD, carboxy-terminal domain; DTT, 
dithiothreitol; EGFR, epidermal growth factor receptor; ICD, intracellular domain; JKC, 
juxtamembrane + kinase + carboxy terminal domain; pJKC, phosphorylated JKC; JM, 
juxtamembrane; KD, kinase domain; MyBP, myelin basic protein; NusA, N-utilization 
substance A; PDGF, platelet derived growth factor; RLK, receptor-like kinase; RTK, 
receptor tyrosine kinase; SERK, somatic embryogenesis receptor-like kinase; SYMRK, 

















 A fundamental challenge in the developmental biology of higher organisms is striking 
a balance between cell proliferation, differentiation, and specification in order to undergo 
proper organogenesis and development.  In mammalian systems, receptor tyrosine kinases 
(RTKs), such as the members of epidermal growth factor (EGF) receptor family, represent a 
class of proteins which perceive and regulate inter- and intracellular processes pertaining to 
stem cell proliferation and differentiation (1, 2).  The architecture of RTKs consists of an 
extracellular ligand binding domain, a transmembrane helix, and an intracellular kinase 
domain.  In the classic example, members of the EGF receptor family undergo ligand 
induced homo- or heterodimerization, followed by intracellular kinase activation via trans 
phosphorylation (3, 4). Homo- or heterodimerization regulates which downstream signaling 
pathways are activated through phosphorylation of specific tyrosine residues and recruitment 
of specific intracellular substrates in response to differential ligand binding (3, 5, 6). 
Mounting evidence, as in the case of the well characterized Brassinosteroid pathway and the 
CLAVATA (CLV) pathway, supports the occurrence of ligand induced, receptor mediated 
signaling involved in plant development similar to RTK signaling in mammalian systems (7, 
8). Although >400 putative receptor-like kinases (RLKs) have been identified in the 
Arabidopsis genome, only a few have been characterized in detail (9, 10). 
First described as a growth factor like receptor in maize, CRINKLY4 (CR4) is a RLK 
involved in the proper formation of the epidermal layer in the leaves and the aleurone 
monolayer in the kernel (11, 12).  The protein consists of an extracellular domain with seven 
repeating regions (each of 39 amino acids), three cysteine-rich regions which are similar to 
the extracellular motifs of the tumor necrosis factor receptor, a single transmembrane 
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spanning region, and an active intracellular serine/threonine kinase domain (11, 13, 14).  An 
ortholog in Arabidopsis, ACR4, contains all the architectural features of maize CR4 and 
functions in a similar manner.  ACR4 primarily affects epidermal cell morphology in the 
ovules and sepal margins of the plant, is required for proper morphogenesis of developing 
embryos, and is necessary for the proper formation of the epidermal layer in leaves. Seeds 
from acr4 plants show defects in seed coat development and loss of epidermal and cuticle 
formation, leading to fusion of tissues (14-17).  Recently, ACR4 has been described as a 
regulator of columella stem cell differentiation in the root apical meristem and lateral root 
formation in the developing root (18, 19).  Loss of ACR4 function results in the proliferation 
of columella stem cells and a module involving interactions between the CLE40 peptide, 
ACR4 and a homeobox transcription factor, WOX5, has been proposed as a signaling 
mechanism that is similar to the CLV signaling pathway that mediates stem cell proliferation 
and differentiation in the apical meristem (19).  
Thus, ACR4 is a RLK whose functions are critical to the development of virtually the 
entire plant (15-19). Importantly, while genetic and cell biology studies have made it 
apparent that the RLK is important in cell fate specification, there is little or no knowledge of 
the biochemical basis of its function and its involvement in regulatory networks. In vitro 
biochemical and biophysical studies of recombinant proteins can often provide valuable clues 
towards an understanding of in vivo physiological functions. Indeed, detailed structural and 
mechanistic studies on a number of recombinantly expressed receptor kinase domains in both 
animal and plant systems have not only facilitated the development of useful biochemical 
models to validate in vivo functions but also fostered the development of various protein 
probes for the dissection of signaling pathways and isolation of interacting proteins. 
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However, such studies require adequate amounts of soluble protein.  To this end, we have 
successfully expressed milligram quantities of the intracellular domain (ICD) of ACR4 in 
fusion with the NusA protein in an E. coli system.  We have characterized the 
autophosphorylation activity, mapped the autophosphorylation sites by mass spectrometry 
and demonstrate that the RLK is a member of the RD family of kinases. 
 
Materials and Methods 
Construction of ACR4 Intracellular Domain (ICD) Expression Plasmid.   
The ACR4 intracellular domain, termed JKC (residues 456-895), was cloned into the 
pET-44b(+) (Novagen) which encodes an N-terminal NusA fusion tag, two 6X His tags, a 
Thrombin cleavage site, and an Enterokinase cleavage site. The ACR4 JKC was PCR 
amplified with primer 1 and primer 2 (Table I), cloned between the BamHI and Sal1 
restriction sites, and verified by DNA sequencing.  The plasmid, termed pNusA:JKC,  was 
used for subsequent protein expression. 
Preparation of the kinase inactive mutant plasmid was completed using the 
QuickChange Multi Site-Directed Mutagenesis Kit (Stratagene) by introducing point 
mutations into pNusA:JKC plasmid at codons encoding residues required for kinase activity.  
Mutagenic primer 3 mutated lysine 540 to alanine (K540A) and primer 4 mutated the 
catalytic aspartate 641 to alanine (D641A). The plasmid, termed pNusA:JKC2m,  was 
subsequently used for expression of the kinase inactive form of the ACR4 ICD, JKC2m. 
Activation loop mutations were similarly made using mutagenic primers 5 through 16 
described in Table I. 
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Protein Expression and Purification of NusA fused ACR4 JKC Proteins.   
The ACR4 JKC was expressed as a C-terminal fusion to the NusA solubility tag.  
Plasmids were transformed into chemically competent BL21 (DE3) pLysS (Promega) E. coli 
cells.  A 500 ml culture was supplemented with ampicillin (100 g/ml) and grown at 37 C, 
with shaking, to an OD600=0.6-0.8.  The temperature was then reduced to 20 C and protein 
expression induced with isopropyl-1-thio-β-D-galactopyranoside (IPTG) to a final 
concentration of 1 mM.  After 6h of incubation, the cells were harvested by centrifugation 
and the cell pellet was used immediately.  The pellet was resuspended in 10 ml of Lysis 
Buffer (1X TBS pH 7.5, 50 mM imidazole, 1% TritonX-100, 1 mM DTT) and supplemented 
with AEBSF (1 mM final concentration). The cell suspension was sonicated to release 
soluble fusion protein and the resulting lysate was centrifuged in a microcentrifuge at max 
speed for 25 min at 4 C.  The lysate was then incubated for 1h at 4 C in batch mode with 
0.5 ml bed volume of Ni2+ IMAC Sepharose High Performance resin (GE Healthcare) 
equilibrated with Lysis Buffer. After incubation, the lysate/resin mixture was added to a 10 
ml disposable chromatography column and the unbound material was allowed to flow 
through.  The resin was then washed with 10 ml of Wash Buffer (1X TBS pH 7.5, 50 mM 
imidazole, 0.1% TritonX-100, 1 mM DTT) and bound protein was successively eluted with 
2ml of Elution Buffer (50 mm Tris-HCl pH 8.0, 150 mM NaCl, 150 mM imidazole, 1 mM 
DTT). The final concentration of metal-affinity purified protein at this stage is typically 
greater than 6 mg/ml. 
A secondary gel filtration step was used to purify the NusA fusion proteins using an 
ÄKTA FPLC system (Amersham).  The metal affinity enriched fusion proteins were passed 
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through a Superdex G200 Global 10/30 column (GE Healthcare) equilibrated with column 
buffer (50 mM Tris-HCl pH 8.0, 150 mM NaCl, and 1 mM DTT).  Peak fractions 
corresponding to the fusion protein were collected, pooled, and concentrated.  The resulting 
purified proteins were used in further experiments.  
 Purification of JKC Proteins without tags.  
The affinity enriched protein sample (as described above) was treated with 1 U/3.5 
mg of Restriction Grade Thrombin (Novagen) for 20 min at room temperature. The cleavage 
reaction was then loaded onto a MonoQ Global 10/50 column (GE Healthcare) equilibrated 
with Anion Exchange Buffer (50 mM Tris-HCl pH 8.0, 1 mM DTT).   Cleaved ACR4 JKC 
was eluted off the column by gradient elution with Anion Elution Buffer (50 mM Tris pH 
8.0, 1 M NaCl, 1 mM DTT).  According to the ExPASy Proteomics Server, the calculated pI 
of the NusA tag is 4.83 and that of the JKC is 6.47. Peak fractions corresponding to the 
ACR4 JKC were collected, pooled, and concentrated. The resulting purified proteins were 
used in subsequent experiments.   Note, after cleavage the ACR4 JKC recombinant protein 
contains 20 extraneous amino acids encoded by the pET-44b(+) vector at the N-terminus. 
Antibodies.  
Polyclonal antibodies to the JKC protein were raised at the Hybridoma Facility at 
Iowa State University by repeated immunizations of rabbits with the highly purified antigen 
and purified IgG was prepared from whole serum by affinity chromatography.  Monoclonal 
antibody to the NusA tag was purchased from Novagen (EMD Chemicals, Gibbstown). This 
antibody specifically detects fusion proteins containing the NusA tag sequence expressed 
with the pET-44 vector series. 
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Circular Dichroism (CD) measurements.  
JKC purified from E. coli (naïve JKC) autophosphorylated JKC (pJKC), and JKC2m 
were dialyzed overnight at 4 C in 10 mM Tris-HCl, pH 7.4 and 0.1 mM TCEP and 
concentrated to an A280 value of approximately 1.0.  Far-UV spectrums of each protein were 
obtained on a Jasco J-710 spectropolarimeter, in a 0.1cm path-length cuvette with excitation 
wavelengths ranging from 190 nm-260 nm.   
Fluorescence Measurements.   
Naïve JKC, JKC2m, and pJKC were dialyzed in 10 mM Tris-HCl, pH 7.4 and 0.1 
mM TCEP and brought to a concentration of A280=0.1 prior to fluorescence scans.  
Measurements were made in a 1 cm cuvette at room temperature with a Cary Eclipse 
spectrofluorimeter (Varian).  Scans were executed at an excitation wavelength of 280 nm and 
a band width of 5 nm and a scan speed of 120 nm/min.   
Kinase Activity Assays.  
The optimal buffer condition for kinase activity was determined to be 20 mM BIS-
TRIS pH 7.2, 25 mM NaCl, 5 mM MnCl2, 1 mM DTT, 25 µM ATP and a temperature of  30 
˚C. This was established by performing individual reactions with 2 µg of NusA:JKC protein 
incubated in varying buffer conditions containing Mn2+ (0.05-50 mM), ATP (1-50 µM), DTT 
(0-10 mM) and NaCl (0-300 mM), in the pH range 5.8-8.8. All reactions were carried out in 
a 20 µl volume in the presence of 5 µCi of [γ32P]ATP (6000 Ci/mmol, Perkin-Elmer) and 
incubated for 1 hr at room temperature. Reactions were terminated by adding 6 µl 4X 
Laemmli buffer and boiled for 5 min. Proteins were resolved by 10% SDS-PAGE, gels 
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stained with Coomassie Brilliant Blue R-250, and then analyzed by exposure to an 
autoradiograph film or a phosphorimaging screen. 
Assays to determine the autophosphorylation mechanism were performed using the 
NusA:JKC and JKC proteins. A series of reactions was carried out containing increasing 
concentrations of NusA:JKC  in the range 0.2-3.4 M (or up to ~2.4 M in the case of JKC). 
The protein was incubated in 20 l reactions of optimized kinase buffer containing 2.5 Ci of 
[γ-32P]ATP.  Reactions were initiated with the addition of the enzyme and incubated for 15 
min at room temperature.  They were then terminated and treated as above. Protein bands 
were excised from the gel and radioactivity was determined by scintillation counting.  
Phosphate incorporation for each sample was calculated based on the radioactive counts and 
the use of a [γ-32P]ATP standard curve.  The data was then used to generate a van’t Hoff plot 
(log of enzyme activity vs log of enzyme concentration) and the intramolecular nature of the 
mechanism inferred from the slope of this plot. Kinetic data were fit using the Sigma Plot 
11.2 (Systat Software Inc., San Jose, CA) Enzyme Kinetics module (version 1.3) to 
determine Michaelis-Menten constants by non-linear regression analysis.  
In a parallel experiment, autophosphorylation assays were also performed 
independently with naïve NusA:JKC, JKC2m, or with both proteins incubated together.  
Incubations of the NusA tag alone or with either protein were used as controls for the assay.  
Each reaction was carried out with 2 µg of protein in optimized kinase buffer containing 5 
Ci of [γ-32P]ATP.  Reactions were allowed to proceed for 1h at room temperature and 
processed as above. To determine if the kinase could phosphorylate other exogenous 
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substrates, naïve NusA:JKC  was  incubated  with 2 µg of Myelin Basic protein (MyBP) and  
the phosphorylation reaction  carried out as described above. 
Analysis of Phosphorylation status.  
Two techniques were utilized to determine the phosphorylation status of JKC2m, 
naïve JKC and pJKC. One approach utilized the phosphoprotein stain, Pro-Q Diamond 
(Invitrogen).  Approximately 1 μg of each protein was separated by 12% SDS-PAGE. The 
gel was first fixed for 2x 30 min with solution containing 50% methanol and 10% acetic acid 
then washed three times with deionized water. It was then stained with Pro Q diamond stain 
for 90 min in the dark and then destained using 50 mM sodium acetate buffer pH 4.0 
containing 20% acetonitrile. Images of the stained gel were acquired on a Molecular 
Dynamics Typhoon scanner (Amersham Biosciences) with an excitation source of 532 nm 
laser and a 580 nm bandpass emission filter.     
In the second approach, phosphorylation was assessed by western blot analysis using a 
polyclonal, anti-phosphothreonine antibody (Cell Signaling Technology, #3981).  Briefly, ~1 
μg of each protein was separated by 12% SDS-PAGE followed by blotting to a PVDF 
membrane.  The membrane was blocked, probed with the primary antibody (1:1000), 
washed, and then probed with a secondary anti-rabbit IgG antibody (1:30,000) conjugated to 
alkaline phosphatase (Sigma).  Protein detection was completed using an AP Conjugate 
Substrate kit (Bio-Rad). 
Sample Preparation for LC-MS/MS Analysis.  
To prepare peptides, the proteins were concentrated by TCA precipitation and 
resuspended in 4 M urea in 50 mM NH4HCO3, pH 7.8.  Proteins were reduced with 10 mM 
TCEP for 30 min at 50 °C followed by alkylation with 20 mM iodoacetamide for 30 min at 
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room temperature in the dark.  50 mM NH4CO3, pH 7.8 was added to the sample to dilute 
urea to less than 1 M.  The protein was then digested with 1:50 (w/w, enzyme to substrate) 
Sequencing Grade Modified Trypsin (Promega) overnight at 37 °C.  The resulting peptides 
were desalted on a SOURCE 15 RPC column (GE Healthcare) and eluted in 90% 
acetonitrile, 0.1% TFA.  The eluted peptides were then dried down in a vacuum centrifuge.  
Phosphopeptides were enriched using the PHOS-Select Ga3+ Silica Spin Column kit 
(Supelco) according to the kit instructions. 
Peptides were eluted into autosampler vials with 60% acetonitrile in 1% formic acid. 
The quality of the peptide digests was assessed using MALDI-TOF mass spectrometry. The 
remaining sample was dried, dissolved in 25 µL of aqueous acetonitrile/formic acid 
(1%/1%), and analyzed by high resolution nano-LC-MS.  
High Resolution Mass Spectrometry.  
The complex peptide mixtures were analyzed using high-resolution nano-LC-MS on a 
hybrid mass spectrometer consisting of a linear quadrupole ion-trap and an Orbitrap (LTQ-
Orbitrap XL, Thermo Fisher Scientific). Chromatographic separations were performed using 
a NanoLC-1D™ Plus (Eksigent) for gradient delivery and a cHiPLC-nanoflex (Eksigent) 
containing a 15 cm x 75 μm C18 column (ChromXP C18-CL, 3 μm, 120 Å, Eksigent). The 
liquid chromatograph was interfaced to the mass spectrometer with a nanospray source 
(PicoView PV550; New Objective). The mobile phases were 1% formic acid in water 
(solvent A) and 1% formic acid in acetonitrile (solvent B). After equilibrating the column in 
98% solvent A and 2% of solvent B, the samples (5 µL) were injected from vials using the 
LC-system autosampler at a flow rate of 500 nL/min. The peptides were eluted at 250 nL/min 
with the following gradient: isocratic at 2% B, 0-3 min; 2% B to 50% B, 3-73 min; 50% to 
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80%, 73-83 min; isocratic at 80%, 83-86 min; 80% to 2%, 86-87; and isocratic at 2% B, 87-
102 min. The total run time, including column equilibration, sample loading, and analysis 
was 128 min. The survey scans (m/z 350-2000) (MS1) were acquired at high resolution 
(60,000 at m/z = 400) in the Orbitrap and the MS/MS spectra (MS2) were acquired in the 
linear ion trap at low resolution, both in profile mode. The maximum injection times for the 
MS1 scan in the Orbitrap and the LTQ were 50 ms and 100 ms, respectively. The automatic 
gain control targets for the Orbitrap and the LTQ were 5 x 105 and 3 x 104, respectively. The 
MS1 scans were followed by six MS2 events in the linear ion trap with collision activation in 
the ion trap (parent threshold = 1000; isolation width = 2.0 Da; normalized collision energy = 
30%; activation Q = 0.250; activation time = 30 ms).  Dynamic exclusion was used to 
remove selected precursor ions (-0.20/+1.0 Da) for 90 s after MS2 acquisition. A repeat 
count of 1, a repeat duration of 45 s, and a maximum exclusion list size of 500 was used. The 
following ion source parameters were used: capillary temperature 200 ºC, source voltage 3.5 
kV, source current 100 μA, capillary voltage 33 V, and the tube lens at 120 V.  The data were 
acquired using Xcalibur, version 2.0.7 (Thermo Fisher). For high resolution targeted analysis, 
the parent ions from an inclusion m/z list within a retention time window were selected for 
acquisition of peptide fragmentation spectra at 7500 resolution. MS/MS spectral acquisition 
was triggered with an isolation width of 4 Da when the signal for the ion of interest exceeded 
10,000 counts. The maximum injection times for the MS1 scan in the Orbitrap and the LTQ 
were both 500 ms, and the maximum injection times for the MSn scan in the Orbitrap and the 
LTQ were 750 ms and 1000 ms, respectively. The automatic gain control targets for the 
Orbitrap and the LTQ were 2 x 105 and 3 x 104, respectively for the MS1 scans and 1 x 105 
and 1 x 104, respectively for the MSn scans. The MS1 scan was followed by one MS2 event 
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with collision activation in the ion trap (parent threshold = 10000; isolation width = 4.0 Da; 
normalized collision energy = 30%; activation Q = 0.250; activation time = 30 ms).  The 
following ion source parameters were used: capillary temperature 200 ºC, source voltage 3.3 
kV, source current 100 μA, capillary voltage 34 V, and the tube lens at 125 V.   
Data Analysis.  
The MS2 spectra were analyzed by searching against the ACR4 sequence and expert 
manual interpretation. The exact masses of the phosphopeptide and fragmentation ions were 
calculated using the MS-Product utility within Protein Prospector 
(http://prospector.ucsf.edu).  For database searches, the LC-MS files were processed using 
MASCOT Distiller (Matrix Science, version 2.3.0.0) with the settings previously described 
(20). The resulting MS2 centroided files were used for database searching with MASCOT, 
version 2.1.6, against a custom, in-house database containing the ACR4 using the following 
parameters: enzyme, trypsin; MS tolerance = 15 ppm, MS/MS tolerance = 0.8 Da with a 
fixed carbamidomethylation of Cys residues and the following variable modifications: 
oxidation (Met) and phosphorylation (Ser, Thr, and Tyr); Maximum Missed Cleavages = 9; 
and 1+, 2+ and 3+ charge states. For analysis of the tandem spectra from spectral acquisitions 
in the Orbitrap (MS2), the raw files were processed using MASCOT Distiller (Matrix 
Science, Oxford, UK) with the following settings: 1) MS processing: 200 data points per Da; 
sum aggregation method; maximum charge state, 3+; minimum number of peaks, 1; 2) 
MS/MS processing: 200 data points per Da; time domain aggregation method; minimum 
number of peaks, 10; use precursor charge as maximum; precursor charge and m/z, “try to re-
determine charge from the parent scan (tolerance, 1.2 Da)”; charge defaults, 1; maximum 
charge state, 3) time domain parameters: minimum precursor mass, 300; maximum precursor 
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mass, 16,000; precursor m/z tolerance for grouping, 0.01; maximum number of intermediate 
scans, 0; minimum number of scans in a group, 1; 4) peak picking: maximum iterations, 500; 
correlation threshold, 0.60; minimum signal to noise, 2; minimum peak m/z, 50; maximum 
peak m/z, 100,000; minimum peak width, 0.002; maximum peak width, 0.2; expected peak 
width, 0.02. The resulting files were used for database searching with a fragment tolerance of 
100 mmu; all other search parameters are identical to those described above. 
Analytical Ultracentrifugation.  
Sedimentation velocity analysis of NusA:JKC, naïve and phosphorylated, was 
performed  on an XL-A analytical ultracentrifuge (Beckman Coulter).  The purified protein 
was dialyzed overnight at 4 C in 10 mM Tris-HCl pH7.4, 50 mM NaCl, and 0.1 mM TCEP.  
The protein sample was concentrated to an Abs280 = 0.6.  300 l of the sample was loaded 
into a preassembled Flow-Through Assembly housing an Epon, 2-channel centerpiece and 
quartz windows. The rotor and sample cell temperatures were allowed to equilibrate to 20 C 
for 2 h.  The sample was spun at 40,000 rpm, at 20 C for a total of 400 scans with a scan 
rate of 1 scan/min. Boundaries were monitored by recording the absorbance at 280nm.  Scan 
analysis was performed using van Holde - Weischet analysis (21) as implemented in the 
program Ultrascan 6. Sedimentation coefficients (S20, w) were corrected for 20 ˚C and water. 
Limited Proteolysis.  
Conformational difference between naïve JKC and pJKC proteins was probed by 
limited proteolysis using trypsin.  The naïve protein was purified as described above and 125 
g of the protein was diluted into 200 l volume containing 50 mM Tris-HCl pH 8.0, 1 mM 
CaCl2, 1 mM DTT.  Trypsin (Promega) was added at a 1:1000 w/w, protease:substrate  and  
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incubated at room temperature.  25 l aliquots were removed at predetermined time points 
and the reaction stopped by the addition of 6 l of 4X SDS sample buffer and boiling for 5 
min.  For pJKC, 125 g of the protein was first incubated in a 200 l reaction containing 1X 
kinase buffer and 100 M ATP for 90 min. Subsequently, 5 l of 2 M Tris-HCl pH 8.0 was 
added to adjust the pH to 8.0 followed by 1 l of 0.2 M CaCl2 to a final concentration of 1 
mM. The digestion reaction was then carried out as described above.  Protein samples (~0.5 
μg/lane) were separated by 7% SDS-PAGE and gels were silver stained using the 
SilverSNAP stain kit from Pierce (Rockford,Ill). 
 
Results 
Expression, Purification and Characterization of JKC.  
The intracellular domain (ICD) of ACR4 (residues 456-895) may be subdivided into 
the juxtamembrane domain (JM), kinase domain (KD) and the carboxy-terminal domain 
(CTD).  Using the NusA protein as the fusion partner we have expressed and purified 
milligram quantities of the ICD for biochemical characterization.  Fig. 1A shows the SDS-
PAGE analysis of protein fractions during various steps in the purification of the NusA:JKC 
(lane 3) and JKC (lane 5) from E. coli cells (as described in Materials & Methods). 
Approximately 6 mg of soluble NusA:JKC and <0.25 mg of JKC protein were obtained from 
a 500 ml culture. Similar yield was obtained for the inactive mutant (JKC2m). The identities 
of the proteins were confirmed by western blots probed with rabbit polyclonal antibodies 
raised against the JKC (Fig. 1B) and antibody to the NusA tag (Fig. 1C). These blots validate 
the homogeneity of the protein preparation and demonstrate the absence of co-purification of 
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non-full length NusA-tagged proteins. The identity of the purified JKC protein was also 
confirmed by MALDI-MS analysis of tryptic peptides of the excised protein band (data not 
shown).  
The far-UV CD spectrum of the JKC (Fig. 2A) is similar to that reported for other 
examples of recombinantly expressed kinase domains of receptor tyrosine kinases (22, 23). 
The three-dimensional structures of several kinase domains show a number of helices and the 
observed CD spectrum for naïve JKC (combined with the robust catalytic activity described 
below) strongly supports the preservation of an ordered structure.  Typical α-helical 
structures display negative bands at 208 nm and 222 nm. The more negative molar ellipticity 
value at 208 nm could be attributed to contributions from the juxtamembrane and carboxy-
terminal regions of the molecule as well as the 20 extraneous amino acids at the N-terminus 
encoded by the pET-44b(+) vector (see Materials & Methods). Fluorescence spectroscopy 
(Fig. 2B) shows almost identical profiles for both the mutant and naïve proteins with an 
emission maximum at 342 nm, consistent with the tryptophan residues being located in 
similar environments.  
Preliminary evidence for the ability of the ICD to oligomerize was obtained during 
the purification of the metal-affinity enriched NusA:JKC protein by size exclusion 
chromatography. Typically, at the affinity-enrichment step, the protein concentration is > 6 
mg/ml and is subsequently diluted to ~ 2 mg/ml (~18 µM) for batch-wise purification by gel 
filtration on a Superdex G200 column. As shown in Fig. 3, in addition to eluting as a 
monomer (peak at ~12.5 ml volume), a small proportion of the protein elutes as an aggregate 
in the void volume.  Analysis of these fractions by SDS-PAGE (inset A) indicates that the 
void volume fraction consists entirely of aggregates of the monomer. An 
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autophosphorylation assay of the aggregate fraction indicated that no kinase activity  could 
be detected in comparison with that of the monomer fraction (inset B). It is also worth noting 
that the propensity for oligomerization may be concentration dependent since little or no 
aggregate is observed in gel filtration experiments at protein concentrations below ~1.5 µM 
(data not shown). 
The self-association of naïve NusA:JKC was also monitored by sedimentation 
velocity experiments. During sedimentation velocity, homogeneous non-interacting 
molecules will sediment with discrete sedimentation coefficient (S) values whereas 
interacting molecules that lead to higher order oligomers will show a broad distribution of 
sedimenting species.  Fig. 4A shows the percent distribution of species (plotted as diffusion 
corrected sedimentation coefficients) along the sedimentation boundary in velocity 
sedimentation experiment for naïve NusA:JKC. Approximately 60% of the protein 
sedimented with an S20,w value of 4 with the remaining 40% showing a considerably wider 
range of much higher S values, commensurate with association to heterogeneous polymeric 
species. We also analyzed the data by the Van Holde-Weischet method (21) (Fig. 4B). In this 
analysis, the sedimenting boundary is first divided into a number of segments and the data fit 
by linear least square analysis to the apparent sedimentation coefficient of each boundary 
segment.  Extrapolation to the y-axis then yields the diffusion-corrected sedimentation 
coefficient for that boundary segment. Typically, a homogeneous sample would be expected 
to have the same sedimentation coefficient as a function of time in all parts of the boundary 
and the extrapolated lines for the various segments should converge to a single value at the y-
axis (24).  It is also clear by this method of analysis that the naïve protein shows a distinct 
propensity to aggregate to species with S values >4.  The NusA protein is not known to 
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dimerize (25-28) and we also did not see any evidence of dimerization with the 
recombinantly expressed NusA protein (data not shown).  In contrast, after 
autophosphorylation the protein does not aggregate and shows a predominantly 
homogeneous monomeric species sedimenting with an S20,w value of ~4 (Fig. 4 C, D). We 
were unable to perform sedimentation velocity experiments with the protein minus the NusA 
tag owing to inadequate recovery of soluble protein. 
Kinase activity of NusA:JKC.  
Interestingly, as observed for some of the other RLK’s characterized so far (29-31) 
the recombinantly expressed ACR4 ICD as a NusA fusion protein prefers Mn2+ over Mg2+ as 
the metal ion for autophosphorylation, although the precise physiological significance of this 
is not obvious.  A linear increase in phosphorylation activity is seen with Mn2+ 
concentrations ranging from 0.1 to 5 mM, with maximal activity occurring at 5 mM and 
quenching at higher concentrations of the metal ion (Fig. 5A). A similar linear relationship is 
seen with Mg2+ but much higher concentrations of Mg2+ are required to achieve activity 
comparable with Mn2+ as the divalent cation i.e., 1 mM Mn2+ versus 50 mM Mg2+ (Fig. 5A). 
This is further illustrated in Fig. 5B that shows an autoradiogram of the kinase activity in the 
presence of 10 mM concentrations of Mg2+, Mn2+ and Ca2+.  No activity is observed with Ca2+ 
and the activity with Mg2+ is significantly less.   In the presence of Mn2+ the reaction is 
completed in 60 min (for JKC as well) (Fig. 5C) at 30 ˚C at an optimal pH of 7.2 in 20 mM 
BIS-TRIS buffer containing 1 mM DTT and 25 mM NaCl (Fig. 5D). The enzyme displays 
typical Michaelis-Menten kinetics with respect to ATP (Fig. 5E) and analysis of the ATP 
dependence for autophosphorylation by fitting the data to the Michaelis-Menten equation 
(using the Enzyme Kinetics Module on SigmaPlot 11.2)  revealed the Km and Vmax for ATP 
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to be 6.68 ± 1.62 M and 193.8 ± 15.14 pmole/min/mg, respectively. The apparent Km for 
ATP is also comparable with that observed for other RLKs (29, 30).  Since the native 
substrate for ACR4 kinase is yet to be determined, we used Myelin Basic Protein (MyBP) as 
a model substrate in an assay to assess the ability of the kinase to phosphorylate exogenous 
proteins. As indicated in Fig. 5F (lane 2), MyBP is phosphorylated by NusA:JKC. 
Autophosphorylation occurs through an intramolecular mechanism.  
Autophosphorylation reactions of kinases can proceed either through an 
intramolecular mechanism (first order with respect to enzyme concentration) or an 
intermolecular mechanism (second order with respect to enzyme concentration). We used 
two approaches to ascertain the mechanism of activity of NusA:JKC. First, we conducted a 
series of kinase reactions using increasing concentrations of NusA:JKC in the range 0.1-3.4 
M. As shown in Fig. 6A, the rate of autophosphorylation was linear with respect to enzyme 
concentration and the amount of phosphate incorporation per molecule remained fairly 
constant over two-orders of magnitude difference in protein concentration (Fig. 6B).  The 
van’t Hoff analysis (plot of logarithm of phosphorylation rate versus logarithm of enzyme 
concentration, with the value of the slope indicating the order of the reaction) gave a slope of 
1.05 ± 0.05 and a correlation coefficient of 0.97 for the linear regression (Fig. 6C), 
suggesting an intramolecular mechanism. Similar results were obtained in assays performed 
with the JKC minus the NusA tag (Fig. 6D-F) and the van’t Hoff plot yielded a slope of ~1.2 
(Fig. 6F).  Importantly, the lower specific activity of JKC in the concentration range 
employed (Fig. 6E) and the decreased solubility of the protein at higher concentrations, 
attests to the stabilizing influence of the NusA tag on the activity of the enzyme. For further 
confirmation of the intramolecular mechanism, we performed kinase assays by incubating the 
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active NusA:JKC with the inactive mutant JKC2m to determine if the latter could be 
phosphorylated. As shown in Fig. 7, panel A, the NusA:JKC could undergo 
autophosphorylation (lane 1) and also phosphorylate the NusA tag (lane 4) but could not 
phosphorylate the inactive mutant (lane 3). The reduced activity of NusA:JKC in lane 3 may 
potentially be attributed to the formation of a less active heterodimer between the wild-type 
and mutant protein. Taken together with the kinetic data, this strongly suggests that the 
dominant mechanism of autophosphorylation is intramolecular.  
Mapping of autophosphorylation sites.  
The data-dependent tandem mass spectrometric analysis of the tryptic peptides and 
searching against ACR4 protein sequence revealed several phosphopeptides. The identified 
phosphopeptides encompassed all the subdomains of the ICD (Fig. 8A). Determination of the 
exact site of phosphorylation within the phosphopeptides was performed by inspection of 
their fragmentation pattern for specific diagnostic site-determining yn and bn ions (32). As an 
example, the collisionally induced tandem mass spectrum for the phosphopeptide 
533DG(pT)TVAVK540 is shown in Fig. 8B. The most prominent ion is the doubly charged 
[M+2H-98]2+ species at a m/z of 386.71. This is characteristic of a neutral loss of phosphoric 
acid by which phosphorylation sites are identified. An unambiguous confirmation of Thr535 
as the phosphorylated residue was afforded by the presence of the phosphorylated b3 
(theoretical m/z 354.1; observed 354.1) and y6 (theoretical m/z 698.3; observed 698.2) ions, 
along with non-phosphorylated b2 (theoretical m/z 173.1; observed 173.1) and y5 (theoretical 
m/z 517.3; observed 517.3) ions. Table II summarizes the site-determining ions for 16 
peptides with confirmed phosphorylation at amino acid residues Ser475, Thr478, Thr501, 
Ser516*, Ser522*, Thr535, Thr536, Ser552, Thr557, Ser563*, Ser644, Ser645, Thr831, Ser837*, Ser875 and 
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Ser888* (Fig. 8A).  Five of these confirmed residues, indicated with an asterisk, are also found 
in the naïve JKC and represent the basal phosphorylation state of the protein expressed in E. 
coli.  One additional phosphorylation site in the naïve protein, is located at either Ser811* or 
Ser812* in the peptide 788ALAQLMGNPSSEQPILPTEVVLGSSR813 (theoretical mass 
including phosphate group, 2789.34; observed [M+3H]3+, m/z 930.79). Specific y-series ions 
were obtained showing phosphorylation at the C-terminal end of the peptide but no site-
determining ions were obtained in the fragmentation spectrum to distinguish between the two 
serine residues.  
In addition to these 16 confirmed sites, we identified parent ions with m/z values 
corresponding to 2 other peptides, each supporting one phosphorylation site. The peptide, 
852SSASEGDVAEEEDEGR867 (theoretical mass including phosphate group, 1745.63; 
observed [M+2H]2+, m/z 873.82) could potentially be phosphorylated at any one of the three 
serine residues, Ser852, Ser853 or Ser855.  However, an exact assignment of the site was not 
possible since the fragmentation pattern did not reveal the characteristic b and y series of 
ions. Similarly, the mass spectrum of the 35-residue tryptic peptide, 
657VADFGLSLLGPVDSGSPLAELPAGTLGYLDPEYYR691 (Fig. 8C) (theoretical mass 
including phosphate group, 3731.81; observed [M+3H]3+, m/z 1244.94), while supporting the 
presence of  one phosphorylated residue among the multiple phosphorylation sites (Ser663, 
Ser670, Ser672, Thr681, Tyr684, Tyr689, Tyr690) did not yield the expected set of diagnostic ions 
in the fragmentation spectrum and hindered a precise localization of the phosphorylated 
residue. Nevertheless, we were able to narrow down the location to either Ser670 or Ser672 on 
the basis of a series of y and b ions without a phosphate group. Thus, Thr681, Tyr684, 
Tyr689and Tyr690 can be eliminated as potential sites based on the [M+H] y ions y5 (m/z 
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727.341), y6 (m/z 842.367), y8 (m/z 1118.513), y9 (m/z 1175.533) and y14 (m/z 1614.782). The 
m/z values clearly indicate the absence of a phosphate group. Similarly, the b ions, b9 (m/z 
916.510) and b10 (m/z 973.530) do not support Ser663 as a phosphorylation site (Fig. 8C).  
We also assessed the phosphorylation levels of the mutant, naïve and phosphorylated  
JKC proteins by staining with Pro-Q Diamond, a phosphospecific stain, and western blot 
analysis using anti-phosphothreonine antibody.  Commensurate with data from 
phosphorylation analysis by mass spectrometry that showed many more phosphorylated 
residues for the pJKC protein compared with the naïve protein, staining with ProQ Diamond 
showed a very intense band for the autophosphorylated protein (pJKC) and a much weaker 
intensity band for the naïve JKC (Fig. 9A). Only a faint band could be seen for the mutant, as 
would be expected from an inactive protein undergoing little or no phosphorylation. In the 
western blot analysis with anti-phosphothreonine antibody, pJKC showed a band of high 
intensity and the naïve protein barely registered a band (Fig. 9B).  This correlates well with 
the observation that all observed phosphorylated sites in the naïve protein are located 
exclusively on serine residues (Ser516*, Ser522*, Ser563*, Ser 811* or 812*, Ser837* and Ser888*) 
whereas pJKC has at least six confirmed phosphorylated threonine residues (Thr478, Thr501, 
Thr535, Thr536, Thr557, Thr831). 
ACR4 RLK belongs to the RD family of kinases.  
Significantly, the large tryptic peptide 
657VADFGLSLLGPVDSGSPLAELPAGTLGYLDPEYYR691 also includes the activation 
loop sequence (the double-underlined residues in between residues DFG and DPE 
respectively in Fig. 8A).  It is known that autophosphorylation of specific residue(s) within 
the activation segment is a critically important regulatory element, and necessary for kinase 
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activity, in many kinases belonging to the Ser/Thr family subgroup (that includes plant 
kinases and plant RLKs), and the Tyr kinase family subgroup (33-37). This is a characteristic 
feature of kinases belonging to the RD family, which contain an Arg residue preceding the 
invariant catalytic Asp (Fig. 10). Crystal structures of RD kinases indicate that 
phosphorylation in the activation segment promotes a conformational change driven by 
electrostatic interactions between the negatively charged phosphorylated residue and a cluster 
of conserved basic residues, including the Arg residue in the RD motif.  This conformational 
change reorients the catalytic and substrate binding residues and presents an optimal spatial 
environment for substrate binding and catalysis. The presence of the RD motif in the ACR4 
kinase domain and evidence of phosphorylation of a Ser residue in the activation segment 
strongly suggest that ACR4 RLK is an RD kinase. To further correlate phosphorylation of 
the activation loop and kinase activity, we conducted autophosphorylation assays with site-
directed mutants in which each of the residues  Ser663, Ser670, Ser672, Thr681 and Tyr684 was 
replaced separately with either an alanine, which cannot be phosphorylated (Fig. 11A), or an 
aspartic acid (Fig. 11B), which mimics phosphorylation. The kinase activity of the S663A 
mutant was indistinguishable from that of the wild type protein but the S663D mutation 
abolished all activity, suggesting that a negatively charged amino acid was unacceptable at 
this position but also simultaneously discounting the likely role of Ser663 as a substrate. With 
regard to Ser672, the fact that neither mutation, S672A nor S672D, changes the kinase activity 
makes it quite unlikely that it is a favored phosphorylation site.  In contrast, the activity of 
the S670A mutant is significantly knocked down but vigorously restored in the S670D 
mutant, even though aspartic acid itself is not a substrate for the kinase. This suggests that a 
negative charge at position 670 is necessary for kinase activity and that this requirement is 
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fulfilled by phosphorylation of Ser670, the most likely candidate residue for phosphorylation. 
Interestingly, complete loss of autophosphorylation activity is observed when Thr681 is 
mutated to either an alanine or an aspartic acid indicating that the loss of activity is not linked 
to the property of the introduced amino acid but is directly attributable to the removal of Thr 
residue.  Importantly, the fact that even the introduction of a negative charge via an aspartate 
as a phosphomimetic does not restore kinase activity implicates Thr681 as a structurally 
important residue (38), in keeping with the tight conservation of this amino acid across a 
number of RLKs (Fig. 10). However, the conserved threonine, Thr760, in the Symbiosis 
Receptor Kinase, SYMRK, (39) and Thr468 in the Arabidopsis thaliana somatic 
embryogenesis receptor-like kinase, AtSERK1, (40) have also been shown to undergo 
phosphorylation in vitro. The complete loss of activity seen when Tyr684 is replaced with Phe, 
Asp, Ser or Thr, attests to the importance of non-phosphoamino acid interactions in 
maintaining the spatial orientations of the activation and catalytic loops in the kinase domain 
(38). 
Autophosphorylation induces a conformational change.  
The "conformational plasticity" and structural modifications of kinases in response to 
phosphorylation and dephosphorylation is well-documented in the literature (41-43). We 
have addressed structural perturbations propagated through phosphorylation of the JKC using 
spectroscopy and limited proteolysis, all techniques that are particularly sensitive to 
conformational changes in proteins (44, 45). Thus, the CD spectrum of pJKC (16 confirmed 
phosphorylated residues) in the far-UV region (Fig. 3A) is indicative of an alteration in the 
secondary structure of the protein towards a less compact state in comparison with the naïve 
form (5 confirmed phosphorylated Ser residues) and the mutant protein that is unlikely to 
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contain any phosphorylated residues based on the Pro-Q Diamond staining described earlier. 
In addition, numerous studies have demonstrated that tryptophan fluorescence in proteins is a 
sensitive probe of folding and tertiary structure and quite revealing of changes in the 
microenvironment of aromatic residues (46, 47). In comparison with the fluorescence spectra 
of naïve  JKC and JKC2m mutant (Fig. 3B),  the intensity of the intrinsic tryptophan 
fluorescence of the pJKC was observed to decrease significantly, accompanied by a blue-
shift in the λmax of emission (from 342 nm to 338 nm) and the appearance of a shoulder at 
310 nm, attributable to tyrosine fluorescence. Limited proteolysis is also a well-established 
technique for probing protein conformation and dynamics and relies on the fact that 
proteolysis occurs at sites with enhanced local flexibility (48-50). Well-folded regions within 
proteins usually resist protease digestion and, therefore, the protected fragments remaining 
after trypsin digestion represent stably folded domains. The digestion patterns of naïve JKC 
and pJKC with trypsin as a function of time (Fig. 12) provide additional evidence of 
phosphorylation induced conformational change. Whereas with naïve JKC, undigested 
protein could be detected through the first 10 minutes of incubation with trypsin (Fig. 12A), 
there was little evidence of undigested protein in the case of pJKC after the first 2.5 to 5 
minutes (Fig. 12B) and there was significantly faster accumulation of the ~37 kDa protein, 
presumably the kinase domain, as indicated by western blot analysis (data not shown). 
 
Discussion 
In this study we have demonstrated that the ACR4 intracellular domain encodes a 
functional kinase that undergoes autophosphorylation on 16 confirmed sites, 2 of which 
occur in the juxtamembrane domain, 10 in the kinase domain and 4 in the carboxy-terminal 
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domain. However, as noted earlier, there is evidence for three other unconfirmed 
phosphorylation sites. Owing to sub-stoichiometric representation of phosphopeptides, it is 
quite likely that additional phosphorylated residues may have gone undetected in our LC-
MS/MS analysis.  Regulation of kinase activity and recruitment of downstream interacting 
proteins via multiple sites of phosphorylation is a common feature of animal RTKs, as 
exemplified by EGFR (5, 6, 51). Their occurrence in many plant RLKs (52) suggests a 
conserved mechanism of control of signal transduction processes across the two kingdoms. 
In the RTKs, for example, phosphorylated residues in the juxtamembrane and carboxy-
terminal regions not only serve a regulatory role (41, 53) but act as docking sites for specific 
signaling molecules such as those containing Src homology 2 (SH2) domains or 
phosphotyrosine-binding (PTB) domains (54-56).  Phosphorylation of Ser/Thr residues also 
creates binding surfaces for diverse phosphoamino acid binding modules such as the 14-3-3, 
WW and Forkhead-associated (FHA) (57, 58). The 14-3-3 modules are well represented in 
the Arabidopsis genome (59-61). An example of the FHA containing module in Arabidopsis 
is the kinase-associated protein phosphatase (KAPP). KAPP binds to phosphorylated Ser/Thr 
residues of several plant RLKs such as CLAVATA 1 (CLV1), SERK1, HAESA and FLS2 
and acts as a negative regulator of receptor signaling (62-65). The phosphorylated Ser and 
Thr residues in the ACR4 juxtamembrane and carboxy-terminal domains of ACR4 could 
very well serve as docking sites for similar interacting proteins.  
Many protein kinases also achieve maximal enzymatic activity only after 
phosphorylation of specific residues in the activation loop sequence that occurs between 
subdomains VII and VIII of the kinase domain (66). In some RD kinases among plant RLKs, 
activation loop phosphorylation is essential for both autophosphorylation and substrate 
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phosphorylation. Thus, in BRI1, the mutation T1049A abolishes autophosphorylation and 
substrate phosphorylation in vitro and the mutant is also unable to rescue the weak bri1-5 
Brassinolide insensitive mutant in planta (37). In the activation segment sequence alignment 
the correspondingly conserved residue in SYMRK (Thr760) is phosphorylated in vitro and the 
Ala mutant has little or no autophosphorylation or substrate phosphorylation activity (39). 
Similarly, the conserved Thr468 in AtSERK1 is important for both autophosphorylation and 
phosphorylation of artificial substrates in vitro (36). The strict conservation of Thr at this 
position in the activation segment of RD-type RLKs (Fig. 10) suggests that it may be an 
important in vivo phosphorylation site. In ACR4, the equivalent residue Thr681 does not 
appear to be phosphorylated by LC-MS/MS analysis but our mutagenesis experiments clearly 
demonstrate that it is required for in vitro kinase activity. This result, however, does not 
preclude the possibility of Thr681 being phosphorylated in vivo. Importantly, as in the case of 
BRI1, SYMRK and AtSERK1, additional phosphorylation sites within the activation 
segment of RD-type RLKs that are not conserved in the sequence alignment appear to be 
required for activation and function. Presumably, multiple phosphorylations induce 
conformational changes that regulate binding sites for ATP and other substrates (67).  
Intriguingly, in addition to regulating kinase activity, phosphorylations in the activation 
segment can also facilitate recruitment of downstream partners, as in the case of the 
interaction between the SH2 domain of the adaptor protein APS and the phosphotyrosines in 
the activation loop of the insulin receptor kinase (68, 69). In another interesting example, in 
the extracellular signal-regulated kinase (ERK), phosphorylation-dependent conformational 
changes in the activation loop affect the subcellular localization of the protein (70) 
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It appears likely that autophosphorylation induced conformational changes also affect 
the gross structure of the intracellular domain. Thus, molecular interactions within the JKC, 
involving both the juxtamembrane and the carboxy-terminal domains, could hold the 
molecule in a 'closed' conformation and the release of these interactions upon 
phosphorylation, results in a more 'open' conformation. Some support for this comes from the 
limited proteolysis experiment that shows a relatively faster accumulation of the 37 kDa 
kinase domain after phosphorylation. Indeed, in the case of BRI1, the carboxy-terminal 
region negatively regulates BRI1 function and deletion of this region enhances kinase 
activity (71). Even in RTKs, proximal regions to the catalytic domain are known to play vital 
roles in kinase activation mechanisms. In several receptors such as the ephrin binding 
receptor (EpH) family, platelet-derived growth factor (PDGF) receptor family and epidermal 
growth factor receptor (EGFR) family, the juxtamembrane domain is a major regulatory 
domain (72-75). Similarly, the domain on the carboxyl side of the kinase domain can be 
autoinhibitory as has been demonstrated for EGFR and the receptor TIE2, an RTK that is 
activated by angiopoietin-1 (76, 77).   
The classical paradigm of receptor kinase function invokes ligand binding, followed 
by dimerization of the receptor, concomitant conformational change and activation of the 
kinase domain by cis- (intramolecular) or trans- (intermolecular) autophosphorylation (1, 2). 
The ligand for ACR4 is as yet unknown, but here we report that the autophosphorylation of 
NusA:JKC occurs through an intramolecular mechanism, a property associated with similar 
domains from RLKs such as the XA21 involved in rice disease resistance (78), BRI1 
(Brassinosteroid Insensitive 1) an essential receptor controlling plant development (31), and 
CrRLK1 from the plant Cantharanthus roseus (30). This would suggest that ligand mediated 
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dimerization may not be essential for activation of kinase activity. However, in vivo, 
alternative modes of activation remain distinctly viable. It is conceivable that ligand binding 
to the extracellular domain of ACR4 induces a conformational change in its intracellular 
domain that enables subsequent interaction with a second kinase (membrane bound or 
soluble) that is capable of trans-phosphorylating at a specific site on the ACR4 intracellular 
domain and 'activating' an intramolecular autophosphorylation event. In Arabidopsis, 
candidate proteins that could be involved in such interactions include the CRINKLY4-related 
(CRR) proteins (13) and the receptor like kinase, ABNORMAL LEAF SHAPE 2 (ALE2) 
(79). The four CRR proteins found in Arabidopsis, AtCRR1, AtCRR2, AtCRR3 and 
AtCRK1 share similar structural features with ACR4 but only AtCRK1 encodes a kinase 
domain with phosphorylation activity in an in vitro assay (13). It is possible that receptor 
activation and autophosphorylation of ACR4 kinase could be stimulated by heteromeric 
interactions with the AtCRR proteins. Evidence for the involvement of ACR4 and the 
AtCRRs in a common signal transduction pathway, perhaps mediated by heterodimerization, 
comes from the observation that, in vitro, the ACR4 kinase domain can phosphorylate the 
inactive kinase domain of AtCRR2 (13).  Similarly, genetic studies indicate that pathways 
involving ALE2 and ACR4 might act positively to regulate the specification of the 
protoderm and/or protoderm specific genes in the formation of leafy organs (79).  
Intriguingly, in in vitro experiments, the kinase domains of ACR4 and ALE2 can also 
phosphorylate each other (79).  
Our experiments suggest that the intracellular domain of ACR4 possesses an intrinsic 
propensity to form higher order oligomers, although the precise contributions of the JM 
region and the CTD remain to be ascertained in future experiments. The fact that the NusA 
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protein itself does not dimerize, rules out the possibility of any influence of the NusA tag on 
the oligomerization of the JKC. The significance of this observation in the context of ACR4 
function remains to be established in more detailed molecular studies both in vitro and in 
vivo.  In animals, in addition to ligand-induced dimerization, RTKs such as NGFR, EGFR 
and the erythropoietin receptor can exist as preformed dimers even in the absence of ligand 
(80-84).  Furthermore, in the case of EGFR, the juxtamembrane domain is required for 
dimerization of the cytoplasmic domain (85). Among RLK’s, BRI1 (86-88) and the S-locus 
receptor kinase (89) have been shown to exist as ligand-independent dimers but structural 
features contributing to the dimerization process are unknown.  The precise mechanism of 
productive oligomer formation and activation among plant RLKs is not completely 
understood and could vary among the receptor subclasses. However, in the case of BRI1, 
biochemical and genetic evidence has been provided for a model in which ligand binding 
activates a pre-exisiting BRI1 dimer which then associates with the co-receptor BAK1 and 
transphosphorylates key residues in the kinase domain, followed by reciprocal 
transphosphorylation  of BRI1 by the activated BAK1 (90).  
The sedimentation velocity experiments also demonstrate that autophosphorylation of 
NusA:JKC prevents oligomerization, perhaps attributable to electrostatic repulsions between 
negatively charged phosphorylated residues on the protein. However, the large size of the 
NusA tag, and the fact that it also is phosphorylated, precludes an unambiguous 
interpretation of the precise effect of autophosphorylation on the association-dissociation 
properties of the intracellular domain.  
In conclusion, in this study we describe for the first time the biochemical properties of the 
intracellular domain of ACR4 and provide key insights into its phosphorylation kinetics.  
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Ongoing and future experiments in our laboratory will address more detailed molecular 
analyses to delineate the role of the subdomains in ACR4 structure and function, interactions 
with putative partners, and mutational analysis of phosphorylation sites. Mutating different 
phosphorylation sites within ACR4 could have strikingly different effects including changes 
in receptor function, changes in receptor stability/turnover and changes in subcellular 
localization. Clearly, the identification of the physiological substrates of the kinase and in 
vivo phosphorylation sites are essential to understanding the signaling pathway mediated by 
ACR4. Our in vitro studies will complement genetic approaches and contribute to an overall 
understanding of ACR4 function in plants. 
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Table 1. Primers used in cloning and mutagenesis experiments. 
 
 
         
Primer   
           
Mutation Sequence (5' > 3') 
1 - GTGGTGGTGGATCCGAGGTACAGATTGAGGAATTG 
2 - GCGCGTCGACTCAGAAATTATGATGCAAG 
3 K540A CCACTGTTGCAGTGGCGAGAGCGATAATGTC 
4 D641A CTCCCGTGATTCACCGGGCCATTAAATCATCAAACATTC 
5 S663A GCTGATTTTGGTCTCGCCTTACTTGGTCCTGTCG 
6 S670A CTTGGTCCTGTCGATGCCGGCTCTCCTTTGGC 
7 S672A  CCTGTCGATAGCGGCGCTCCTTTGGCAGAAC 
8 T681A  GAACTACCAGCAGGAGCTCTCGGTTACCTTG 
9 Y684F  GCAGGAACTCTCGGTTTCCTTGATCCCGAGTAC 
10 T681D  GAACTACCAGCAGGAGATCTCGGTTACCTTG 
11 Y684D GCAGGAACTCTCGGTGACCTTGATCCCGAGTAC 
12 Y684S GCAGGAACTCTCGGTTCCCTTGATCCCGAGTAC 
13 Y684T GCAGGAACTCTCGGTACCCTTGATCCCGAGTAC 
14 S663D GCTGATTTTGGTCTCGACTTACTTGGTCCTGTCG 
15 S670D CTTGGTCCTGTCGATGACGGCTCTCCTTTGGC 
16 S672D CCTGTCGATAGCGGCGATCCTTTGGCAGAAC 
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Table 2. Site-discriminating ions for phosphorylated residues (in red) in phosphopeptides. 
The percentage of maximum intensity for each site-discriminating ion in the averaged high 
resolution CID spectrum are shown in parenthesis (supporting ion information is available 



























ion y ion 
Phosphorylated y 
ion 
471SSKDSAFTK479 b4 (+1, 0.14) b5 (+1, 27.6 ) y4 (+1, 1.14) y5 (+2, 1.62) 
474DSAFTKDNGK483 b4 (--) b5 (+1, 4.9) y5 (+1, 10.7) y6 (+2, 2.5)
499VFTYEELEK507  b2 (+1, 6.04) b3 (+1, 5.77) y6 (+1, 12.82) y7 (+1, 22.62) 
508AADGFKEESIVGK520 b8 (+1, 0.77) b9 (+1, 1.07) y4 (+1, 0.45) y5 (+1, 0.54) 
508AADGFKEESIVGKGSFSCVYK528 b14 (+2, 0.82) b15 (+2, 3.92) y6 (+1, 6.07) y7 (+1, 1.85) 
533DGTTVAVK540  b2 (+1, 1.54) b3 (+1, 1.34) y5 (+1, 097) y6 (+2, 2.91) 
533DGTTVAVK540 b3 (+1, 2.03) b4 (--) y4 (+1, 3.51) y5 (+1, 1.79) 
549QKNSNEFR556 b3 (+1, 0.31) b4 (--) y4 (+2, 2.50) y5 (+2, 1.46) 
551NSNEFRTELDLLSR564 b6 (+1, 0.71) b7 (+1, 2.59) y7 (+1, 3.33) y8 (+1, 0.55)
557TELDLLSR564 b6 (+1, 3.16) b7 (+1, 3.64) y1 (--) y2 (--) 
641DIKSSNILIDEEHNAR656 b3 (+1, 2.82) b4 (+1, 2.63) y12 (+3, 8.75) y13 (+2, 26.46)
641DIKSSNILIDEEHNAR656 b4 (+1, 3.62) b5 (--) y11 (+2, 9.37) y12 (+2, 6.06) 
826SGSENTEFR834 b5 (+1, 2.38) b6 (+1, 0.42) y3 (+1, 5.06) y4 (+1, 5.44) 
835GGSWITFPSVTSSQR849 b2 (--) b3 (--) y12 (+2, 5.39) y13 (+2, 4.55) 
875SLEEEIGPASPGQSLFLHHNF895 (--) b1 (--) y20 (+2, 0.15) y21 (--) 
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Figure 2.  Conformational analysis of JKC proteins. (A)  Far-UV CD spectra of the inactive 
JKC2m, naïve JKC, and autophosphorylated pJKC in 10 mM Tris, pH 7.4 and 0.1 mM TCEP 
with an A280 value of ~1.0. (B)  Intrinsic fluorescence spectra of JKC2m, JKC, and pJKC in 
the same buffer with an A280 of 0.1.  Measurements were made in a 1cm cuvette at room 
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Figure 4. Sedimentation velocity analysis of NusA:JKC (panel A) and 
autophosphorylatedNusA:JKC (panel C) performed on an XL-A analytical ultracentrifuge 
using a protein sample with an Abs280 of 0.6. The sample was spun at 40,000 rpm at 20 ˚C for 
a total of 400 scans with a scan rate of 1 scan/min. van Holde-Weischet analysis of 
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blue) and the CTD (box with dashed lines). Confirmed phosphorylated sites are numbered 
and highlighted in red and those that are found in the naïve protein are denoted with an 
asterisk. Potential phosphorylation sites are numbered in black and the two Ser residues (670 
& 672) within the activation loop are circled. (B) Collision-induced low resolution 
fragmentation spectrum of the phosphopeptide DGpTTVAVK (Mascot ion score 41), 
encompassing residues 533-540 of the ACR4 sequence. The presence of phosphorylated b3 
(theor. m/z 354.1; obs’d 354.1) and y6 (theor. m/z 698.3; obs’d 698.2) ions, along with 
nonphosphorylated b2 (theor. m/z 173.1; obs’d 173.1) and y5 (theor. m/z 517.3; obs’d 517.3) 
ions, confirms Thr535 as the site of phosphorylation. The inset panel shows the MS spectrum 
of the doubly charged protonated molecular ion [M+2H]2+.  Isotope clusters are separated by 
0.505 Da, confirming the charge state of the peptide.  (C) Mass spectrum of the 35-residue 
tryptic peptide 657VADFGLSLLGPVDSGSPLAELPAGTLGYLDPEYYR691 supporting a 
singly-phosphorylated residue with a mass of 3731.81 corresponding to the identification of 
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CHAPTER 3.  RECOMBINANT EXPRESSION AND PURIFICATION OF SOLUBLE 
CYTOPLASMIC KINASE DOMAINS OF THE ACR4, ACR4 HOMOLOGS, AND 
ALE2 RECEPTOR-LIKE KINASES FROM ARABIDOPSIS 
 
Matthew R. Meyer and A. Gururaj Rao 
Abstract 
 
 Arabidopsis CRINKLY4 (ACR4) is a receptor-like kinase (RLK) involved in the 
proper formation of epidermis in the leaves and reproductive tissues of the plant and is 
necessary for stem cell differentiation in the root meristem.  Importantly, there are five 
additional RLKs, four of which are homologs of ACR4 (AtCRR1, AtCRR2, AtCRR3 and 
AtCRK1 termed Arabidopsis Crinkly4 Related, AtCRRs) that contain similar sequence and 
structural features while the remaining RLK, ABNORMAL LEAF SHAPE 2 (ALE2), is 
involved in proper epidermal layer formation. ALE2 is also known to synergistically enhance 
ACR4 kinase activity in vitro. However, the precise signaling pathway mediated by these 
RLKs and the molecular basis of their biological role remain to be elucidated. There is little 
understanding of the biochemical functions of these RLKs although genetic and cell biology 
studies implicate their critical role in cellular differentiation and patterning. In vitro 
biochemical and biophysical studies of recombinant proteins can often provide important 
clues for understanding in vivo physiological functions.  To this end, we have recombinantly 
expressed and purified milligram quantities of the intracellular domains (ICD) of ACR4, the 
AtCRRs, and ALE2 as C-terminal fusions to the Small Ubiquitin like MOdifier (SUMO) 
protein and describe some biochemical properties of the proteins.  Additionally, we 
demonstrate Ala substitutions of the ACR4 autophosphorylation sites have differential effects 




ACR4, Arabidopsis CRINKLY4; AEBSF, 4-(2-aminoethyl) benzenesulfonyl fluoride 
hydrochloride; ALE2, ABNORMAL LEAF SHAPE2; ATP, adenosine triphosphate; BRI1, 
brassinosteroid insensitive 1; BAK1, BRI1 associated receptor kinase 1; CR4, maize 
CRINKLY4; AtCRR, Arabidopsis CRINKLY4 related; DTT, dithiothreitol;  ICD, 
intracellular domain; IPTG, isopropyl β-D-1-thiogalactopyranoside; KD, kinase domain; Ni-
NTA, nickel-nitrilotriacetic acid; PVDF, polyvinylidene fluoride; RLK, receptor-like kinase; 



















 Maize CRINKLY4 (CR4) was initially described as a growth factor like receptor-like 
kinase (RLK) affecting the epidermal layer in leaves and aleurone layer of the kernel (1, 2).  
Subsequent genomic studies revealed orthologs to CR4 in Arabidopsis (ACR4) and rice 
(OsCR4) that were similar in both sequence and domain architecture (3).  Genetic and cell 
biology investigations of ACR4 have shown this receptor to affect epidermal layer formation 
in the leaves and reproductive tissues in the aerial organs of the plant (4-6).  Additionally, 
ACR4 has been described as a central player in the dual processes of maintaining stem cell 
identity and lateral root initiation during development (7).  Another key RLK, ABNORMAL 
LEAF SHAPE 2 (ALE2), is also involved in proper formation of epidermal tissue in the 
leaves (8).  In addition to ACR4, four homologs with structural features analogous to ACR4 
have been described (3). Referred to as Arabidopsis thaliana Crinkly4-related proteins 
(AtCRRs), they represent the ACR4 receptor kinase gene family in Arabidopsis and consist 
of AtCRRs 1, 2 and 3, and AtCRK1. In investigations on the role of ACR4 in root 
development, De Smet et al. (7) demonstrated that double and triple-mutant combinations of 
ACR4 with mutations in the AtCRRs caused uncharacteristic lateral root formation and 
mutant plants showed increased formation and irregular patterning of lateral root meristems. 
 To complement ongoing in planta studies in various laboratories, our laboratory is 
focused on the in vitro biochemical and biophysical analyses of RLKs involved in cell-fate 
specification and proper development of the plant.  To this end, we have recently 
characterized the biochemical properties of the intracellular domain of ACR4 expressed in E. 
coli, including its Ser/Thr kinase activity (9). However, investigations to address fundamental 
questions about protein structure and function and protein-protein interactions require 
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milligram quantities of protein. It is well established that detailed in vitro structural and 
mechanistic studies of recombinantly expressed proteins can provide key insights into our 
understanding of physiological/cellular functions, generate testable models and facilitate 
development of protein reagents for the dissection of signaling pathways. In this paper, we 
report on the expression of milligram quantities of the ICDs of ACR4, the AtCRRs, and 
ALE2 in fusion with the yeast SUMO protein in an E. coli system.  The SUMO tag has been 
successfully used in the overexpression and solubilization of insoluble target proteins (10-
12).   
 
Materials and Methods 
Materials.  
Platinum pfx polymerase, TOP10 cells, dNTPs, and Pro-Q Diamond stain were 
purchased from Invitrogen.  The pE-SUMO vector was acquired from Life Sensors.  T4 
DNA ligase, T4 DNA polymerase, T7 Express cells, and restriction enzymes, except AarI 
(Fermentas), were purchased from New England Biolabs.  Deoxyoligonucleotide primers 
were purchased from Integrated DNA Technologies Inc.  The Rosetta2 (DE3) pLysS 
expression cells were obtained from Novagen.  Ni-NTA Superflow resin was purchased from 
Qiagen.  γ-32P labeled ATP, 6000Ci/mmol, was acquired from Perkin Elmer.  All other 
chemicals were from local sources. 
Vector Construction.  
The ICDs of ACR4, the AtCRRs, and ALE2 were PCR amplified using Platinum pfx 
and the appropriate primers (Table 1).  The amplified genes of interest were then cloned into 
the pE-SUMO (Kan) vector (Life Sensors) according the manufacturer’s instructions and 
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using the appropriate set of enzymes for each gene (Table 1).  The resulting ligated vectors 
were transformed into chemically competent TOP10 cells and spread onto LB agar plates 
supplemented with 50 μg/ml Kanamycin.  The plates were incubated overnight at 37 °C.  
Positive colonies for each construct were selected for DNA sequencing to verify correct 
insertion of the desired gene into the pE-SUMO vector.  To generate the Ala point mutations 
of the ACR4 autophosphorylation sites, the vector encoding the SUMO-tagged ACR4 
intracellular domain was mutagenized using the QuickChange Lightning Multi Site-Directed 
Mutagenesis Kit (Stratagene) using the corresponding primers outlined in Table 2. 
Recombinant protein expression.  
The recombinant vector was transformed into Rosetta2 (DE3) pLysS cells, plated on 
LB agar plates supplemented with 50 μg/ml Kanamycin, and incubated overnight at 37 °C.  
For a typical expression, a single colony was used to inoculate a 5 ml LB-broth starter culture 
supplemented with 50 μg/ml kanamycin and allowed to incubate overnight at 37 °C with 
shaking.  The starter culture was then used to inoculate, 1:100, a 100 ml LB-broth culture 
supplemented with the appropriate antibiotic, described above.  The culture was grown at 37 
°C with shaking until an OD600 = 0.6-0.8 was reached, ~2-3 h.  The cultures were then cooled 
to 20 °C followed by induction with 1 mM IPTG and allowed to incubate for 5h with 
shaking.  Cells were then harvested by centrifugation at 6000 rpm for 10 min at 4 °C.  Cell 
pellets were then used immediately or stored at -80 °C until needed. 
Purification of recombinant proteins.  
The SUMO constructs encode an N-terminal His6-tag for one-step purification of the 
proteins by Ni2+ metal affinity enrichment chromatography. A 100 ml cell pellet was 
resuspended in 10 ml of ice-cold Lysis Buffer (50mM Tris-HCl pH 7.4, 150mM NaCl, 1mM 
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DTT, 30 mM imidazole and 0.1% Triton X-100) supplemented with 1mM AEBSF.  Cells 
were lysed by sonication with chilling on ice in between sonication rounds.  The lysate was 
then centrifuged at 13,200 rpm for 30 min at 4 °C to pellet insoluble material.  The soluble 
lysate was transferred to a 10 ml disposable column containing a 200 μl bed volume of Ni-
NTA Superflow resin equilibrated with Lysis Buffer.  The lysate/resin mixture was incubated 
for 1 h at 4 °C with rocking.  After incubation, the lysate containing the unbound protein was 
allowed to flow through.  The resin containing the bound recombinant protein was washed 
with 10 ml of ice-cold Wash Buffer (50mM Tris-HCl pH 7.4, 150mM NaCl, 1mM DTT, 30 
mM imidazole) to remove unbound protein.  The recombinant fusion proteins were eluted 
from the resin with three consecutive 200 μl aliquots of ice-cold Elution Buffer (50 mM Bis-
Tris pH 7.2, 50 mM NaCl, 1mM DTT, and 150 mM imidazole) and pooled.  Resulting 
protein fractions were analyzed by 12% SDS-PAGE and coomassie staining.  Protein 
quantification was performed by the Bradford method (13).  Densitometric analysis with 
ImageJ v1.45b of the SDS-PAGE gels was used to determine the quantity of fusion protein in 
the crude lysate and purified protein fractions.  For the crude lysate fraction, total protein 
amount was determined by a Bradford assay.  Quantification of the SUMO fusion in the 
crude lysate was determined by multiplying the ratio of the density of the SUMO fusion 
protein band to the density of the total crude lysate.  The amount of SUMO fusion in the 
purified fraction was determined by the same method.  
Protein Detection by Western Blot.  
To assess the fidelity of protein expressions, the recombinant SUMO fused proteins 
were analyzed by western blot.  Briefly, 1 μg of each purified protein was separated by 12% 
SDS-PAGE and blotted to a PVDF membrane and blocked with milk protein.  The proteins 
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were incubated with either polyclonal rabbit, anti-SUMO (yeast) antibody (Rockland 
Immunochemicals, 1:10,000) or anti-ACR4 KD (1:2,000) (9).  The membrane was washed 
then probed with anti-rabbit IgG conjugated to Alkaline Phosphatase (Sigma) at a 1:30,000 
dilution.  Colorimetric detection the proteins was performed with an AP Substrate Kit (Bio-
Rad).   
Gel Filtration Analysis.  
The oligomerization property of each fusion protein was assessed by gel filtration 
using a Superdex G200 column (GE Healthcare) coupled to an AKTA FPLC (Amersham).  
Each protein was diluted to a concentration of 5 μM in 500 μl with Column Buffer (50 mM 
Tris-HCl, 100 mM NaCl, 1 mM DTT) and allowed to incubate at room temperature 30 min 
prior to injection onto the column.  The column was equilibrated with Column Buffer prior to 
each run.  Proteins were eluted off the column at a flow rate of 0.5 ml/min and 1 ml fractions 
corresponding to the peak fractions were collected.  Each fraction was TCA precipitated and 
proteins were analyzed by 12% SDS-PAGE and Coomassie Blue staining. 
Determination of autophosphorylation activity.  
The recombinant proteins were subjected to an in vitro autophosphorylation assay to 
determine if the recombinant proteins had kinase activity (9).  Briefly, 1 μg of each purified 
kinase was incubated in a 20 μl reaction of Kinase Buffer (20mM Bis-Tris pH 7.2, 25 mM 
NaCl, 5mM MnCl2, and 1mM DTT) containing 25 μM ATP and 2 μCi of γ-32P ATP.  The 
reactions were allowed to proceed for 1 h at room temperature followed by termination with 
6 μl of 4X SDS sample buffer and boiling for 5 min.  Proteins were resolved by 12% SDS-
PAGE and radioactive bands were monitored by phosphorimaging.  Alanine mutants of the 
ACR4 autophosphorylation sites were expressed, purified, and assayed for 
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autophosphorylation activity as described above.  Densities of the bands in the autoradiogram 
were quantified with the UN-Scan-It software v6.1. 
Analysis of Phosphorylation status by staining with Pro-Q Diamond.  
Approximately 1 μg of each protein was separated by 12% SDS-PAGE. The gel was 
first fixed for 2 x 30 min with solution containing 50% methanol and 10% acetic acid then 
washed three times with deionized water. It was then stained with Pro Q diamond stain for 90 
min in the dark and then destained using 50 mM sodium acetate buffer pH 4.0 containing 
20% acetonitrile. Images of the stained gel were acquired on a Molecular Dynamics Typhoon 
scanner (Amersham Biosciences) with an excitation source of 532 nm laser and a 580 nm 
bandpass emission filter.     
Intrinsic Fluorescence measurements 
SUMO fusion proteins were dialyzed against 10 mM Tris-HCl pH7.4, 0.1 mM TCEP 
and diluted to an A280 of 0.1.  Measurements were made in a 1 cm cuvette at room 
temperature with a Cary Eclipse spectrofluorimeter (Varian) as described previously (9).  
Scans were executed at an excitation wavelength of 280 nm and a band width of 5 nm and a 
scan speed of 120 nm/min.   
 
Results 
Cloning and expression of SUMO fusion proteins 
 Fig.1A shows the schematic for the expression of the ICDs of ACR4, the AtCRRs, 
and ALE2 as C-terminal fusions to the yeast SUMO protein.   The ICD of each gene was 
PCR amplified using appropriate primers (Table 1) and further processed for ligation into the 
pE-SUMO vector according to the instruction manual using standard ligation procedures. 
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The SUMO fusion vectors were transformed into Rosetta2 (DE3) pLysS cells for expression 
of the recombinant proteins followed by a one-step protein purification as described in 
Materials and Methods. Figure 2 shows the SDS-PAGE analysis of protein fractions at each 
step of the purification protocol starting with the total E. coli lysate (L), unbound proteins 
from the Ni-NTA column (U), proteins removed at the washing step (W) and the final step of 
purification (E).  Typical yields of the purified SUMO fusions ranged from 0.5 to 2.4 
milligrams from 100 ml cultures and the overall yield of pure protein from the crude lysate 
ranged from 60 to 85% (Table 3). Western blot analysis of the purified proteins using 
antibody to the SUMO protein demonstrated >95% purity (Fig. 3 upper panel).  
Analysis of kinase activity  
 We have previously optimized the in vitro kinase assay conditions for ACR4 (9).  
Kinase activity of the recombinantly expressed fusion proteins was assessed using the same 
protocol by incubating the proteins in kinase buffer in the presence of γ-32P ATP followed by 
separation by SDS-PAGE and phosphorimaging. It is evident from this study (Fig.4A, top 
panel) that in addition to SUMO:ACR4 (lane 1), the kinase domains of AtCRR3 (lane 4), 
AtCRK1 (lane 5) and ALE2 (lane 6) are active kinases whereas AtCRR1 (lane 2) and 
AtCRR2 (lane 3) are inactive.  We also assessed the phosphorylation status of the proteins by 
staining with Pro-Q Diamond, a phosphospecific stain used extensively in the 
characterization of kinase activity (14, 15) and identification of phosphoproteins (16). In 
accordance with their demonstrated kinase activity, ACR4, AtCRR3, AtCRK1 and ALE2 
showed intense bands with ProQ Diamond staining (Fig. 4B, top panel lanes 1, 4, 5 and 6) 
whereas the inactive kinases AtCRR1 and AtCRR2 showed no staining (Fig. 4B, top panel 
lanes 2 and 3)   as would be expected from an inactive protein undergoing little or no 
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phosphorylation. The bottom panels in Fig. 4 represent the corresponding Coomassie Blue 
stained gels to demonstrate equivalent protein loading amounts. 
Gel filtration analysis  
 The hydrodynamic properties of the naïve, unphosphorylated proteins were examined 
by gel filtration on a Sephadex G200 column (Fig. 5).  At a concentration of 5 µM, 
SUMO:CRR1 eluted predominantly in the void volume. Analysis of these fractions by SDS-
PAGE (inset) indicates that the void volume fraction consists entirely of aggregates of the 
monomer. Similarly, a small proportion of SUMO:ACR4 elutes as an aggregate in the void 
volume as reported earlier (9).  There was no evidence of oligomerization of SUMO:CRR2, 
SUMO:CRR3 and SUMO:CRK1. 
Intrinsic Fluorescence  
 Fluorescence spectroscopy is a sensitive technique for comparing conformational 
states of proteins or conformational changes within a given protein and is dependent on the 
presence of tyrosine (Tyr) and tryptophan (Trp) (17).  At 280 nm both these aromatic 
residues absorb and contribute to the emission spectra.  The intrinsic fluorescence spectra of 
SUMO-fused proteins, acquired by excitation at 280 nm, are depicted in Fig. 6 and the inset 
table indicates the number of Trp and Tyr residues within each protein. In all cases, the 
number of Tyr residues exceeds the number of Trp residues but there is no evidence of an 
emission peak attributable to Tyr residues.  The SUMO protein itself has just one Tyr residue 
and no Trp residue and has low fluorescence intensity.  
Effect of point mutants on ACR4 autophosphorylation 
 Autophosphorylation of a receptor intracellular kinase domain is critical for maximal 
activation and for recruitment of downstream signaling components.  Phosphorylation in 
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subdomains such as the juxtamembrane domain (JMD), activation loop, and the C-terminal 
domain (CTD) are required to relieve cis inhibitory elements, thus allowing for enhanced 
kinase activity (18-21).  To determine the effects the ACR4 autophosphorylation sites on 
kinase autophosphorylation, 15 individual point mutants were generated in which the 
phosphorylation site Ser/Thr was substituted with Ala (Table 2).  Multiple attempts to 
transform the S:ACR4 S837A vector into Rosetta (DE3) pLysS cell were made, however no 
colonies grew and the mutation appeared to be E. coli lethal.  Therefore, this mutation was 
not considered in our study.  Each protein was expressed and purified as described in 
Materials and Methods.  The yields of individual mutant proteins were comparable to the 
S:ACR4 wild-type protein, indicating proper folding of each enzyme.  Proteins were then 
subjected to an in vitro phosphorylation assay in the presence of [γ-32] ATP.  The 
autoradiogram in Fig. 7A demonstrates that each mutant had varying effects on ACR4 kinase 
autophosphorylation.  The majority of the mutants, encompassing the JMD, KD, and CTD, 
displayed decreased autophosphorylation activity when compared to the wild-type enzyme 
(Fig. 7B), suggesting that phosphorylation at these sites is critical for maximum kinase 
activity.  Interestingly, the S645A in the kinase domain showed enhanced activity when 
compared to wild-type.  This may indicate that phosphorylation in this region is involved in 
repression of kinase activity.  Point mutants of the ACR4 autophosphorylation sites 
substituted with the phosphomimetic Asp residue may provide some insight into the 










 Multicellular organisms require a highly regulated array of signal transduction 
networks to promote cell fate specification and differentiation.  Strict control of these 
networks ensures proper cell patterning and tissue development within the organism.  Thus, 
in both animal and plant cells, directed cell differentiation, growth and development are 
facilitated via a variety of external stimuli that are appropriately interpreted by a multitude of 
cell-surface receptors.  Over 400 putative RLKs are encoded in the Arabidopsis genome (22-
25).  However, although the biological functions of several RLKs are known, very few of the 
RLKs have been characterized in detail at the molecular level and there is little or no 
knowledge of the biochemical basis of the regulatory network mediated by ACR4, its 
homologs, and ALE2 in plant development and signaling.  It is possible that receptor 
activation and autophosphorylation of ACR4 kinase could be stimulated by heteromeric 
interactions with the AtCRR proteins as has been reported for other mammalian receptors 
(26-28) and Arabidopsis brasssinosteroid receptor BRI1 and BAK1 (29). Similarly, genetic 
studies indicate that pathways involving ALE2 and ACR4 might act positively to regulate the 
specification of the protoderm and/or protoderm specific genes in the formation of leafy 
organs . Intriguingly, in the same study, in in vitro experiments, the kinase domains of ACR4 
have been demonstrated to phosphorylate each other (8).  
 In light of the studies described above it becomes important to study the structural 
and functional aspects of the cell-surface RLKs as potential predictors of in vivo function. In 
this regard, the inability to purify these proteins from natural sources in sufficient quantities 
for biochemical and cell biological experimentation has been a major constraint. We have 
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now removed this constraint by recombinant expression of the proteins in E. coli in fusion 
with the SUMO-tag.  
 One measure of proper folding and functional integrity of the produced protein is its 
solubility in aqueous buffers since misfolded proteins generally tend to precipitate.  We have 
developed a relatively simple one-step affinity purification scheme to obtain a >95% pure 
protein preparation (Fig. 2 and Fig. 3).  As shown in Table 2, we have recovered high yields 
(60-85%) of soluble protein using small volumes (100 ml) of expression medium and have 
also not encountered any loss of efficiency in scaling it up to larger volumes (data not 
shown).  
 Biological activity is yet another paradigm of a correctly folded protein. The 
cytoplasmic domains of ACR4, AtCRR3, AtCRK1 and ALE2 have kinase domains (KD) that 
are predicted to be functional and indeed we have demonstrated that the recombinantly 
expressed proteins possess kinase activity in vitro (Fig. 4A top panel, lanes 1, 4, 5 and 6). 
These results confirm the previously reported kinase activity of the proteins (3, 8, 9). On the 
other hand, the cytoplasmic domains of AtCRR1 and AtCRR2 are predicted to harbor 
inactive kinases owing to the deletion of key residues within subdomain VIII (3). 
Accordingly, the recombinant fusion proteins showed no autophosphorylation activity (Fig. 
4A top panel, lanes 1 and 2). 
 Importantly, receptor kinase autophosphorylation also leads to enhanced activity and 
the ability to recruit substrate proteins.  Indeed in the classic example of the EGF receptor, 
receptor activation and kinase autophosphorylation promotes conformational changes that 
allow the recruitment of co-receptors and/or substrate proteins (30, 31).  Among RLKs, BRI1 
autophosphorylation leads to potential conformational changes in the C-terminal domain that 
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allow for binding to the co-receptor BAK1 and to recruit intracellular targets (32, 33).  Our 
results indicate that individual ACR4 autophosphorylation sites make a partial contribution to 
maximal kinase activity (Fig. 7) and concomitant conformational changes (9) may be 
important for regulation of activity in vivo.   
 It is pertinent to point out that the kinase domains of AtCRR1, AtCRR2, AtCRR3, 
AtCRK1 share an amino acid sequence identity of 41%, 40%, 43%, 42% respectively with 
the ACR4 kinase domain. In contrast, in the case of ALE2, the primary structure is less well 
conserved and the kinase domain exhibits only a 33% identity to the ACR4 KD. Proteins 
with similar primary structure can be expected to show topographic or functional similarities 
and in the case of kinases the basic fold of the protein family is remarkably well conserved 
(34).  It is therefore not entirely unreasonable to expect that the homologs would also have 
specific epitopes that would be cross-reactive to antibody raised to the ACR4 kinase domain. 
Indeed, in western blot analysis all the ACR4 homologs react positively to the anti-ACR4 
KD polyclonal antibody (data not shown). However, no cross-reactivity was observed with 
the KD of ALE2 or the SUMO protein, indicating possible differences in linear and/or 
conformational epitopes (data not shown). 
 Fluorescence spectroscopy is a widely used technique to study structural features and 
conformations of protein molecules (17). In particular, the fluorescence of Trp residues is 
sensitive to the polarity of the local environment and is reflected in the λmax of the emission 
spectrum. In tryptophan containing proteins, five different spectral classes have been 
described, each exhibiting significantly different emission peak maxima and quantum yields 
(35). When the Trp residues in the protein are buried in the three-dimensional structure in a 
low-polar hydrophobic environment and protected from the aqueous phase, the λmax can be as 
101 
 
low as 308 nm with a low quantum yield (Class A). On the other hand, in proteins containing 
exposed Trp residues in a high-polar aqueous environment, the λmax can be ≥ 350 nm with a 
quantum yield equal to or greater than that of free aqueous tryptophan (Class III). The three 
other classes, S, I and II  exhibit emission spectra with λmax values in between 308 and 350 
nm accompanied by varying spectral shapes and widths (35). Therefore, in proteins 
containing multiple Trp residues, the emission spectrum is reflective of multiple 
contributions of the five spectral classes. In relative terms, the emission spectra of ACR4, 
AtCRR1, AtCRR2, AtCRR3 and AtCRK1 (λmax 323-336 nm) are supportive of Trp residues 
being in a more non-polar environment compared with the red-shifted λmax of 346 nm 
observed in the emission spectra of ALE2, indicative of a more polar environment for the Trp 
residues (Fig. 6). These studies therefore suggest subtle differences in the conformations of 
the folded state of the ICDs. 
 The movement of proteins through a gel filtration matrix is related to its mass, 
aggregation state and shape. Generally, a narrow and symmetrical elution peak is observed 
for a protein that is folded as a single compact entity, whereas a broader non-symmetrical 
peak is more illustrative of a conformationally flexible molecule that exists as a 
heterogeneous population of species (36). Thus, the symmetrical, single-peak elution profiles 
for SUMO fused ACR4, CRR2, CRR3, CRK1 and ALE2 (Fig. 5) suggest that they have well 
defined compact conformations. In contrast, the elution profile of SUMO:CRR1 is more 
irregular and indicative of a heterogeneous mixture of conformers, some of which could be 
contributing to the aggregated form that elutes close to the void volume. Potentially, this 
behavior could be attributed to a misfolded SUMO:CRR1 with exposed hydrophobic 
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surfaces although the solubility of the protein and the fluorescence emission spectrum are 
contrarian indicators. 
 In conclusion, in this paper we describe for the first time a scheme for the expression 
and purification of the ICDs of some plant RLKs implicated in cell fate specification in the 
aerial organs of plants as well as maintenance of stem cell identity at the root tip meristem. 
Ongoing and future experiments in our laboratory will address fundamental questions related 
to protein-protein interactions and regulation of phosphorylation activity by members of this 
group. We expect that these in vitro studies will complement genetic approaches and 
contribute to an overall understanding of signal transduction events mediated by ACR4, the 
ACR4 homologs, and ALE2. In the larger context, we yet do not know the functions of 
hundreds of RLKs and their putative ligands. Our focused effort exemplifies the need for the 
development of technologies for production and characterization of the RLKs that will 
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Table 1. Primer design of respective fusion proteins  
Construct Residues Cloneda
Restriction 
Enzymes Primer Primer Sequence (5’  3’)
SUMO:ACR4 456-895 BbsI, XbaI ForwardReverse
GGTGGTGAAGACTTAGGTAGGTACAGATTGAGGAATTG
GGTGGTTCTAGATCAGAAATTATGATGCAAGAACAAG
SUMO:CRR1 462-775 BsaI, XbaI ForwardReverse
GGAGGAGGAGGTCTCGAGGTCGGATTGTCACTAGTCCTAAT
GGTGGTGGTTCTAGATCATCAGAAGATCAATGCATCTCTTGC  
SUMO:CRR2 455-776 BsaI. XbaI ForwardReverse
GGAGGAGGAGGTCTCGAGGTAAGATGACAAAAGGTAGTAAAC
GGTGGTGGTTCTAGATCATCAAAAAGTGAGGCCAGACTTGA  
SUMO:CRR3 419-814 BsaI ForwardReverse
GGAGGAGGAGGTCTCGAGGTACTGGAGTTTGCTTGGGGA
GGAGGAGGTCTCTCTAGATCATCAATCAGAGACAATAGAACAAATG
SUMO:CRK1 388-751 AarI ForwardReverse
GGAGGAGGACACCTGCGAGAAGGTAAAAGCCACTGTCGATGCC
GGTGGTCACCTGCGAGTCTAGATCATCAATAAGTGTTTGATCGAGATACG



























Subdomain  Mutation  Primer Sequence (5’  3’)  
JMD S475A CAAGGTCTTCTAAAGATGCAGCCTTTACGAAAGAT  
JMD T478A CTAAAGATTCAGCCTTTGCGAAAGATAATGGCAAAATCCG  
KD T501A GAAGGGCTAGAGTTTTCGCTTATGAGGAACTTG  
KD S516A GGATTCAAAGAAGAAGCAATAGTGGGGAAAGGG  
KD S522A ATAGTGGGGAAAGGGGCTTTCTCATGTGTGTACAA  
KD T535A GTACTGAGAGATGGAGCCACTGTTGCAGTGAAG  
KD T536A CTGAGAGATGGAACCGCTGTTGCAGTGAAGAG  
KD S552A GACAAACAGAAGAATGCAAATGAGTTTCGCACG  
KD T557A AATGAGTTTCGCGCGGAGCTTGATCTGTTA  
KD S563A GAGCTTGATCTGTTAGCAAGACTCAACCATGCTC  
KD S644A CACCGGGATATTAAAGCATCAAACATTCTTATAGATG  
KD S645A CCGGGATATTAAATCAGCAAACATTCTTATAGATGAAG  
CTD T831A TCTGGTTCCGAGAACGCGGAATTCAGAGG  
CTD S837A GAATTCAGAGGCGGAGCATGGATAACATTCC 
CTD S875A GAATTCAGAGGCGGAGCATGGATAACATTCC  
CTD S888A CCAGCTTCTCCTGGACAGGCCTTGTTCTTGCATCAT  
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Table 3. Protein recovery at each step of the protein purification scheme as outlined in 
Materials & Methods. 
a  Protein amounts were estimated using the Bradford assay 
b Densitometric analysis of SDS-PAGE gels using Image J 1.45b software as described in 

















































SUMO:ACR4 13.00 0.83 6 0.51 0.50 98 60.2
SUMO:CRR1 15.05 0.57 4 0.48 0.47 99 83.3
SUMO:CRR2 18.25 2.02 11 1.63 1.61 99 79.7
SUMO:CRR3 15.15 2.37 16 1.99 1.94 97 81.7
SUMO:CRK1 19.35 2.36 12 1.84 1.81 98 76.7
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CHAPTER 4.  EVIDENCE FOR AN INTRAMOLECULAR INTERACTION 
BETWEEN THE JUXTAMEMBRANE AND KINASE SUBDOMAINS IN ACR4 AND 
IMPLICATIONS FOR REGULATION OF KINASE ACTIVITY 
 
A paper to be submitted for publication. 
M.R. Meyer, S. Shah, and A.G. Rao 
 
Abstract 
 Arabidopsis CRINKLY4 (ACR4) is a receptor-like kinase required for the proper 
development of both aerial and underground organs of the plant.  Loss of ACR4 function 
results in epidermal defects in the leaves and reproductive tissues and is necessary for stem 
cell differentiation in the root apical meristem.  ACR4 is a Type 1 membrane protein and has 
architecture analogous to receptor tyrosine kinases (RTK).  ACR4 includes an extracellular 
ligand binding domain, a transmembrane helix, and an intracellular kinase domain. The 
intracellular domain contains the juxtamembrane domain (JMD) and the C-terminal domain 
(CTD) subdomains, which flank the core kinase domain (KD).  While the salient in vitro 
biochemical properties of the ACR4 intracellular domain have been previously described, the 
role of the flanking JMD and CTD in the structure and function of the kinase domain remains 
to be ascertained.  In this study, we provide evidence for an intramolecular interaction 
between the ACR4 JMD and the amino-terminal region of the KD and its potential role in the 
regulation of kinase activity.  We demonstrate that peptides derived from the JMD region can 
repress kinase activity of the KD in the unphosphorylated state.  Importantly, the peptides are 
able to bind to ACR4 in vitro. To gain further insight into the nature of this interaction, we 
screened the unphosphorylated and phosphorylated JMD peptides against a combinatorial 
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peptide library expressed on M13 phage pIII coat protein and have identified the sequence 
LLSLL in the N-terminal region of the KD as preferred interaction motif for the 
phosphorylated peptide. Furthermore, we also show through kinetic analyses of JMD mutants 























ACR4, Arabidopsis CRINKLY4; ATP, adenosine triphosphate; BRI1, Brassinosteroid 
insensitive 1; CR4, maize CRINKLY4; CD, circular dichroism; AtCRR, Arabidopsis 
CRINKLY4 related; CTD, carboxy-terminal domain; DTT, dithiothreitol; EGFR, epidermal 
growth factor receptor; ICD, intracellular domain; KC, kinase + carboxy terminal domain; 
JM, juxtamembrane; KD, kinase domain; MyBP, myelin basic protein; NusA, N-utilization 
substance A; PDGF, platelet derived growth factor; RLK, receptor-like kinase; RTK, 
receptor tyrosine kinase; SERK, somatic embryogenesis receptor-like kinase; TCEP, Tris (2-
carboxyethyl) phosphine hydrochloride;  UV, ultraviolet; WOX5, WUSCHEL RELATED 

















 Higher organisms are required to maintain a controlled equilibrium between cell 
proliferation and differentiation throughout their growth and development.  Failure to retain 
this balance results in developmental problems which leads to increased disease states and 
decreased survival.  Organisms make use of cell-surface receptors to detect external or 
internal signals that impact cellular function.  Mammalian systems have acquired signal 
transduction mechanisms via the use of receptor tyrosine kinases (RTK) to regulate cellular 
processes such as proliferation, migration, differentiation, and cell-cycle control (1).  RTKs 
consist of an extracellular ligand binding domain, a single transmembrane helix, and an 
intracellular tyrosine kinase domain.  The general paradigm of RTK activation entails ligand 
binding to the extracellular domain of the receptor, followed by receptor oligomerization, and 
activation of the kinase domains via trans phosphorylation (2, 3).  Activation of the 
intracellular kinase domain of the receptor initiates a signal transduction cascade involving 
cytoplasmic components that eventually regulate gene transcription in the nucleus (1, 4). 
Importantly, structural, biochemical and biophysical studies of a variety of RTKs have 
revealed the effects of phosphorylation and the regulatory role of non-catalytic domains such 
as the JMD and the CTD on kinase activity and function (5-13). 
The CRINKLY4 (CR4) gene was first identified in maize and encodes a receptor-like 
kinase (RLK) that is involved in the proper specification of epidermal tissues in the leaves 
and the aleurone of the kernel (14).  Architectural features of the RLK include an 
extracellular domain containing seven repeating regions, termed ‘Crinkly’ repeats, and three 
cysteine-rich repeats similar to the extracellular motifs found in the tumor necrosis factor 
receptor, a membrane spanning region, and an intracellular serine/threonine kinase domain 
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(14, 15).  An ortholog to CR4 has been identified in Arabidopsis that retains all of the 
features of maize CR4 (16), including a functional serine/threonine kinase domain (17-19).  
The Arabidopsis genome encodes four homologs to ACR4, termed Arabidopsis CRINKLY4-
Related proteins (AtCRRs), which contain sequence similarity and architectural features 
analogous to ACR4 (19). Genetic and biological studies have characterized the 
functional properties of ACR4 in some detail.  ACR4 primarily effects epidermal formation 
in the leaves and reproductive tissues of the plant, similar to CR4 function (16-18).  
Furthermore, ACR4 has been demonstrated to affect root growth and morphology.  
Examination of developing roots has shown that ACR4 is required for proper columella stem 
cell differentiation in the root apical meristem and is essential for proper lateral root 
formation (20, 21).  ACR4 mutant plants lacking ACR4 function show increased numbers of 
columella stem cells in the root tip.  A signaling module has been suggested involving a 
postulated peptide ligand, CLE40, the ACR4 RLK, and the WOX5 transcription factor that 
engage in a possible feedback mechanism controlling stem cell differentiation (21, 22).  
Molecular biology investigations have revealed that ACR4 requires the extracellular 
‘Crinkly’ repeat domain for receptor function (23).  However, the importance of the active, 
intracellular kinase domain is being debated (18, 23).  Biochemical studies involving the 
transmembrane domains (TMD) of CR4, ACR4, and the AtCRRs demonstrate their ability to 
homodimerize and that residues within the TMDs of ACR4 and CR4 can significantly 
influence dimer propensity (24, 25).  However, biochemical knowledge regarding the 
mechanisms of receptor activation and intracellular KD activation and regulation is needed in 
order to fully understand receptor function. 
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 We have recently reported on some salient in vitro biochemical properties of the 
ACR4 intracellular domain including its kinase activity and identification of 16 
autophosphorylation sites encompassing the JMD, KD, CTD (26).   In RTKs, the importance 
of the JM region in the regulation of kinase function is well documented (5, 9).  However, the 
role of the JMD in regulating ACR4 kinase activity is unclear. To this end, we have 
undertaken this in vitro study to delineate the contribution of the JMD in ACR4 kinase 
activity and establish the ground for more detailed characterization.  Thus, we provide 
evidence for an intramolecular interaction between the ACR4 JMD and KD and its potential 
role in the regulation of kinase activity.  We demonstrate that peptides derived from the JMD 
region can repress kinase activity of the KD in the unphosphorylated state.  Importantly, the 
JMD peptides are able to bind to ACR4 in vitro. To gain further insight into the nature of this 
interaction, we screened the unphosphorylated and phosphorylated JMD peptides against a 
combinatorial peptide library expressed on M13 phage pIII coat protein and have identified 
the sequence LLSLL in the N-terminal region of the KD as preferred interaction motif for the 
phosphorylated peptide. Furthermore, we also show through kinetic analyses of JMD mutants 
that prior autophosphorylation of the JMD may contribute to more efficient substrate 
phosphorylation of myelin basic protein.   
 
Materials and Methods 
Protein Mutagenesis 
 The SUMO fused ACR4 intracellular domain (sACR4) was prepared as previously 
described (Chapter 2).  The sACR4 KC protein which lacks the intracellular juxtamembrane 
domain, residues 456-483 (26), was cloned into the pE-SUMO vector (Life Sensors) using 
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the forward primer 5’-GGTGGTGAAGACTTAGGTATCCGTCCGGATCTTGATG-3’ and 
the reverse primer 5’-GGTGGTTCTAGATCATGCAAGCGCTCGTTCCAAT-3’ containing 
a BbsI and a XbaI site, respectively.  Standard cloning procedures were followed according 
to the instruction manual that was provided with the vector.  The resulting construct was 
verified by sequencing to ensure protein was in frame and no mutations had occurred.  
 To generate the JMD mutant proteins, the vector encoding the SUMO-tagged ACR4 
intracellular domain was mutagenized using the QuickChange Lightning Multi Site-Directed 
Mutagenesis Kit (Stratagene).  Sequential mutagenesis was required to produce the JMD 
double alanine (JMD-2A) and double aspartate (JMD-2D) mutants.  To generate the JMD-2A 
mutant, first S475 was mutated to alanine using the S475A primer, 5’-
CAAGGTCTTCTAAAGATGCAGCCTTTACGAAAGAT-3’.  The mutation was verified 
by sequencing and the resulting vector was subjected to a second round of mutagenesis using 
the T478A primer, 5’-CTAAAGATGCAGCCTTTGCGAAAGATAATGGCAAAATCCG-
3’.  The double alanine mutant vector was verified by sequencing.  The JMD-2D was 
produced using the same method using the S475D primer, 5’- 
GATACAAGGTCTTCTAAAGATGACGCCTTTACGAAAGATAATGGC-3’, followed by 
the T478D primer, 5’- 
CTTCTAAAGATTCAGCCTTTGACAAAGATAATGGCAAAATCCGTC-3’.  Sequencing 
verified the correct mutations. 
Protein expression and purification 
 Vectors encoding the SUMO fused kinase domains of ACR4 were transformed into 
Rosetta2 (DE3) pLysS (Novagen) cells and plated on Kanamycin plates.  Luria Broth 
cultures supplemented with 50 μg/ml Kanamycin were initiated by standard procedures.  
123 
 
Cultures were grown with shaking at 37 °C for ~3 h until an OD600 = 0.6-0.8 was reached.  
The temperature was reduced to 20 °C and cultures were induced with 1 mM IPTG.  The 
cultures were incubated for 5 h, harvested by centrifugation, and stored at -80 °C until 
needed.  To purify the SUMO fused proteins, frozen pellets from 250 ml cultures were 
thawed on ice and resuspended in 10 ml Lysis Buffer (50 mM Tris-HCl pH7.4, 150 mM 
NaCl, 40 mM imidazole, 0.1% Triton X-100, 1 mM DTT, and 1 mM AEBSF).  Cells were 
lysed by sonication on ice and the resulting lysate was centrifuged at 13,200 rpm for 15 min 
at 4°C.  Supernatants were then transferred to a 10 ml column containing 250 μl of Ni-NTA 
Superflow resin (Qiagen) equilibrated with Lysis Buffer.  The resin/lysate mixture was 
incubated on a rocker at 4°C for 1 h.  After incubation, the unbound proteins were allowed to 
flow through the column.  The resin was washed with 10 ml of Wash Buffer (50 mM Tris-
HCl pH7.4, 150 mM NaCl, 50 mM imidazole, 1 mM DTT).  Bound proteins were eluted into 
individual microfuge tubes with three successive 250 μl aliquots of Elution Buffer (50 mM 
Bis-Tris pH7.2, 50 mM NaCl, 150 mM imidazole, 1 mM DTT) on ice.  Protein quantities 
were determined by the Bradford method.   
Autophosphorylation time course assays 
 Autophosphorylation time course assays were performed to determine the effect of 
mutations in the JMD on sACR4 autophosphorylation.  First, 300 μl reaction volumes  of 
Kinase Buffer (20 mM Bis-Tris pH 7.2, 25 mM NaCl, 5 mM MnCl2, 1 mM DTT, 25 μM 
ATP) supplemented with 30 μCi of [γ-32P] ATP (Perkin Elmer, 6,000 Ci/mmol) were 
prepared.  Subsequnetly, reactions were initiated with the appropriate enzyme to a final 
concentration of 1 μg/20 μl of reaction.  20 μl aliquots were taken at the time points indicated 
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and terminated with the addition of 4X SDS Laemmli buffer and boiled.  Proteins were 
separated by 12% SDS-PAGE and gels were analyzed by phosphorimaging.   
Peptide synthesis 
The JMD peptides and the carboxy-terminal domain peptides (CTD) were chemically 
synthesized (Genscript) with a biotin tag at the amino terminus (Table 1).   
Peptide inhibition assays 
 Inhibition of sACR4 kinase activity was  assessed by incubating  20 μl reaction 
volume of Kinase Buffer containing 2 μCi [γ-32P] ATP, 1 μg of sACR4 KC, and increasing 
concentrations of JMD1 peptide (0-200 μM) for 20 min at room temperature.  Reactions were 
initiated with the enzyme followed by incubation at room temperature for 30 min before 
terminating the reaction by the addition of 4X Laemmli buffer and boiling.   Proteins were 
separated by 12% SDS-PAGE and resulting gels were analyzed by phosphorimaging.   
Substrate phosphorylation assays 
  Phosphorylation of MyBP by ACR4 (26) was assessed with or without prior 
autophosphorylation.  240 μl reactions were set up as described above containing 12 μg of 
sACR4, 24 μg of MyBP, and 24 μCi of [γ-32P] ATP.  For the reaction requiring 
autophosphorylation of the kinase, the reaction was set up without [γ-32P] ATP and MyBP, 
initiated with the kinase, and incubated at room temperature for 1 h.  After 
autophosphorylation, the reaction was spiked with the [γ-32P] ATP and MyBP.  For the 
experiment with no prior autophosphorylation, all reaction components were mixed and the 
reaction was initiated with the addition of the enzyme.  20 μl aliquots were taken at the 
indicated time points, stopped and processed as described above.  Densities of the protein 
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bands from the autoradiogram were quantified using the UN-Scan-It v6.1 software (Silk 
Scientific, Inc.) and plots of density versus time were generated. 
 In order to determine if the JMD affects substrate phosphorylation, sACR4 wild-type 
and JMD mutant proteins were incubated with increasing concentrations of MyBP.  A series 
of 20 μl reactions were prepared with Kinase Buffer containing 0.5 μg (0.3 μM) of kinase, 2 
μCi of [γ-32P] ATP, and MyBP (0.7-54.3 μM).  Reactions were initiated with the addition of 
the enzyme and incubated at room temperature for 15 min.  Reactions were terminated with 
the addition of 4X SDS Laemmli buffer and boiled.  Proteins were separated by 12% SDS-
PAGE and resulting gels bands were stained with Coomassie blue.  Protein bands 
corresponding to MyBP were excised from the gel and radioactive counts quantified by 
liquid scintillation counting.  Phosphate incorporation was calculated using a [γ-32P] ATP 
standard curve and the radioactive counts.  Kinetic analysis was performed as described (26). 
Phage peptide library construction   
The phagemid vector pCANTAB 5E (GE healthcare) was used to construct a random 
21-amino acid library fused to the pIII coat protein (Rao laboratory, unpublished data). 
Briefly, two oligonucleotide primers were first synthesized (Integrated DNA Technologies). 
The forward primer 5’-
CGTGGTGGCCCAGCCGGCC(NNK)21GCGGCCGCAGCACGACAG-3’ contained the 
degenerate codon NNK encoding all 20 amino acids and the TAG stop codon. The 
oligonucleotide also incorporated Sfi1 and Not1 restriction enzyme sites at the 5’ and 3’ ends 
respectively.  A complementary reverse primer 5’-CTGTCGTGCTGCGGCCGC-3’ was used 
for double-strand synthesis, followed by digestion with Sfi1/Not1 and ligation into the 
similarly digested phagemid vector.  Multiple transformations of highly electro-competent 
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(competency > 1.0x1010) SS320 E. coli cells and phage preparation resulted in a phage-
peptide library with a diversity of ~ 1x109. The library was validated by first screening 
against the anti-FLAG monoclonal antibody that recognizes the sequence epitope 
DYKDDDDK.  Four rounds of screening against the antibody yielded >95% clones 
containing the core sequence DYKxxD 
Phage peptide library screening of JMD1 peptides 
Biotinylated peptides were immobilized on 20 µl of streptavidin coated beads 
(Dynabeads® MyOneTM Streptavidin T1, Invitrogen) and dispersed in 100 µl of phosphate 
buffer saline pH, 7.4 (PBS) at room temperature with gentle rotation for 45 mins. The beads 
were washed three times with PBS containing 0.1 % BSA. Peptide coated beads were 
blocked with PBS containing 0.1 % BSA for 30 mins followed by 2 washes with PBS 
containing 0.1 % BSA. Beads were then incubated with phage (100 µl diluted in 900 µl of 
PBS containing 0.1 % BSA) for 3 h at room temperature with gentle rotation. The unbound 
phage was washed 3 times with PBS and then the beads were transferred into fresh eppendorf 
tubes. The bound phage was eluted by incubating with 500 µl of 0.1 M HCl for 5 mins at 
room temperature with the aid of shaking. The eluted phage was immediately neutralized by 
the addition of 167 µl of 1M Tris-HCl buffer pH 8.0, followed by infection of XL1-Blue 
cells (grown to < 0.6 OD in 10 µg/ml tetracycline) with the phage. Infected XL1-Blue cells 
were incubated at 37 °C for 20 mins followed by addition of helper phage and again 
incubating at 37 °C for 30 mins. The phage infected XL1-Blue cells were transferred into a 
conical flask containing 50 ml of 2YT media containing 10 µg/ml of tetracycline and 100 
µg/ml ampicillin and was further incubated at 37 °C overnight with shaking at 210 rpm. 
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Phage preparation was carried out by centrifuging the overnight culture at 8000 rpm for 10 
mins. The supernatant was collected into another centrifuge tube and the phage was 
precipitated by adding 12.5 ml of 20 % PEG 8000 and 2.5 M NaCl solution at room 
temperature. The precipitated phage were collected by centrifugation at 12,000 rpm for 20 
mins and diluted with 1 ml of PBS. This was the first round of enriched phage. The entire 
process was repeated for four rounds and for each subsequent round of biopanning, enriched 
phage from previous round was used. During the 3rd and 4th round of panning, the wash 
buffer contained 0.01 % Tween 20.  Following 3rd and 4th round panning, phage infected 
XL1-Blue cells were grown on 2YT ampicillin plates and 50 colonies were characterized by 
DNA sequencing after plasmid preparation.  
Phage ELISA for binding specificity  
For phage ELISAs, streptavidin coated plates were washed three times with PBS 
containing 0.05 % Tween 20 (PBST). Juxtamembrane peptides (10ug/ml in PBS) were 
immobilized on streptavidin coated plate by incubating 100 µl of peptide per well at room 
temperature for 1 h. Plate was washed two times with PBST followed by blocking with 
PBST containing 0.1 % BSA for 1 h. The plate was then washed three times with PBST 
followed by incubation with the appropriate phage-peptide (pd-LHSLL phage, pd-AHALA 
phage) and helper phage for 2 h at room temperature with gentle shaking. Then the plate was 
washed three times with PBST followed by incubation with anti-M13 HRP conjugated 
antibody for 1h. Again the plate was washed four times with PBST. The bound phage in each 
well was detected by incubating with 50 μl of substrate solution (0.01 % hydrogen peroxide 
+ 0.8 mg/ml o-Phenylenediamine dihydrochoride) for ~10 min.  Reactions were terminated 
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by the addition of 50 μl of 3 M HCl and measuring the absorbance of the developed yellow 
color at 405 nm. In the case of ACR4 kinase peptide derived phage (acr4-LLSLL and acr4-
ALALA), all the washing steps before phage binding were performed using TBS containing 
0.05 % Tween 20 and thereafter only with TBS. 
Peptide overlay assays 
 The JMD1 peptides were diluted in 2.5 mM in Tris-HCl buffer, pH 8.0.   To 
demonstrate peptide binding to sACR4 KC protein, 2 μg of sACR4 KC and 2 μg of SUMO 
protein were separated by 12% SDS-PAGE and blotted to nitrocellulose membrane.  Blots 
were briefly stained with a 0.1% Ponceau S solution to locate the protein bands.  Bands were 
then cut from the blot, appropriately labeled, then destained in successive washes with 
distilled water and a final wash in 1X TBS (50 mM Tris-HCl pH 7.4, 150 mM NaCl) to 
remove Ponceau S staining.  Blots were then blocked with 5% milk protein in TBS + 0.1% 
Tween 20 for 1 h.   After blocking, blots were washed three times with TBS + 0.1% Tween 
20, 5 min each wash.  They were then placed in individual microfuge tubes containing 1 ml 
of TBS, followed by addition of the appropriate peptide to a final concentration of 100 μM.  
To demonstrate specific binding to ACR4, peptides were also incubated with SUMO protein 
as a control.  Blots were incubated on a rotating platform for 2 h at room temperature, 
followed by two washes with 1.5 ml of TBS at 5 min intervals.  To detect peptide binding, 1 
ml of TBS containing 1:500 streptavidin conjugated Alkaline Phosphatase (AP) (Pierce) was 
added to each tube.  Blots were incubated on a rotator for 1 h at room temperature, washed as 
described above to remove excess streptavidin-AP followed by colorimetric detection of 
peptide binding using the AP Substrate kit (Bio-Rad).  The presence of sACR4 and SUMO 
proteins were confirmed in separate blots probed with anti-SUMO primary antibody 
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(Rockland Immunochemicals, 1:1000) and polyclonal anti-rabbit secondary antibody (Sigma, 
1:15,000). 
Peptide binding assays 
  The binding of JMD1 peptides to sKC protein was demonstrated as follows.  First, a 
96 well nickel coated plate (XpressBio) was washed three times with TBS + 0.1% Tween 20.  
A 0.8 μM solution of sKC (5 μg/100 μl) or SUMO protein (1 μg/100 μl) was prepared in 
TBS + 0.1% Tween 20.  100 μl of appropriate protein solution was added to individual wells 
and incubated on an orbital shaker for 1 h at room temperature to allow protein to bind to the 
plate through the His tag.  Wells containing immobilized sKC or SUMO protein were 
washed three times with TBS + 0.1% Tween 20 to remove unbound material.  JMD1 peptide 
solutions were prepared in TBS to a final concentration of 200 μM.  50 μl of the peptide 
solutions were added to appropriate wells and allowed to incubate on an orbital shaker for 2 h 
at room temperature.  After incubation, excess peptide solution in the wells was discarded.  
Wells were then washed with TBS two times with gentle shaking to remove unbound 
peptides.  50 μl of a streptavidin-AP solution (1:500) was added to each well and incubated 
on an orbital shaker for 1 h at room temperature.  Streptavidin-AP solution was discarded and 
the wells were washed twice with TBS using gentle shaking.  Colorimetric detection of 
peptide binding was initiated by adding 100 μl of a p-nitrophenyl phosphate (pNPP) solution 
(100 mM ethanolamine pH 9.8, 10 mM pNPP) to each well.  The reactions were allowed to 
incubate for 5 min with occasional manual shaking.  Reactions were terminated with the 
addition of 50 μl of 2N NaOH to each well.  100 μl of each reaction was diluted with 400 μl 
of water and absorbance at 405 nm measured.  Data were generated by accounting for the 
dilution factor and subtracting the absorbance of the control (SUMO) wells from the 
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experimental (sACR4 KC) wells.  Each peptide binding experiment was performed in 
triplicate. 
CD analysis of JMD1 peptides 
 Circular dichroism (CD) analysis of JMD1 peptides was carried out by dissolving the 
JMD1 peptides in CD Buffer (10 mM Tris pH 7.2, and 0.1 mM TCEP) to a final 
concentration of 125 μM.  For assays involving TFE, peptides were dissolved in CD Buffer 
containing either 15 or 40 % TFE.  Far-UV spectra of each peptide were obtained on a Jasco 
J-710 spectropolarimeter, in a 0.1 cm path length cuvette with excitation wavelengths 
ranging from 190-260 nm. 
Homology model of ACR4 kinase domain 
Homology modeling was used to build the model for the ACR4 kinase domain 
encompassing the sequence of residues starting from 512 through 785 in the whole receptor. 
The Discovery Studio v 3.1 (Accelrys, San Diego, USA) was used for homology model 
construction. Sequence analysis identified Interleukin-1 receptor associated kinase (PDB 
identification 2NRU_B) as the optimal template based on 50% homology and 34% identity 
in the amino acid sequence.  The protein model was generated by MODELER, which was 
originally developed by Sali (27) and the refined model was validated using the Verify 
Protein (Profiles-3D) protocol, which assesses the compatibility of the 3D structure of the 








Effect of the JMD on ACR4 autophosphorylation 
 We have previously reported on the autophosphorylation activity of ACR4 kinase 
domain, its mechanism and the identification of 16 autophosphorylation sites, including two 
sites, Ser475 and Thr478, in the JM region (26). Protein kinases are often regulated by cis-
acting elements outside the catalytic domain i.e. the juxtamembrane domain and the carboxy 
terminal domain (8, 28-30). Therefore, to determine if the JM region and the two 
autophosphorylation sites within are important for kinase activity an autophosphorylation 
time course experiment was carried out using the sACR4 wt,  sACR4 KC (missing the JM) 
and sACR4 JMD mutants in which both Ser475 and Thr478 were replaced with Ala (sACR4 
JMD-2A) or Asp, a phosphomimetic residue (sACR4 JMD-2D) (Fig. 1A). All proteins were 
prepared as described in Materials & Methods and assayed as previously described (26).  It is 
evident from the autoradiograms (Fig. 1B) that there is no difference in the time course of 
autophosphorylation activity between the wild type and mutant proteins, suggesting that the 
JMD has little effect on kinase autophosphorylation. 
 We therefore decided to test whether the addition of exogenous peptides from the 
JMD could act in trans to either repress or enhance the kinase activity of sACR4 KC. Thus, 
four different 15mer peptides corresponding to residues 468-482 of the ACR4 primary amino 
acid sequence were generated. The wild type peptide, JMD1, contains the unmodified Ser475 
and Thr478 residues.  In the mutant peptide JMD1m, both sites of autophosphorylation have 
been replaced with Ala. In the peptide pJMD1 Ser475 is phosphorylated and in ppJMD1 both 
Ser475 and Thr478 are phosphorylated (Fig. 2A). Our results (Fig. 2B) indicate that when 
sACR4 KC is incubated with increasing concentrations of these peptides (0-200 µM), the 
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singly (pJMD1) and doubly (ppJMD1) phosphorylated derivatives have only slight inhibitory 
effects (~10% decrease) on autophosphorylation even at the highest concentration (Fig. 2A 
and B).  On the other hand, the JMD1 reduced sACR4 KC autophosphorylation efficiency 
~20% when incubated at the highest concentration of 200 μM and, interestingly, the mutant 
peptide JMD1m, was able to inhibit kinase activity by as much as 40% at a concentration of 
200 μM (Fig. 2A and B).  These results indicate that the JMD of ACR4 may contribute to the 
regulation of kinase activity although, given that full inactivation of the kinase was not 
observed, other regions of the protein  such as the activation loop (26) and the C-terminal 
domain may play a significant role.   
Effect of JMD on substrate phosphorylation 
 It has been noted in the case of the Brassinosteroid Insensitive1 (BRI1) receptor 
kinase that mutations in the JM region have little or no effect on autophosphorylation but 
dramatically affect substrate phosphorylation in vitro (31). We therefore assessed the role of 
the JMD on ACR4 kinase substrate phosphorylation using the exogenous substrate Myelin 
Basic Protein (MyBP) as reported previously (26).  To this end, we incubated each of the 
ACR4 JMD mutants with MyBP (0.7-54 μM) and examined the kinetics of substrate 
phosphorylation.  The data, fitted to a Michaelis-Menten equation (using the Enzyme 
Kinetics Module in SigmaPlot v11.2), showed typical Michaelis-Menten kinetics for all 
proteins (Fig. 3).    The wild-type sACR4 protein kinetics exhibited Vmax and Km values of 
6.37 ± 0.47 nmol min-1 mg-1 and 0.68 ± 0.29 μM, respectively (Table 2) whereas the sACR4 
JMD-2A mutant showed a dramatic decrease in the efficiency of substrate phosphorylation 
activity (Vmax and Km values of 4.57 ± 0.18 nmol min-1 mg-1 and 0.92 ± 0.20 μM, 
respectively), suggesting that autophosphorylation of Ser475 and Thr478 is required for full 
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activity against substrate proteins.  Support for this comes from the kinetics data for the 
sACR4 JMD-2D protein in which the two Asp residues may be regarded as mimicking the 
negatively charged  phosphorylated Ser475 and Thr478 residues in the JMD of ACR4.  Clearly, 
the phosphomimetic derivative is able to restore the efficiency of substrate phosphorylation 
to wild-type levels (Fig. 3D, Table 2).  The sACR4, JMD-2A and 2D mutants have similar 
binding affinities for MyBP and are comparable to the wild-type enzyme, regardless of the 
type of mutation present (Table 2).  Interestingly, substrate phosphorylation is also 
significantly enhanced in the absence of the JMD in the sACR4 KC protein (Vmax = 7.50 ± 
0.38 nmol min-1 mg-1) although the binding affinity (Km = 1.98 ± 0.46 μM), which is >2-fold 
higher than that of sACR4 wt (Km = 0.68 ± 0.29 μM) suggests that residue(s) within the JMD 
may play a critical role in binding to substrates.  Taken together, these results indicate that 
autophosphorylation of Ser475 and Thr478 in the ACR4 JMD may be necessary for optimal 
substrate phosphorylation in vitro. We also examined whether prior autophosphorylation was 
necessary for efficient substrate phosphorylation. Thus, the time course of MyBP 
phosphorylation (Fig. 4) shows that the autophosphorylated sACR4 (+AutoP) has a subtle 
but distinct ability to phosphorylate at an earlier time point (0.5 min) than the protein that is 
not autophosphorylated (2 min) (-AutoP) suggesting that substrate recognition may be 
regulated by autophosphorylation. 
Phage panning of JMD1 peptides  
 Structural studies on several receptor tyrosine kinases have established that activation 
and inhibition of kinase activity is often mediated by the juxtamembrane domain through 
intramolecular interactions with residues in the active site (9, 32-36).  Based on our 
observation that the unphosphorylated JMD1 peptide inhibits kinase activity, we invoked the 
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possibility that the JMD in the ACR4 kinase could serve a similar structural role via an 
intramolecular interaction. Ideally, knowledge of the x-ray or NMR derived three-
dimensional structure of ACR4 kinase domain would provide the necessary atomic level 
detail to unequivocally delineate specificity of interactions within the molecule.  However, 
this is not a trivial exercise.  In the absence of structural information, phage display screening 
of random peptide libraries has become a widely used method to identify peptide ligands, 
probe structure-function relationships in proteins and map protein-protein interaction sites 
(37-39).  Typically, phage-display screening yield peptides that harbor linear 
sequences/motifs that have the potential to interact with the target molecule. A priori, the 
probability of finding an exact match to the sequence of a binding partner is rather low.  
Consequently, consensus analysis provides the basis for identifying candidate natural 
sequences that may interact with the protein. 
 Thus, we used a random 21-mer phage peptide library to identify potential interaction 
sites for the JMD1 peptides. The target peptides JMD1 (468DTRSSKDSAFTKDNG482) and 
the phosphorylated pJMD1 peptide  (468DTRSSKDpSAFTKDNG482) were immobilized 
through their N-terminal biotin tag on streptavidin coated plates and subjected to four rounds 
of panning as described in Materials & Methods.   Phage isolated from the fourth round were 
enriched in clones harboring peptides with specificity and affinity for the target JMD1 
peptides.   
 In panning against the nonphosphorylated JMD1 peptide, 46 clones were randomly 
chosen from the 4th round and amino acid sequences of displayed peptides were deduced by 
DNA sequence analysis. While there was no single dominating sequence, some sequences 
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were represented multiple times (Fig. 5).  Significantly, the majority of the peptides 
contained the consensus tripeptide motif ‘SXL’.  There were miscellaneous other sequences.   
Fig. 6 shows the amino acid sequences of 46 randomly chosen clones from the 4th 
round of panning against the phosphorylated peptide, pJMD1. A single dominant sequence, 
YRWWDSAINLHSLLFSPPLFG, was represented 16 times. Interestingly, this peptide 
contains the sequence NLHSLLF (and there are three other peptides with a sequence of 
amino acids that are similar, LLHSNDF, NLSLSYL AND KLHTSPW).  The sequence 
NLHSLLF harbors the motif LXXLL that is known to be involved in numerous protein-
protein interactions in plants and animals, most notably in mammalian nuclear receptor 
signaling (40-43).  
 The results of our phage panning experiments highlights the discriminatory power of 
the method in distinguishing the subtle differences in the binding interactions of JMD1 and 
pJMD1. Whereas the JMDI appears to have an affinity for sequences containing the SXL 
motif, the pJMD1 appears to favor the LHSLL sequence. However, the fact that clones 
containing this sequence are also seen in the panning against JMD1 (Fig. 5) underscores the 
plasticity in the conformations of JMD1 and pJMD1 that differ only by one phosphorylation. 
We employed a phage ELISA to confirm the interaction between JMD1, JMD2, their 
phosphorylated derivatives and the phage displaying the “LHSLL” motif (pd-LHSLL). First, 
a homogenous population of pd-LHSLL phage particles was generated and tested for binding 
to JMD1, pJMD1, ppJMD1, JMD2, pJMD2, and the control peptides CTD2 and its 
phosphorylated form, pCTD2 derived from the C-terminal domain of ACR4 kinase (Table 1).  
In Figs. 7A and B, it is evident that all of the JMD1 peptides bind to the pd-LHSLL phage, 
thus reconfirming our phage panning results.  Furthermore, pd-LHSLL also bound the JMD2 
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peptides. This was not entirely surprising, since the JMD1 and JMD2 peptides share 
overlapping sequences and differ by only three amino acids.  The fact that little or no color 
was produced in the phage ELISA using the control peptides CTD2 and pCTD2 (Fig. 7), is 
an affirmation of the specificity of the LHSLL motif to the JMD peptides. To further confirm 
the specificity of interaction between LHSLL and the JMD peptides, we created a mutant 
motif AHALA in which the first Leu, the middle Ser and the last Leu residues of LHSLL 
motif were replaced with Ala. Subsequently, a homogenous population of phage particles 
displaying the mutant peptide sequence YRWWDSAINAHALAFSPPLFG (pd-AHALA) 
was produced and used in the phage ELISA. Relative binding affinities were reduced ~60-80 
% compared to pd-LHSLL phage binding, thus indicating the mutated residues are essential 
for efficient binding to the JMD1 peptides.   
LLSLL motif in ACR4 binds to the ACR4 JMD peptides 
 As mentioned earlier, consensus peptide sequences identified in phage display 
experiments can be searched against protein sequence databases to identify natural sequences 
that represent interaction partners with biological relevance. The predominant peptide 
(YRWWDSAINLHSLLFSPPLFG) isolated from panning against pJMD1 peptide contains 
the sequence LHSLL or the LXXLL motif.  Searching the Arabidopsis protein database with 
the motif LXXLL, retrieved a number of potential interacting proteins, including ACR4 and 
two of its homologs AtCRR3 and AtCRK1.   Indeed, the sequence LHSLL is almost identical 
to the sequence LLSLL found within the N-lobe of the ACR4 kinase domain. The similarity 
in residues on either side of this sequence is even more striking (AINLHSLLFS identified in 
the phage panning versus HAHLLSLLGY in ACR4).  This region in ACR4 is located on the 
back side of the kinase distal to the active site and comprises part of the β4 strand in the 
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model structure (Fig.8).  Interestingly, it is also worth noting that ACR4 contains a GLSLL 
sequence comprised of the Gly residue in the conserved DFG motif and the N-terminus of 
the activation loop (Fig. 8).  Crystal structures of the kinase domains of the Eph receptor 
family have shown that the juxtamembrane region is able to form intramolecular contacts 
with the kinase N-lobe and activation loop to stabilize the kinase in an inactive conformation 
(36, 44).  Therefore, we considered the intriguing possibility that the JMD of ACR4 may 
participate in intramolecular interactions involving the LLSLL motif and possibly via the 
LSLL sequence in the proximity of the activation loop.   
 To test this hypothesis, we also performed phage ELISAs (Fig. 9A) on immobilized 
JMD1, JMD2, and CTD2 peptides using a homogeneous population of phage displaying a 
15mer peptide LNHAHLLSLLGYCEE, corresponding to the LLSLL motif in ACR4 (acr4-
LLSLL) as well as the triple Ala mutant in which the first and last Leu and the central Ser of 
the LLSLL motif (acr4-ALALA) were changed to Ala.  The assays demonstrated the best 
binding between pJMD1 and acr4-LLSLL phage whereas affinity for the JMD1 and ppJMD1 
peptides was ~20% lower compared to pJMD1 (Fig. 9B).  The JMD2 peptide was also able 
to bind to the acr4-LLSLL phage, again indicating that the binding motif is conserved among 
the JMD1 and JMD2 peptides, as would be expected from their overall identity.  However, 
the binding of the acr4-ALALA mutant phage to the JMD1 and JMD2 series of peptides was 
distinctly less, once more demonstrating the importance of the mutated residues in binding to 
JMD peptides (Fig. 9A and B). Thus, our results indicate that JMD specific peptides can 
distinctively bind to the LLSLL motif within the ACR4 kinase N-lobe.   
JMD1 peptide binding to ACR4 KC 
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 Although we have demonstrated peptide-peptide interactions between JMD1 peptides 
and the ACR4 LLSLL peptide, the binding in the context of the full-length kinase domain 
remained to be ascertained.  Therefore, we performed peptide overlay assays to determine 
whether the JMD1 peptides could bind to the ACR4 kinase.  To ensure no interference from 
the juxtamembrane domain we used the sACR4 KC protein lacking the JMD.  As described 
in Materials & Methods, peptide binding to the blotted protein was assessed by colorimetric 
assay using streptavidin conjugated Alkaline Phosphatase.  All the peptides, JMD1, pJMD1, 
and ppJMD1 peptides bound to sACR4 KC (Fig. 10A, upper panel) but did not bind to the 
SUMO protein which was blotted as a control (Fig. 10A, lower panel).  Western blots using 
SUMO antibodies confirmed the presence of the sACR4 KC and SUMO proteins. In parallel 
experiments, we assessed peptide binding to sACR4 KC that was immobilized on Ni2+ coated 
plates via the N-terminal 6X His tag and incubated with either JMD1, pJMD1, or ppJMD1 
(Fig. 10B).  It is evident from this experiment that the phosphorylation state of the JMD1 
peptide has an effect on the binding efficiency with the doubly phosphorylated peptide 
(ppJMD1) exhibiting the strongest binding followed by the singly phosphorylated peptide 
(pJMD1) and the naïve peptide (JMD1). This influence of phosphorylation on JMD1 peptide 
binding was not obvious in the experiments involving peptide-peptide interactions and phage 
ELISAs and strongly suggests that structural features other than just the LLSLL motif in 
ACR4 may play an additional role in JMD1 peptide binding.  
Conformation of JMD1 peptides by circular dichroism 
Structure analyses of the kinase domains of several RTKs have shown that the JM 
regions adopt secondary structures that promote interactions with regions on the kinase 
domain (8, 29, 33, 45).  We determined the secondary structures of the JMD1 peptides by CD 
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analysis in aqueous buffer and in the presence of the helix inducer 2,2,2-trifluoroethanol 
(TFE).  In the absence of TFE, the JMD1 peptides form an extended coil conformation with 
the lowest negative molar ellipticity at 200 nm (Fig. 11A).  Phosphorylation at the two 
autophosphorylation sites does not appear to affect JMD1 conformation but a shallower 
minimum at ~222 nm indicates that the peptides can form some α-helical structure.  
Although the extended coil conformation is dominant among the three JMD1 peptides in 
aqueous buffer, it does not preclude the possibility that the JMD may form ordered secondary 
structures when in context of the full-length intracellular domain when anchored at the inner 
membrane surface.     
 To determine if we could promote an ordered conformation within the JMD1 
peptides, we measured the CD spectra in the presence of increasing concentrations of 
trifluoroethanol (TFE).  TFE is considered a helix inducer and has been used to monitor 
helical formation in oligopeptides (46-48).  In the presence of increasing concentrations of 
TFE, the minimum absorption peak shifts from 200 to 204 nm and there is an obvious 
increase in the negative ellipticity at 222 nm, indicating the adoption of a helical 
conformation in the phosphorylated peptides (Fig. 11B and C).  The shape of the curves is 
also increasingly characteristic of a helical conformation. Interestingly, pJMD1 shows the 
greatest increase in negative molar ellipticity at 222 nm, implying that the singly 
phosphorylated peptide can adopt a more ordered structure.  These results suggest that the 
JMD1 peptides have the capacity to adopt a more ordered conformation depending on the 
phosphorylation status. However, further studies of the entire 28 amino acid JMD need to be 





 Multicellular organisms require a highly regulated array of signal transduction 
networks to promote cell fate specification and growth. Strict control of these networks 
ensures proper cell patterning and tissue development within the organism. In both animals 
and plant cells, directed cell differentiation, growth and development are facilitated via a 
variety of external stimuli that are appropriately interpreted by a multitude of cell surface 
receptors. In animal cells, this response is mediated predominantly through RTKs and in 
plants by RLKs. The classical paradigm of signal transduction involves ligand binding to 
receptor, activation/autophosphorylation of kinase domain and subsequent activation of 
downstream signaling pathways.   
However, the regulation of kinase activity through reversible phosphorylation is of 
critical importance to maintaining cellular homeostasis and ensuring the fidelity of 
physiological processes. There are a multitude of mechanisms that regulate kinase activity 
and important insights into the molecular basis of regulation have come from 
crystallographic studies of several RTK kinase domains (7, 49).  One common mechanism 
involves the ordered phosphorylation of key residues in the activation loop or segment (50, 
51).  Autophosphorylation at these sites causes a conformational change that relieves cis-
autoinhibitory constraints (52-54).  Importantly, other biochemical and structural studies 
provide evidence for the involvement of non-catalytic regions in regulation of kinase activity. 
Thus, in several receptors such as the ephrin binding receptor (EpH) family (29), platelet-
derived growth factor (PDGF) receptor family (33), and the epidermal growth factor receptor 
(EGFR) family (55), the juxtamembrane domain, proximal to the N-terminus of the kinase 
domain, is a major regulatory domain (9). Similarly, a domain on the carboxyl side of the 
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kinase domain can be autoinhibitory as has been demonstrated for the receptor TIE2 (56). 
Among plant RLK’s, the CTD of BRI1 is a negative regulator of kinase activity and the 
phosphorylation of this domain enhances the activity (11). 
In the absence of structural information, we have probed the role of the JMD in 
ACR4 kinase through mutagenesis and peptide binding studies. On this basis, we present 
evidence for a model that strongly suggests that the JMD is involved in an intramolecular 
interaction that may inhibit the activation segment in the kinase domain from adopting the 
activated conformation for optimal activity.  Thus, in kinetic experiments, the significant 
decrease in the efficiency of substrate phosphorylation (Fig. 3 and Table 2) by the JMD-2A 
mutant (phosphorylation sites Ser475 and Thr478 knocked out with Ala substitutions) and the 
restoration of wild-type activity levels in JMD-2D (Ser475 and Thr478 replaced with the 
phosphomimetic Asp residue) attests to the importance of phosphorylation at these two sites 
for kinase activity against substrates. This is not surprising since it is well established in 
many receptor kinases that phosphorylation of sites within the JM and CTD regions not only 
serve a regulatory function but are a prerequisite for efficient substrate binding and 
phosphorylation (30, 31, 57).   Alanine scanning mutagenesis studies with the BRI1 
intracellular domain has demonstrated that loss of autophosphorylation sites in the JMD can 
in fact decrease BR13 peptide substrate phosphorylation in vitro without any noticeable 
effect on autophosphorylation (31). On the other hand, removal of the JMD in ACR4 kinase 
enhances substrate phosphorylation compared to the wild-type protein (Fig. 3B). These 
observations can be correlated with a model in which the JM region, in the unphosphorylated 
state, occludes the active site and prevents efficient substrate binding. Significantly, this 
negative effect is relieved by phosphorylation of Ser475 and Thr478 in the JMD. Indeed, 
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biochemical and structural information on RTKs such as FLT3, cKIT, cFMS-1, MuSK and 
members of the Eph receptor family demonstrate a similar mode of regulation in which the 
unphosphorylated JMD allosterically regulates kinase activity by making extensive contacts 
across the kinase domain causing disruption of the αC helix and/or sterically hindering the 
activation loop from adopting an active conformation. Maximal kinase activity is restored 
when the phosphorylated juxtamembrane moves away from the active site (29, 32-34, 36, 44, 
53).  Interestingly, in the case of ErbB2, mutational studies indicate that the αC-β4 loop 
functions as an intramolecular switch in controlling the kinase activity (58).  This region is 
analogous to the LLSLL region in the ACR4 kinase domain as shown in Fig.8.  
 However, our kinetic experiments do not provide information about the molecular 
details or the mechanism of the proposed intramolecular interaction. It is also well known 
that short linear motifs or SLiMS, which consist of a peptide sequence less than 10 residues 
long, often mediate protein-protein interactions and are found predominantly in signaling and 
regulatory networks (59-61). Linear peptide-peptide interactions are governed not only by 
primary sequence, but spatial arrangements of side chains within peptide secondary 
structures that can act as “hot points” for specific interactions (62). Some of the best 
exemplified linear motifs are those interacting with the Src Homology 2 (SH2), 
phosphotyrosine-binding (PTB) and 14-3-3 domains. Typically, interactions mediated by 
linear motifs are transient in nature and are characterized by weak affinities with dissociation 
constants in the micromolar range, perhaps attributable to the small number of residues that 
are involved in direct contact. Screening with phage-peptide libraries offers a facile way of 
identifying short peptides with varying affinities and specificities owing to the control that 
can be exercised in the binding and washing steps in each cycle of panning (63).  
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Our phage display experiments have defined consensus peptide binding motifs for the 
unphosphorylated and phosphorylated JMD peptides. The two peptides differ only in the 
phosphorylated Ser475 in pJMD1. The predominant peptide sequences binding to the 
unphosphorylated JMD1 contained an SXL motif whereas the pJMD1 preferred the 
consensus binding sequence LXSLL.  This suggests that phosphorylation at Ser475 promotes 
a structural change that shifts the affinity of the phosphorylated peptide to a similar but 
subtly different target sequence.  The specificity of interaction between the phage-selected 
peptide pd-LHSLL and pJMD1 was confirmed in our phage ELISA assays (Fig. 7).  
Furthermore, mutations in the LHSLL motif (i.e. AHALA) significantly diminished binding 
to the pJMD1 sequence indicating the critical role of the two Leu and one Ser residues. Most 
intriguingly, the sequence NHAHLLSLLGY found in the ACR4 kinase N-lobe, contains the 
LXSLL motif and, indeed, the phage displayed peptide corresponding to the LLSLL region 
of ACR4 (acr4-LLSLL) recognizes and binds to the JMD1 peptides in a phage ELISA (Fig. 
9). Significantly, mutations of the LLSLL motif to ALALA drastically reduce the efficiency 
of binding.  These observations reinforce the contention that there is an interaction between 
the juxtamembrane region and the kinase domain.  
In addition, it is particularly interesting that the SXL signature is found in the 
sequence GLSLL at the beginning of the activation loop just after the DFG sequence in the 
kinase domain.  This, along with the fact that the unphosphorylated JMD1 has a preferential 
interaction with the SXL sequence, hints to the GLSLL region as a possible site of interaction 
for the unphosphorylated JMD with the kinase domain. On the basis of these experiments, we 
invoke a possible mechanism for the regulation of ACR4 kinase activity modulated by 
autophosphorylation of Ser475 and Thr478 of the JMD.  In our model, in the unphosphorylated 
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state, the juxtamembrane domain holds the kinase in a ‘closed’ inactive conformation 
perhaps through interactions with the GLSLL sequence located in the proximity of the 
catalytically important αC helix and the activation loop. Upon autophosphorylation, the 
phosphorylated juxtamembrane undergoes a conformational change, which switches its 
affinity to the LLSLL region towards the back side of the kinase (Fig. 12).  Based on the 
proximity of the LLSLL and the GLSLL regions to one another in the modeled kinase 
tertiary structure (Fig. 8), it would not be unreasonable to speculate that the JMD can move 
back and forth between these two positions.  Thus, phosphorylation-dephosphorylation of 
Ser475 and/or Thr478 in JMD could act as a molecular switch to regulate ACR4 kinase activity 
through conformational changes in the activation segment and the N-lobe of the kinase. The 
ability of the JMD peptides, in particular pJMD1 and ppJMD1, to adopt an α-helical structure 
in the presence of TFE (Fig. 11B and C) is supportive of the intrinsic ability of this region to 
switch from an unordered to an ordered state subsequent to phosphorylation.  Further support 
for a conformational switch mechanism comes from our peptide inhibition studies (Fig. 2) in 
which we have demonstrated the inability of the phosphorylated JMD1 to repress the 
autophosphorylation activity in comparison with the distinct ability of the unphosphorylated 
and mutant JMD1 to exert significant repression. Our observation is analogous to that 
observed for the inhibition of the Kit RTK kinase activity by the wild type JM region but not 
by the phosphorylated derivative (8). 
   In this body of work, we have described a putative model for the intramolecular 
regulation of ACR4 kinase activity by the juxtamembrane region. Clearly, however, more 
detailed experiments are needed to provide the contextual specificity of this model in 
conjunction with the potential role of the 105 amino acid carboxyl terminal domain which 
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has at least 6 autophosphorylation sites (26).  Indeed, the carboxy-terminal tail is known to 
function as a negative regulator of receptor kinase activity in the RLK BRI1 (11) and the 
RTK TIE2 (56, 64).  Phosphorylations within the JMD/CTD may also be responsible for 
recruitment of substrate proteins (65-68) by creating docking sites for the recruitment of 
downstream interaction partners. It is therefore important to understand the connection 
between kinase activation and the sequestration or release of phosphorylation sites.  
Complementary mutagenesis studies in vivo, which may drive varied phenotypic effects, will 
also help understand the molecular basis of kinase function and the ACR4 mediated signaling 
network. Finally, the determination of the three dimensional structure of the kinase in the 
activated and inhibited state will provide atomic level detail of the mechanistic aspects of 
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CHAPTER 5.  INTERMOLECULAR INTERACTIONS BETWEEN THE 
INTRACELLULAR DOMAINS OF ACR4 AND THE AtCRRs SIGNIFIES 
POTENTIAL CROSSTALK AMONG THE RECEPTOR FAMILY 
 
A paper to be submitted for publication in ACS Biochemistry. 
M.R. Meyer, S. Shah, J. Zhang, C.F. Lichti, R.R. Townsend, and A.G. Rao 
 
Abstract 
Arabidopsis CRINKLY4 (ACR4) is a receptor-like kinase (RLK) involved in the 
global development of the plant.  acr4 mutant plants show disorganized epidermal formation 
in leaves and reproductive tissues consequentially affecting aerial organ development.  
Additionally, loss of ACR4 function results in proliferation of columella stem cells (CSC) in 
the root tip and increased lateral root initiation in developing roots.  A negative feedback 
mechanism has been proposed between the CLE40 peptide, ACR4, and the WOX5 
transcription factor to regulate CSC differentiation.     The Arabidopsis genome encodes four 
homologs to ACR4 that contain sequence similarity and analogous architectural elements to 
ACR4, termed Arabidopsis CRINKLY4 Related (AtCRRs) proteins.  Genetic and cell 
biology studies have suggested potential communication between members of the ACR4 
gene family.  However, little biochemical evidence is available to ascertain the molecular 
aspects of receptor hetero-oligomerization and the role of phosphorylation in these 
interactions.  Therefore, we have undertaken an investigation of the in vitro interactions 
between the intracellular domains (ICD) of ACR4 and the CRRs and an additional RLK 
involved in epidermis formation, ALE2.  We demonstrate that ACR4 can interact with all 
four CRRs in a phosphorylation independent manner.  Furthermore, sequence analysis of the 
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ACR4 gene family has revealed a conserved ‘KDSAF’ motif that may be involved in protein-
protein interactions among the receptor family.  We demonstrate that CRR3, CRK1, and 
ALE2 peptides harboring this conserved motif are able to bind to the ACR4 kinase domain, 
presumably through the LLSLL motif in the kinase N-lobe.  We also employed multiple 
techniques to characterize a potential interaction between ACR4 and WOX5 and, show for 
the first time, that WOX5 is able to bind to ACR4 in a phosphorylation independent fashion. 
Furthermore, mass spectrometry analysis shows WOX5 is phosphorylated by ACR4 at four 
different sites in vitro.  Lastly, phage display panning of a phosphorylated peptide in the 
juxtamembrane domain has identified two consensus interaction motifs, LXSLL and 

















ACR4, Arabidopsis CRINKLY4; ALE2, ABNORMAL LEAF SHAPE 2; AP, alkaline 
phosphatase; AtCRR, Arabidopsis CRINKLY4-Related; ATP, adenosine triphosphate; BRI1, 
Brassinosteroid insensitive 1; CR4, maize CRINKLY4; CD, circular dichroism; AtCRR, 
Arabidopsis CRINKLY4 related; CTD, carboxy-terminal domain; DTT, dithiothreitol; 
EGFR, epidermal growth factor receptor; ICD, intracellular domain; KC, kinase + carboxy 
terminal domain; JM, juxtamembrane; KD, kinase domain; MyBP, myelin basic protein; 
NusA, N-utilization substance A; PBS, phosphate buffered saline; PDGF, platelet derived 
growth factor; pNPP, p-nitrophenyl phosphate; RLK, receptor-like kinase; RTK, receptor 
tyrosine kinase; SERK, somatic embryogenesis receptor-like kinase; TCEP, Tris (2-
carboxyethyl) phosphine hydrochloride;  TFE, trifluoracetic acid; TBS, tris buffered saline; 















 Mammalian systems have acquired signal transduction mechanisms via the use of 
receptor tyrosine kinases (RTK) to coordinate cellular processes such as proliferation, 
migration, differentiation, and cell-cycle control (1).  RTKs are comprised of an extracellular 
ligand binding domain, a single membrane spanning region, and an intracellular tyrosine 
kinase domain.  The classical paradigm of RTK activation involves ligand binding to the 
extracellular domain and receptor homo- or heterodimerization through interactions among 
receptor subdomains (1-5).   
 Similar to RTKs in architecture, plant RLKs contain an extracellular ligand binding 
domain, a transmembrane helix, and an intracellular serine/threonine kinase domain and are 
involved in various plant signaling processes (6-9).  It is evident from structural and 
biochemical studies that mechanisms of RLK signaling are similar to RTKs where ligand 
binding leads to receptor activation and initiation of an intracellular signaling cascade.  
Furthermore, it has been demonstrated in RTKs that homo- or heterodimeric receptor 
complexes can elicit differential signaling cascades based on intracellular kinase 
autophosphorylation and recruitment of specific signaling molecules as classically 
exemplified by the EGF receptor family (10-12).  Among RLKs, the heterodimeric 
interactions between BRI1 and BAK1 and its effects on downstream signaling are well 
documented (13, 14).   
 Arabidopsis CRINKLY4 (ACR4) is a RLK involved in the proper growth and 
development of the plant (15-18).   We have recently reported on some significant in vitro 
biochemical properties of the ACR4 intracellular domain including its kinase activity, its 
oligomerization properties, and the identification of at least 16 autophosphorylation sites 
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encompassing all three subdomains (19).  Genetic and biological experiments have detailed 
the functional properties of ACR4 in developing and mature tissues.  The RLK primarily 
effects epidermal formation in the leaves, sepal margins, and reproductive tissues of the plant 
(15, 16, 18).  Another RLK, ALE2, has been shown to affect epidermis related tissues and to 
function in the same genetic pathway as ACR4.  Furthermore, recombinant kinase domains 
of both receptors have been shown to synergistically enhance their activities in an in vitro 
kinase assay (20).  ACR4 is also known to influence root development and morphology.  
Thus, ACR4 is required for columella stem cell differentiation in the root apical meristem 
and is essential for proper lateral root formation (21, 22).   A signaling module has been 
proposed including a postulated peptide ligand, CLE40, the ACR4 RLK, and the WOX5 
transcription factor that engage in a possible feedback mechanism controlling stem cell 
differentiation similar to CLAVATA signaling in the shoot apical meristem (22-24).   
 The Arabidopsis genome encodes four homologs to ACR4, termed Arabidopsis 
CRINKLY4-Related proteins (AtCRRs), which are similar in sequence and architecture to 
ACR4 (17).  Both CRR1 and CRR2 have been described as kinase-defective due to the 
absence of the activation loop, a stretch of sequence critical for activity (17, 25).  
Recombinant CRR2 kinase domain has been shown to have little to no activity in vitro (17) 
but can be phosphorylated by ACR4 kinase, suggesting a possible intermolecular interaction.  
Functional redundancy has been suggested to account for the five members of the ACR4 
gene family (17). Developing Arabidopsis roots showed significant enhancement of lateral 
root densities in acr4/crr triple mutant backgrounds compared to acr4 single mutants, 
suggesting that the CRRs may be able to compensate for loss of ACR4 function in restricting 
lateral root initiation (21).  Various genetic and cell biology experiments have hinted at 
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multiple players/interactions potentially involved in the ACR4 signaling network.  However, 
the molecular aspects of these interactions with potential membrane-associated or cytosolic 
protein targets at the cell surface is vaguely understood.   
To better understand the role of protein-protein interactions mediated by ACR4, we 
have undertaken an in vitro study of the interactions between the intracellular domains (ICD) 
of ACR4 and the CRRs. We have utilized in vitro kinase assays to show that the ACR4 can 
phosphorylate the CRRs and ALE2.  Furthermore, the ACR4 ICD can interact with all of the 
CRR ICDs in a phosphorylation independent manner.  Notably, interactions seen between 
ACR4 and CRR3 and CRK1 are mitigated by kinase autophosphorylation. Additionally, 
peptide binding assays demonstrate a conserved ‘KDSAF’ motif in the helix-C region of 
CRR3, CRK1, and ALE2 bind to the ACR4 kinase domain. Phage display screening of 
‘KDSAF’ motif peptide has identified two consensus motifs, LXSLL and FXPYEL, as 
interaction sequences.  For the first time, we also provide evidence for the direct interaction 
of ACR4 ID with WOX5 in the absence of autophosphorylation. Importantly, ACR4 can 
phosphorylate WOX5 in vitro and mass spectrometry analysis has identified four 
phosphorylation sites within the WOX5 protein sequence.   
 
Materials and Methods 
Protein expression and purification 
 Vectors encoding the SUMO fused kinase domains of ACR4, the CRRs, and ALE2 
were transformed into Rosetta2 (DE3) pLysS (Novagen) cells and plated on Kanamycin 
plates.  Luria Broth cultures supplemented with 50 μg/ml Kanamycin were initiated by 
standard procedures.  Cultures were grown with shaking at 37 °C for ~3 h until an OD600 = 
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0.6-0.8 was reached.  The temperature was reduced to 20 °C and cultures were induced with 
1 mM IPTG.  The cultures were incubated for 5 h, harvested by centrifugation, and stored at -
80 °C until needed.  To purify the SUMO fused proteins, frozen pellets from 250 ml cultures 
were thawed on ice and resuspended in 10 ml Lysis Buffer (50 mM Tris-HCl pH 7.4, 150 
mM NaCl, 40 mM imidazole, 0.1% Triton X-100, 1 mM DTT, and 1 mM AEBSF).  Cells 
were lysed by sonication on ice and the resulting lysate was centrifuged at 13,200 rpm for 15 
min at 4°C.  Supernatants were then transferred to a 10 ml column containing 250 μl of Ni-
NTA Superflow resin (Qiagen) equilibrated with Lysis Buffer.  The resin/lysate mixture was 
incubated on a rocker at 4°C for 1 h.  After incubation, the unbound proteins were allowed to 
flow through the column.  The resin was washed with 10 ml of Wash Buffer (50 mM Tris-
HCl pH 7.4, 150 mM NaCl, 50 mM imidazole, 1 mM DTT).  Bound proteins were eluted 
into individual microfuge tubes with three successive 250 μl aliquots of Elution Buffer (50 
mM Bis-Tris pH 7.2, 50 mM NaCl, 150 mM imidazole, 1 mM DTT) on ice.  Protein 
quantities were determined by the Bradford method.  Protein yields depended on the protein 
being purified and typically ranged from 1-5 mg of protein.   
 To isolate the mACR4 protein, the vector encoding the MBP fused ACR4 kinase was 
transformed into T7 Express cells (New England Biolabs) and plated on Ampicillin plates.  
Protein expression and purification was performed as described above, except Ampicillin 
(100 μg/ml) was used in cultures.  Further purification of the IMAC enriched protein was 
required.  Enriched protein, ~1 mg in 500 μl, was passed over a Global 10/300 Superdex 
G200 column (GE Healtchare) equilibrated with Column Buffer (50 mM Tris-HCl 7.4, 100 
mM NaCl, 1 mM DTT).  Protein was eluted at a rate of 0.4 ml/min and fractions 
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corresponding to the full length mACR4 protein were collected and pooled to be used for 
further study. 
Pull-down assays 
 The mACR4 kinase (20 µg per reaction) was used as bait to pull out sCRR/ALE2 
kinase domains (30 µg per reacton).  Depending on the assay conditions, proteins were 
autophosphorylated in proteins 200 µl Kinase Buffer (20 mM Bis-Tris pH 7.2, 25 mM NaCl, 
5 mM MnCl2, 1 mM DTT) and 100 µM ATP.  Proteins were allowed to autophosphorylate 
for 1 h prior to pull-down experiments.  Potential binding partners were added to each 
reaction and Binding Buffer (50 mM Tris-HCl pH 7.4, 150 mM NaCl, 1 mM DTT, 0.02% 
NP-40) was added to a final volume of 500 µl.  Proteins were incubated on a rotator for 1 h at 
room temperature.  25 µl bed volume of amylose resin was added to each reaction and 
incubated an additional 1 h on a rotator at room temperature.  Reactions were spun down at 
1,000 rpm for 30 sec to pellet the resin.  The resin was washed three times with Binding 
Buffer to remove unbound protein.  After the third wash, the supernatant was removed and 
100 µl of Laemmli buffer was added to the resin.  The resin/protein mixture was boiled at 95 
ºC for 5 min then centrifuged at max speed to pellet resin.  10 µl of supernatant from each 
reaction was separated by 12% SDS-PAGE and proteins were analyzed by coomassie 
staining or by western blots with polyclonal anti-MBP (Rockland Immunochemicals, 1:3,000 
dilution) or anti-SUMO (Rockland Immunochemials, 1:2,000 dilution) 
The kinase active proteins were used for conditions requiring phosphorylated or 
unphosphorylated proteins of both interacting partners (Fig. 2, panels A and D).  The inactive 
kinase mutants were used for conditions which required one protein of the interaction pair to 
be unphosphorylated (Fig. 2, B and C).  A special case was made for the sALE2 protein for 
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which an inactive mutant was unstable (Fig. 2B).  First, mACR4 protein was 
autophosphorylated as described above, immobilized on 25 µl of amylose resin, and washed 
three times with Binding Buffer to remove excess ATP.  Binding of naïve, active sALE2 then 
proceeded as described above.  
mWOX5 protein was used to pull down sACR4 protein similar to the protocol 
outlined above.  Briefly, 20 μg of mWOX5 protein was incubated with 30 μg of sACR4 
protein.  Depending on the assay conditions, sACR4 was autophosphorylated as described 
above.  mWOX5 and sACR4 were added to a reaction and Binding Buffer was added to a 
final volume of 500 µl.  Proteins were incubated and pulled-down as described above.  10 µl 
of supernatant from each reaction was separated by 10% SDS-PAGE and proteins were 
analyzed by coomassie staining or by western blots with polyclonal anti-MBP (Rockland 
Immunochemicals, 1:3,000 dilution) or anti-SUMO antibody (Rockland Immunochemicals, 
1:2000 dilution). 
Gel filtration studies 
 Purified sACR4 protein was incubated with a sCRR/ALE2 protein at equimolar 
concentrations to determine possible interactions.  5 µM sACR4 was incubated with 5 µM of 
binding partner in 500 µl of Column Buffer (50 mM Tris pH 7.4, 100 mM NaCl, 1 mM DTT, 
and 100 µM MnCl2) for 1 h at room temperature.  Protein mixtures were then loaded onto a 
Global 10/300 Superdex G-200 Column (GE Healthcare) coupled to an AKTA FPLC system.  
Prior to protein loading the column was equilibrated with Column Buffer.  Proteins were 
passed through the column at a flow rate of 0.5ml/min and 1 ml fractions were collected.  
Proteins in subsequent fractions were analyzed by 12% SDS-PAGE.   
In vitro phosphorylation assays 
174 
 
 Active sACR4 protein was incubated with the inactive sCRRm/ALE2m proteins.  For 
each reaction 1 μg of sACR4 was incubated with ~1 μg of sCRRm/ALE2m in 20 μl of 
Kinase Buffer (20 mM Bis-Tris pH 7.2, 25 mM NaCl, 5 mM MnCl2, 1 mM DTT, 25 μM 
ATP) supplemented with 2 μCi of [γ-32P] ATP (Perkin Elmer, 6,000 Ci/mmol).  Proteins 
were incubated at room temperature for 1 h.  Reactions were then terminated with the 
addition of 4X SDS sample buffer and boiled.  Proteins were separated by 12% SDS-PAGE 
and radioactive bands were analyzed by phosphorimaging.   
 A modified in vitro phosphorylation assay was used for sACR4 and mWOX5 since 
they migrate similarly on an SDS-PAGE gel.  Phosphorylation proceeded in a 50 μl reaction 
containing 2 μg of sACR4 and 30 μg of mWOX5 (or 30 μg of MBP as a control) in Kinase 
Buffer as described above.  Following incubation, mWOX5 protein was pulled-down using 
amylose resin.  The phosphorylation reactions were brought up to 500 μl with Wash Buffer 
(50 mM Tris-HCl pH 7.4, 150 mM NaCl, 1 mM DTT, and 0.5% NP-40).  25 µl bed volume 
of amylose resin was added to each reaction and incubated an additional 1 h on a rotator at 
room temperature.  Reactions were spun down to pellet the resin and the supernatant was 
removed.  The resin was washed five times with 500 μl of Wash Buffer to remove unbound 
protein.  After washing, the supernatant was removed and 100 µl of Laemmli buffer was 
added to the resin.  The resin/protein mixture was boiled at 95 ºC for 5 min then centrifuged 
to pellet resin.  Proteins from each reaction were separated by 10% SDS-PAGE and analyzed 
by phosphorimaging. 
 To examine sACR4 phosphorylation of the CRR3, CRK1, and ALE2 hC peptides, a 
similar assay was used as described above.  For each reaction 1 μg of sACR4 was incubated 
with 10 μg of peptide in 20 μl of Kinase Buffer supplemented with 2 μCi of [γ-32P] ATP.  
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Proteins/peptide reactions were incubated at room temperature for 1 h.  Reactions were then 
terminated with the addition of 4X SDS sample buffer and boiled. Proteins/peptides were 
separated by 16.5% Tris/tricine gel (Bio-Rad). Peptide bands were fixed into the gel by 
incubating in 12.5% glutaraldehyde for 30 min.  The gel was then washed three times with 
distilled water then stained with coomassie blue. Radioactive bands were analyzed by 
phosphorimaging.   
Identification of WOX5 phosphorylation sites by mass Spectrometry.  
This was performed as described by Meyer et al. (19). Briefly, tryptic peptides were 
generated from the reduced-alkylated protein using Sequencing Grade Modified Trypsin 
(Promega).  The resulting peptides were desalted on a SOURCE 15 RPC column (GE 
Healthcare) and eluted in 90% acetonitrile, 0.1% TFA.  The eluted peptides were then dried 
down in a vacuum centrifuge.  Phosphopeptides were enriched using the PHOS-Select Ga3+ 
Silica Spin Column kit (Supelco) according to the kit instructions. The complex peptide 
mixtures were analyzed using high-resolution nano-LC-MS on a hybrid mass spectrometer 
consisting of a linear quadrupole ion-trap and an Orbitrap (LTQ-Orbitrap XL, Thermo Fisher 
Scientific). Chromatographic separations were performed using a NanoLC-1D™ Plus 
(Eksigent) for gradient delivery and a cHiPLC-nanoflex (Eksigent) containing a 15 cm x 75 
μm C18 column (ChromXP C18-CL, 3 μm, 120 Å, Eksigent). The liquid chromatograph was 
interfaced to the mass spectrometer with a nanospray source (PicoView PV550; New 
Objective). The survey scans (m/z 350-2000) (MS1) were acquired at high resolution (60,000 
at m/z = 400) in the Orbitrap and the MS/MS spectra (MS2) were acquired in the linear ion 
trap at low resolution, both in profile mode. The MS1 scan was followed by one MS2 event 
with collision activation in the ion trap (parent threshold = 10000; isolation width = 4.0 Da; 
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normalized collision energy = 30%; activation Q = 0.250; activation time = 30 ms).  The 
following ion source parameters were used: capillary temperature 200 ºC, source voltage 3.3 
kV, source current 100 μA, capillary voltage 34 V, and the tube lens at 125 V.   
Data Analysis.  
The MS2 spectra were analyzed by searching against the WOX5 sequence and expert 
manual interpretation. The exact masses of the phosphopeptide and fragmentation ions were 
calculated using the MS-Product utility within Protein Prospector 
(http://prospector.ucsf.edu).  For database searches, the LC-MS files were processed using 
MASCOT Distiller (Matrix Science, version 2.3.0.0) with the settings previously described 
(20). The resulting MS2 centroided files were used for database searching with MASCOT, 
version 2.1.6, against a custom, in-house database containing the WOX5 sequence using the 
following parameters: enzyme, trypsin; MS tolerance = 15 ppm, MS/MS tolerance = 0.8 Da 
with a fixed carbamidomethylation of Cys residues and the following variable modifications: 
oxidation (Met) and phosphorylation (Ser, Thr, and Tyr); Maximum Missed Cleavages = 9; 
and 1+, 2+ and 3+ charge states. For analysis of the tandem spectra from spectral acquisitions 
in the Orbitrap (MS2), the raw files were processed using MASCOT Distiller (Matrix 
Science, Oxford, UK) with the following settings: 1) as described previously (19).  
Hydrogen/Deuterium Exchange Mass Spectrometry 
 Differential, solution phase HDX experiments were performed to detect the 
conformational change of sACR4 induced by the addition of sALE2 or sCRK1. Each 
exchange reaction was initiated by incubating 4 l of protein complex (with or without ALE2 
or CRK1) with 16 l of D2O protein buffer (50 mM Bis Tris pH 7.2, 25 mM NaCl, 0.1 mM 
MnCl2, 1 mM DTT) for a predetermined time (10, 30, 60, 120, 900, and 3600 s) at 4 °C. The 
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exchange reaction was quenched by mixing with 30 l of 3 M urea, 1% TFA at 1 °C. The 
mixture was passed across an in-house packed pepsin column (2 mm X 2 cm) at 200 l/min 
and digested peptides were captured onto a 2mm X 1cm C8 trap column (Agilent) and 
desalted (total time for digestion and desalting was 3 min). Peptides were then separated 
across a 2.1 mm X 5 cm C18 column (1.9 Hypersil Gold, Thermo Scientific) with linear 
gradient of 4%–40% CH3CN, 0.1% formic acid, over 5 min. Protein digestion and peptide 
separation were performed within a ice water bath to reduce D/H back exchange. Mass 
spectrometric analyses were carried out with capillary temperature at 225 °C, and data were 
acquired with a measured resolving power of 100,000 at m/z 400. Three replicates were 
performed for each on-exchange time point. 
Peptide Identification and HDX Data Processing 
 MS/MS experiments were performed with a LTQ Orbitrap mass spectrometer 
(ThermoFisher). Product ion spectra were acquired in a data-dependent mode and the six 
most abundant ions were selected for the product ion analysis. The MS/MS *.raw data files 
were converted to *.mgf files and then submitted to Mascot (Matrix Science, London, UK) 
for peptide identification. Peptides included in the peptide set used for HDX had a MASCOT 
score of 20 or greater. The MS/MS MASCOT search was also performed against a decoy 
(reverse) sequence and ambiguous identifications were ruled out. The MS/MS spectra of all 
of the peptide ions from the MASCOT search were further manually inspected, and only 
those verifiable are used in the coverage. The intensity weighted average m/z value (centroid) 
of each peptide isotopic envelope was calculated with HD Desktop (26). The deuterium level 
was calculated as described previously (27).  Deuterium level (%) = {[m(P) - m(N)]/[m(F) - 
m(N)]} X 100%, where m(P), m(N) and m(F) are the centroid value of partly deuterated 
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peptide, nondeuterated peptide, and fully deuterated peptide, respectively. The correction of 
accounting for the known 80% deuterium content of the on-exchange buffer was made. No 
back exchange correction was made and all values are therefore reported as relative. 
Homology models of ACR4 and AtCRK1 kinase domains 
Homology models for the ACR4 kinase domain (residues 512 through 785 in the 
whole receptor) and the AtCRK1 kinase domain (residues 444 through 729 in the whole 
receptor) were built using Discovery Studio v 3.1 (Accelrys, San Diego, USA). Sequence 
analysis identified Interleukin-1 receptor associated kinase (PDB identification 2NRU_B) as 
the optimal template based on ~50% homology and 34% identity in the amino acid 
sequences.  Protein models were generated by MODELER, which was originally developed 
by Sali (28) and the refined model was validated using the Verify Protein (Profiles-3D) 
protocol, which assesses the compatibility of the 3D structure of the protein model with its 
amino acid sequence. 
Peptide overlay assays 
 The ‘KDSAF’ motif containing peptides (Fig. 7A) were chemically synthesized 
(Genscript) and engineered with an N-terminal biotin tag.  Peptides were diluted 2.5 mM in 
Tris-HCl buffer, pH8.0.   To demonstrate peptide binding to sACR4 KC protein, 2 μg of 
sACR4 KC and 2 μg of SUMO protein were separated by 12% SDS-PAGE and blotted to 
nitrocellulose membrane.  Blots were briefly stained with a 0.1% Ponceau S solution to 
locate the protein bands.  Bands were then cut from the blot, appropriately labeled, and 
destained in successive washes with distilled water and a final wash in 1X TBS (50 mM Tris-
HCl pH 7.4, 150 mM NaCl) to remove Ponceau S staining.  Blots were then blocked with 5% 
milk protein in TBS + 0.1% Tween 20 for 1 h.   After blocking, blots were washed three 
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times with TBS + 0.1% Tween 20 (5 min each wash) and then added to individual microfuge 
tubes containing 1 ml of TBS and the appropriate peptide to a final concentration of 100 μM.  
To demonstrate specific binding to ACR4, peptides were also incubated with SUMO protein 
as a control. Blots were incubated on a rotating platform for 2 h at room temperature, 
followed by two washes with 1.5 ml of TBS at 5 min intervals.  To detect peptide binding, 1 
ml of TBS containing 1:500 streptavidin conjugated Alkaline Phosphatase (AP) (Pierce) was 
added to each tube.  Blots were incubated on a rotator for 1 h at room temperature, washed as 
described above to remove excess streptavidin-AP followed by colorimetric detection of 
peptide binding using the AP Substrate kit (Bio-Rad).  The presence of sACR4 and SUMO 
proteins were confirmed in separate blots probed with anti-SUMO primary antibody (1:1000) 
and polyclonal anti-rabbit secondary antibody (Sigma, 1:15,000). 
Peptide binding assays 
 The binding of ‘KDSAF’ peptide binding to sACR4 KC protein was demonstrated as 
follows.  First, a 96 well nickel coated plate (XpressBio) was washed three times with TBS + 
0.1% Tween20, excess wash buffer was discarded.  A 0.8 μM solution of sKC (5 μg/100 μl) 
or SUMO protein (1 μg/100 μl) was prepared in TBS + 0.1% Tween 20.  100 μl of 
appropriate protein solution was added to individual wells and incubated on an orbital shaker 
for 1 h at room temperature to allow protein to bind to the plate.  Wells containing 
immobilized sKC or SUMO protein were washed three times with TBS + 0.1% Tween 20 to 
remove unbound material.  ‘KDSAF’ peptide solutions were prepared in TBS to a final 
concentration of 200 μM.  50 μl of the peptide solutions were added to appropriate wells and 
allowed to incubate on an orbital shaker for 2 h at room temperature.  After incubation, 
excess peptide solution in the wells was discarded.  Wells were then washed with TBS two 
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times with gentle shaking to remove unbound peptides.  50 μl of a streptavidin-AP solution 
(1:500) was added to each well and incubated on an orbital shaker for 1 h at room 
temperature.  Streptavidin-AP solution was discarded and the wells were washed twice with 
TBS using gentle shaking, excess wash buffer was discarded.  Colorimetric detection of 
peptide binding was initiated by adding 100 μl of a pNPP solution (100 mM ethanolamine 
pH 9.8, 10 mM pNPP) to each well.  The reactions were allowed to incubate 5 min with 
occasional manual shaking.  Reactions were terminated with the addition of 50 μl of 2N 
NaOH to each well.  100 μl of each reaction was diluted with 400 μl of water and 
absorbances at 405 nm were obtained.  Bar diagrams were generated by accounting for the 
dilution factor and subtracting the absorbance of the control (SUMO) wells from the 
experimental (sACR4 KC) wells.  Each peptide binding experiment was performed in 
triplicate. 
Phage peptide library construction   
The phagemid vector pCANTAB 5E (GE healthcare) was used to construct a random 
21-amino acid library fused to the pIII coat protein (Rao laboratory, unpublished data). 
Briefly, two oligonucleotide primers were first synthesized (Integrated DNA Technologies). 
The forward primer 5’-
CGTGGTGGCCCAGCCGGCC(NNK)21GCGGCCGCAGCACGACAG-3’ contained the 
degenerate codon NNK encoding all 20 amino acids and the TAG stop codon. The 
oligonucleotide also incorporated Sfi1 and Not1 restriction enzyme sites at the 5’ and 3’ ends 
respectively.  A complementary reverse primer 5’-CTGTCGTGCTGCGGCCGC-3’ was used 
for double-strand synthesis, followed by digestion with Sfi1/Not1 and ligation into the 
similarly digested phagemid vector.  Multiple transformations of highly electro-competent 
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(competency > 1.0x1010) SS320 E. coli cells and phage preparation resulted in a phage-
peptide library with a diversity of ~ 1x109. The library was validated by first screening 
against the anti-FLAG monoclonal antibody that recognizes the sequence epitope 
DYKDDDDK.  Four rounds of screening against the antibody yielded >95% clones 
containing the core sequence DYKxxD. 
Phage peptide library screening of the pJMD1 peptide 
Biotinylated peptides were immobilized on 20 µl of streptavidin coated beads 
(Dynabeads® MyOneTM Streptavidin T1, Invitrogen) and dispersed in 100 µl of phosphate 
buffer saline pH, 7.4 (PBS) at room temperature with gentle rotation for 45 mins. The beads 
were washed three times with PBS containing 0.1 % BSA. Peptide coated beads were 
blocked with PBS containing 0.1 % BSA for 30 mins followed by 2 washes with PBS 
containing 0.1 % BSA. Beads were then incubated with phage (100 µl diluted in 900 µl of 
PBS containing 0.1 % BSA) for 3 h at room temperature with gentle rotation. The unbound 
phage was washed 3 times with PBS and then the beads were transferred into fresh eppendorf 
tubes. The bound phage was eluted by incubating with 500 µl of 0.1 M HCl for 5 mins at 
room temperature with the aid of shaking. The eluted phage was immediately neutralized by 
the addition of 167 µl of 1M Tris-HCl buffer pH 8.0, followed by infection of XL1-Blue 
cells (grown to < 0.6 OD in 10 µg/ml tetracycline) with the phage. Infected XL1-Blue cells 
were incubated at 37 °C for 20 mins followed by addition of helper phage and again 
incubating at 37 °C for 30 mins. The phage infected XL1-Blue cells were transferred into a 
conical flask containing 50 ml of 2YT media containing 10 µg/ml of tetracycline and 100 
µg/ml ampicillin and was further incubated at 37 °C overnight with shaking at 210 rpm. 
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Phage preparation was carried out by centrifuging the overnight culture at 8000 rpm for 10 
mins. The supernatant was collected into another centrifuge tube and the phage was 
precipitated by adding 12.5 ml of 20 % PEG 8000 and 2.5 M NaCl solution at room 
temperature. The precipitated phage were collected by centrifugation at 12,000 rpm for 20 
mins and diluted with 1 ml of PBS. This was the first round of enriched phage. The entire 
process was repeated for four rounds and for each subsequent round of biopanning, enriched 
phage from previous round was used. During the 3rd and 4th round of panning, the wash 
buffer contained 0.01 % Tween 20.  Following 3rd and 4th round panning, phage infected 
XL1-Blue cells were grown on 2YT ampicillin plates and 50 colonies were characterized by 
DNA sequencing after plasmid preparation.  
 
Results 
In vitro Interactions between the ACR4 and CRR ICDs 
 We examined potential interactions between the ICDs of ACR4 and the CRRs by gel 
filtration chromatography (Fig. 1), demonstrated to be useful in the analysis of the 
hydrodynamic properties of oligomeric kinase protein complexes (29-31).  We first 
recombinantly expressed the intracellular domains of ACR4, its homologs and ALE2, as C-
terminal fusions to the yeast SUMO protein, termed sACR4, sCRR, and sALE2.  Pairs of 
unphosphorylated proteins were then incubated together at equimolar concentrations (5 μM 
each) and subjected to gel filtration. It is evident by this analysis that purified sACR4 protein 
is predominantly monomeric, although there is evidence of higher order oligomers (Fig. 1A 
and inset). This is in agreement with our previous gel filtration studies of the NusA fused 
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ACR4 ICD (19) and indicates that the solubility tag does not influence oligomerization.  
When sACR4 was incubated with sCRR2 or sCRK1, the gel filtration profile clearly 
indicated interactions between these proteins. Thus,  the elution profiles showed the 
formation of oligomeric complexes containing sACR4/sCRR2 (Fig. 1B, left panel) and 
sACR4/sCRK1 (Fig. 1D, left panel) when analyzed by SDS-PAGE (Fig. 1B and D, left 
panels inset).  Importantly, neither sCRR2 (Fig. 1B, right panel) nor sCRK1 (Fig. 1D, right 
panel) by themselves showed any evidence of self-association in the absence of 
phosphorylation at the concentrations examined during gel filtration. These results suggest 
that ICDs of CRK1 and CRR2 can interact with the ICD of ACR4 in the absence of 
phosphorylation.  No oligomeric complexes were observed with the sACR4/sCRR3 or the 
sACR4/sALE2 samples.  It is possible that ACR4 ICD has a higher propensity for self-
association than for heteromeric association with either sCRR3 or sALE2.  Therefore, higher 
concentrations of sCRR3 or sALE2 may be required to drive a heteromeric association with 
sACR4.  Furthermore, other regions of the receptor, the transmembrane domain or 
extracellular region, may also be important. The interaction between sACR4 and sCRR1 
could not be studied by gel filtration owing to the propensity of sCRR1 to aggregate under 
these conditions. The reason for this is not entirely clear, although it is possible that other 
structural elements lacking in the CRR1 ICD may influence its aggregation propensity (17).   
Effects of phosphorylation on heteromeric interactions 
 The kinase domains of many plant receptors are known to undergo phosphorylation 
during receptor activation and oligomerization (32-34).  To determine if the interactions 
between the ICD of ACR4 and the ICDs of the CRRs and ALE2 was influenced by 
phosphorylations, in vitro pull-down experiments were performed with various combinations 
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of autophosphorylated kinases.  The MBP-fused ICD of ACR4 (mACR4) protein (~0.4 μM) 
was used as the bait and the sCRRs/sALE2 proteins (~1 μM) were used as the prey.  
Therefore, the target proteins were in ~ 2.5 molar excess over the mACR4 bait protein.  In 
the naïve, unphosphorylated state, mACR4 was able to pull out all of the naïve sCRR 
proteins (Fig. 1D).  This suggests that these kinases possess the intrinsic propensity to hetero-
oligomerize in the unphosphorylated state.  It is worth noting that this experiment was able to 
demonstrate an interaction between the naïve mACR4 and sCRR3 when the concentration of 
sCRR3 was in excess of sACR4, suggesting that concentration effects may indeed drive 
hetero-association of these two proteins not seen in our gel filtration studies that was 
performed at a lower protein concentration.  Additionally, the SUMO tagged ACR4 (sACR4) 
intracellular domain was pulled out by mACR4 confirming previous sedimentation velocity 
experiments using the NusA fused ACR4 ICD that indicated kinase domain oligomerization 
in the absence of phosphorylation (19).  Control reactions showed these interactions were 
specific towards the ICDs and were not due to interactions with the SUMO and MBP 
solubility tags or nonspecific binding of fusion proteins to the amylose resin (data not 
shown).  The presence of mACR4 in each reaction was confirmed with western blots using 
polyclonal, anti-MBP antibody (Fig. 2, lower panel) and the sCRRs were confirmed by 
western blots probed with a polyclonal, anti-SUMO antibody (Fig. 2A-D).   
 Interestingly, autophosphorylation of the ICDs had striking effects on ACR4 
interactions with the CRR homologs.  Loss of interaction occurs between mACR4/sACR4 
(Fig. 2A, lane 1).  The fact that phosphorylated mACR4 does not interact with 
phosphorylated sACR4 supports our previous observation that ACR4 monomerizes upon 
autophosphorylation (19).  The interaction between phosphorylated mACR4 and 
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phosphorylated sCRK1 is attenuated but not completely abolished, suggesting this kinase 
complex may form at the cell surface during receptor activation (Fig. 2A).  Intriguingly, the 
interaction between sACR4 and sCRR3 is completely abolished, demonstrating that 
autophosphorylation of the ICDs forces disassociation of these two proteins.  The 
dissociation may be due to conformational changes that accompany autophosphorylation (19) 
and/or electrostatic repulsion due to increases in net negative charge from 
autophosphorylation.   
 The interactions observed between the mACR4/sACR4 and mACR4/sCRR3 showed 
decreased binding ability depending on whether the bait protein (mACR4) or the target 
protein (sACR4, sCRR3) was in the phosphorylated state (Fig. 2B and C) as compared to the 
two extremes of where the participating proteins are either in the phosphorylated state (Fig. 
2A) or unphosphorylated state (Fig. 2D).   These results indicate that autophosphorylation of 
both partners is required to disrupt the intracellular contact between ACR4/ACR4 and 
ACR4/CRR3 kinase domains.  The fact that mACR4 is able to strongly interact with sCRR1 
and sCRR2 regardless of phosphorylation state (Fig. 1A-D), raises the possibility that ACR4 
may be able to signal through the use of dead kinase domains (35, 36).  We did not observe 
any interactions between mACR4 and sALE2 in the pull-down experiments regardless of 
phosphorylation status or using an excess molar ratio of sALE2 compared to mACR4.  This 
observation suggests that the intracellular domains of ACR4 and ALE2 may not interact with 
each other directly but may do so in the presence of other proteins or could be modulated by 





ACR4 can phosphorylate the CRR homologs 
  Receptor activation through homo- or heterodimerization is accompanied by intra 
and intermolecular phosphorylation reactions, recruitment of proteins to the intracellular 
domain of the receptor and subsequent activation of signaling events inside the cell (1, 10, 
14).  Previous studies have proposed that ACR4 can phosphorylate CRR2 in an in vitro 
phosphorylation assay (17).  We further assessed the ability of ACR4 to phosphorylate the 
CRRs by incubating the active mACR4 kinase with the kinase dead, sCRR and sALE2 
mutants (sCRRms/sALE2m) (Fig. 3A).  Since CRR3, CRK1, and ALE2 have robust kinase 
activity (Chapter 2), we mutated the catalytic Asp (37) of each kinase to Ala in order to 
inactivate each enzyme (Materials and Methods).  Although CRR1 and CRR2 have 
intrinsically very weak kinase activity attributable to the absence of the activation loop in 
each protein (17), in order to completely eliminate autophosphorylation activity, we also 
mutated the catalytic Asp in both CRR1 and CRR2 to Ala.  Inactivity of each mutant was 
confirmed by an in vitro autophosphorylation assay (Fig. 3B).  However, in the case of 
ALE2, mutation of the catalytic Asp to Ala resulted in an unstable protein. Therefore, the 
essential Lys residue (37) was mutated to Ala to obtain a more stable protein albeit one with 
weak residual kinase activity (Fig. 3B, lane 5).  The ACR4 kinase can in fact phosphorylate 
the intracellular kinase domains of all four CRR homologs in vitro.  Amongst the CRRs, the 
weakest phosphorylation activity was seen against sCRR1m (Fig. 3A, lane 1) and relatively 
stronger activity was seen against the sCRK1m ICD (Fig. 3A, lane 4). Thus, these in vitro 
experiments suggest that ACR4 may also have the potential to phosphorylate the CRRs in 
vivo.  Interestingly, sACR4 showed the strongest phosphorylation activity against the sALE2 
ICD (Fig. 3A, lane 5) and is in agreement with the observations of Tanaka et al. (20).  No 
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phosphorylation of the yeast SUMO protein was observed when incubated with sACR4 
indicating that the phosphorylations of the SUMO-tagged CRRs and ALE2 was specific to 
the intracellular domain and not to the fusion tag (Fig. 1A, lane 6). 
Mapping ACR4/CRK1 interaction sites by H/D exchange 
 Thus far, our interaction studies have shown that ACR4 can interact with all of the 
CRR homologs in the unphosphorylated state.  To assess the molecular basis of these 
interactions, we used hydrogen-deuterium exchange coupled to mass spectrometry in order to 
map potential intermolecular interactions sites within the ACR4 ICD.  Hydrogen-deuterium 
exchange (HDX) is an effective tool to map in solution protein-ligand interaction sites and 
determining conformational dynamics of proteins (38, 39).  This technique makes 
advantageous use of backbone amide hydrogens and their availability for isotopic labeling 
with deuterium from the solvent.  Amide hydrogens undergoing intra- or intermolecular 
hydrogen bonding have reduced exchange rates when compared to amide hydrogens exposed 
to the solvent.  Therefore, hydrogen exchanged with deuterium can be monitored by mass 
spectrometry to delineate specific regions within a protein sequence that are solvent 
accessible.  Binding interfaces within a protein complex can be determined by comparing 
HDX rates of the bound and unbound state (40-42).  Consequently, mapping of isotopically 
labeled peptides along a given protein sequence provides a general idea of potential protein-
protein interactions sites. 
  On the basis of the gel filtration, pull-down, and phosphorylation studies, we 
determined that CRK1 was a good candidate for mapping potential interactions sites between 
the unphosphorylated ACR4 and CRK1.  The experiment was initially performed with the 
unbound, apo-sACR4 protein to determine individual HDX profiles for all peptides produced 
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from the in-line pepsin digest of the sample.  Overall, 100 peptides with overlapping 
sequence corresponding to the ACR4 ICD were identified in the mass spectrometry analysis 
of peptic fragments generated from the apo-sACR4 enzyme.  Peptide sequence coverage was 
~98% of the ACR4 intracellular domain.  This data was then compared to peptide HDX 
profiles generated from the holo-sACR4 protein bound to sCRK1 after prior incubation at 
ratios of 1:1 or 1:3 (see Materials and Methods).  Evaluation of the mass spectrometry data 
revealed two sites of protection within the ACR4 ICD.  One site, corresponding to the peptic 
fragment FRTELDL, is a part of helix-C in the N-terminal lobe of the kinase domain.  This 
region displayed a significant average decrease in percent deuteration of 5%.  The second 
peptide, YRLHY, occurs in the C-lobe of the kinase domain, just downstream of the C-
terminal hinge of the activation loop, and showed a 6% average decrease in deuterium uptake 
compared to the apo-ACR4 sample (Fig. 4).  The decrease in deuterium uptake is indicative 
of a significant involvement of these two regions in interfacial contacts between ACR4 and 
CRK1.  Interestingly, as depicted in the modeled structure, both regions fall on the same side 
of the ACR4 kinase molecule (Fig. 5).  Our experiments did not reveal any differences in HD 
exchange for peptides corresponding to the JMD or CTD of ACR4.  However, further studies 
are needed to ascertain the exact role of these subdomains in potential protein-protein 
contacts. 
Phage panning of pJMD1 peptide 
Many cellular functions in eukaryotic cells are mediated by modification-dependent 
interactions between small protein recognition modules (PRM) and their cognate ligands. 
Examples of PRMs include the Src homology 2 (SH2) domain binding to phosphotyrosines, 
Src homology 3 (SH3) and WW domains binding to polyproline motifs (43, 44).  In general, 
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the recognition sequences for the PRMs are short stretches of continuous peptide sequence 
<10 residues long, called Short Linear Motifs (SLiM) that occur within the cognate 
interacting protein (45).  Peptide ligands have been isolated from phage peptide libraries (46-
48) that in many instances show conservation of the motifs in native interacting proteins, 
facilitating the first step towards identification of natural candidate proteins in vivo (49, 50).  
Phosphorylation of Ser/Thr residues also creates binding surfaces for diverse phosphoamino 
acid binding modules such as the 14-3-3, WW and forkhead-associated (FHA) (51).  
However, the structure and mechanism of phosphobinding are quite diverse (52) and 
combinatorial peptide library screening has been very successful in defining the specificity of 
these PRMs to identify consensus peptide sequences as well as discover novel binding motifs 
(53).  Furthermore, biochemical studies have demonstrated that phosphorylation of residues 
within the noncatalytic juxtamembrane and/or C-terminal regions flanking the core kinase 
domain of several receptors act as recruitment sites for intracellular substrate proteins (54-
58).  Thus, as described in the previous chapter, we utilized a random 21 amino acid phage 
peptide library to identify potential binding motifs to the phosphorylated Ser475 in the pJMD1 
peptide 468DTRSSKDpSAFTKDNG482.  The target peptide was immobilized on a 
streptavidin coated plate via the N-terminal biotin tag and subjected to four rounds of 
biopanning (see Materials and Methods).  Phage binding after the fourth round were enriched 
for peptides that bind the pJMD1 peptide.   
 After the fourth round of panning, 46 phage isolates were selected at random and 
sequenced. Interestingly, 35% of the clones selected had the sequence, 
YRWWDSAINLHSLLFSPPLFG (Fig. 6).  Notably, this peptide contains the sequence 
LXXLL, a motif that has been identified as regulating protein-protein interactions among the 
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mammalian nuclear receptors, transcription factors, and coactivators (59-61).   Additionally, 
30% of the selected sequences contained variations of the LXXLL motif further defining it as 
the predominant binding motif to the pJMD1 peptide.  Recently, identification of a LXXLL 
motif in the Tomato Atypical Receptor-like Kinase (TARK1) was shown to be responsible 
for direct binding to the XopN virulence factor (62).  In the same study, XopN was shown to 
also contain a LXXLL motif that is required to bind to TARK1 (62).  Remarkably, sequence 
analysis of ACR4, CRR3, and CRK1 revealed that they all harbor LXXLL motifs within 
their ICDs.  ACR4 houses this motif in two locations, one in the N-lobe (LLSLL) which is 
most similar to the LXSLL motif found in the YRWWDSAINLHSLLFSPPLFG peptide and 
one in the C-lobe of the kinase domain (LLELL), while CRR3 and CRK1 contain this motif 
in the respective kinase C-lobes.  A second motif was also preferentially selected through our 
phage display screening.  Two peptides containing the consensus motif, FXPYEL, were 
selected and represented 24% of the peptides that were sequenced.  The observation of this 
motif indicates an additional linear sequence that is able to recognize the pJMD1 
phosphopeptide and potential protein-protein interactions mediated by this motif is addressed 
later in this article. 
‘KDSAF’ motif binds ACR4 kinase domain 
 Results from our phage display experiments suggested that conserved features among 
the JMDs of the CRR homologs or ALE2 could be involved in protein-protein interactions 
among these proteins.  Therefore, we performed sequence similarity searches between the 
JMD of ACR4 and the intracellular domains of the CRRs and ALE2.  Interestingly, a close 
scrutiny of the amino acid sequences of ACR4, CRR3 and CRK1 revealed a highly 
conserved ‘KD/ESAF’ motif and a similar RDREF motif in ALE2 (Fig. 7A).  The inactive 
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CRR1 and CRR2 ICDs do not contain this motif, suggesting that this region may serve a 
critical role in the kinase-active members of the ACR4 family.  Whereas the KDSAF 
sequence is found in the JMD of ACR4, in CRR3, CRK1, and ALE2 it occurs in the kinase 
domain towards the N-terminal portion of the presumed helix-C region (Fig. 8).  The 
identification of conserved KDSAF and LXXLL motifs therefore allows us to propose an 
intriguing model for interaction among these proteins based on the ‘KDSAF’ motifs of 
CRR3, CRK1, and ALE2 forming intermolecular contacts between themselves and the 
LLSLL region in the ACR4 N-lobe. 
 To test this hypothesis, we synthesized peptides corresponding to the helix-C regions 
of CRR3, CRK1, and ALE2 (termed hC peptides), and the unphosphorylated JMD1 peptide 
which contains the ‘KDSAF’ motif in ACR4, for use in a peptide overlay assays (Fig 7A).  
The unphosphorylated JMD1 peptide was used in our experiments since we are currently 
unaware of phosphorylation at the Ser/Thr residue within the ‘KDSAF’ motif of CRR3, 
CRK1, or ALE2.  As described in Materials and Methods, peptide binding was assessed by 
colorimetric detection using streptavidin conjugated Alkaline Phosphatase.  Our results 
unequivocally show direct binding of the ‘KDSAF’ containing peptides to the sACR4 KC, a 
protein lacking the JMD (Fig. 7B, upper panel).  Importantly, the peptides do not bind to the 
SUMO protein used as a control (Fig. 7B, lower panel).  The presence of blotted sACR4 KC 
or SUMO protein was verified by independent western blots using anti-SUMO antibody 
(data not shown).   
 In a comparable experiment we determined peptide binding to sACR4 KC that was 
immobilized on Ni2+ coated plates through the N-terminal histidine tag to ensure that the 
‘KDSAF’ peptides binding to sACR4 KC was not an artifact caused by nonspecific binding 
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to a misfolded protein.  The data in Fig. 7C, demonstrates that all four ‘KDSAF’ motif 
containing peptides are able to bind to the sACR4 KC protein to different extents.  The 
CRR3 and CRK1 hC peptides showed the highest binding affinity to sACR4 KC and had 
similar binding capacity under our assay conditions.  The ALE2 hC peptide also interacted 
with sACR4 KC, but with ~4-fold less affinity than either CRR3 or CRK1 hC peptides.   
Interestingly, the JMD1 peptide was capable of binding to sACR4 KC, indicating that the 
unphosphorylated JMD can make intramolecular contacts with the ACR4 kinase domain.  
Autoregulation of receptor kinase domains by the neighboring, non-catalytic JMD is a 
common mechanism to regulate kinase activity (63-69).  The differences in binding affinities 
seen with these peptides suggest that variations in the flanking residues of the core ‘KDSAF’ 
motif may influence binding affinity. The peptide binding results provide strong support for 
the involvement of the ‘KDSAF’ region in intermolecular contacts among CRR3, CRK1, and 
ALE2. 
ACR4 can phosphorylate ‘KDSAF’ region of CRR3 
 We next examined whether ACR4 could phosphorylate the hC peptides as 
phosphorylation within this region could represent a potential regulatory mechanism for 
ACR4 association with its binding partners.  The CRR3 and CRK1 hC peptides contain a Ser 
or Thr within their respective ‘KDSAF’ regions whereas, in ALE2, the central position is 
replaced with arginine. Nonetheless, it does contain a Thr residue at the N-terminus that 
could be phosphorylated (Fig. 7A).  In vitro kinase assays performed with wild-type sACR4 
and individual hC peptides showed intermolecular phosphorylation of the CRR3 hC peptide 
(Fig. 7D).  This is commensurate with our phosphorylation assays demonstrating that CRR3 
ICD is phosphorylated by ACR4 (Fig. 3).  However, in contrast to the kinase assay with the 
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whole protein (Fig. 3), no phosphorylation signal was seen with CRK1 and ALE2 hC 
peptides. In part, this may perhaps be attributed to the more important role of distal 
sequences in phosphorylation.  
ACR4 directly interacts with WOX5 
 Previous reports have suggested a signaling module involving ACR4 and the WOX5 
transcription factor.  WOX5 expression dynamics are proposed to be influenced by ACR4 
acting through the perception of a postulated CLE40 peptide ligand.  ACR4 is primarily 
expressed in the D1-D3 cell layers in the root tip, whereas WOX5 is solely expressed in 
quiescent center (QC) (22, 23, 70).  Overexpression of the CLE40 gene or application of 
exogenous CLE40 peptide expands the ACR4 expression domain to include the QC (22, 23).  
We therefore hypothesized that the ACR4 intracellular domain may have the capability to 
directly interact with WOX5 and phosphorylate it, thus affecting WOX5 function inside the 
cell. We cloned and expressed milligram quantities of  WOX5 as a C-terminal fusion to the 
maltose binding protein (MBP) with a 6X histidine tag at the C-terminus to aid in 
purification of full length protein (see Materials and Methods).    
  To examine the in vitro association of ACR4 with WOX5, we first incubated the 
purified sACR4 and mWOX5 proteins together and used amylose resin to pull-down the 
mWOX5 protein.  Additionally, in a parallel experiment, we determined the effect of 
autophosphorylation of the ACR4 ICD on interaction with WOX5.  Our results demonstrate 
that mWOX5 is indeed pulled-down by naïve sACR4 protein (Fig. 9A, upper panel, lane 2, 
arrow) but not by phosphorylated protein indicating that autophosphorylation is not a 
requirement for association. To unequivocally show that mWOX5 is pulling out sACR4 and 
that the protein band observed (Fig. 9A, upper panel, lane 2, arrow) is not a degradation 
194 
 
fragment of mWOX5, we performed separate western blots using anti-SUMO and anti-MBP 
antibodies to demonstrate the presence or absence of each protein.  In addition, control 
reactions using either the SUMO or MBP solubility tags demonstrate the observed interaction 
was specifically between the ACR4 ICD and WOX5 (Fig. 9A and B, lanes 3-5).  
Interestingly, the autophosphorylated sACR4 is unable to interact with mWOX5 (Fig. 9B, 
lane 2).  However, this is not a complete surprise since WOX5 is a transcription factor that 
may be phosphorylated by ACR4, thus activating the protein.   
Mapping of in vitro WOX5 phosphorylation sites 
 The in vivo expression patterns of WOX5 and ACR4 have been demonstrated to 
overlap in the Arabidopsis root tip (22, 23).  In addition, our pull-down studies indicate that 
the ICD of ACR4 can interact with WOX5. Therefore, we considered the possibility that the 
ACR4 kinase domain could phosphorylate WOX5, thus affecting WOX5 function in the root.  
Transcription factors can be regulated through reversible phosphorylation, therefore 
regulating their function inside the cell.  For example, Stat transcription factors can be 
directly phosphorylated by the EGF receptor kinase domain to modulate their DNA binding 
activity (72, 73).  Thus, we incubated sACR4 with mWOX5 in an in vitro kinase assay in the 
presence of [γ-32P] ATP.  We clearly demonstrate that WOX5 is phosphorylated by sACR4, 
in vitro (Fig. 10, lanes 2-4).  Since sACR4 and mWOX5 have similar migration patterns on 
an SDS-PAGE gel, we wanted to ensure the signal in the autoradiogram was due to WOX5 
phosphorylation and not sACR4 autophosphorylation.  Therefore, after incubation, the 
phosphorylated mWOX5 protein was pulled-down by amylose resin and extensively washed 
to remove autophosphorylated sACR4.  Indeed, the appearance of the radioactive band was 
due to mWOX5 phosphorylation, as seen by the absence of sACR4 when incubated alone 
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(Fig. 10, lane 1).  A separate control reaction performed under the same conditions with 
sACR4 and MBP confirmed that the phosphorylation was specific towards WOX5 and not 
the MBP solubility tag (Fig.10, lanes 5-7).  Thus, ACR4 may also have the potential to 
phosphorylate WOX5 in vivo. 
 We next determined the sites of phosphorylation within the WOX5 protein by 
collision induced dissociation (CID) tandem mass spectrometry. The data dependent analysis 
of tryptic peptides and a search against the mWOX5 protein sequence (Fig. 11) yielded 
several phosphorylated peptides.  Assignment of the phosphorylation site was performed by 
verifying the presence of diagnostic site-discriminating y and b series ions.  For example, the 
CID tandem mass spectrum of the phosphopeptide encompassing the junction between the C-
terminal end of the solubility tag and the N-terminal sequence of WOX5, 
GSAGAALG(pS)FSVK, is shown in Fig. 11B.  The predominant species is the [M+2H-98]2+ 
ion (m/z of 567.3) carrying a +2 charge state. This is characteristic of a neutral loss of 
phosphoric acid which is indicative of a phosphorylated peptide.  Exact assignment of the 
phosphorylation at Ser2 (in WOX5 amino acid sequence) was verified by the presence of site-
discriminating ions including the phosphorylated b9 (theoretical m/z 654.32, observed m/z of 
654.33) and y5 (theoretical m/z 549.30, observed m/z of 549.33) ions and the 
unphosphorylated b8 (theoretical m/z 585.30, observed m/z of 585.17) and y4 (theoretical m/z 
480.28, observed m/z of 480.30) ion.  The absence of the phosphorylated b series of ions 
corresponding to b2-b8 and y series ions y3-y4, further confirmed that phosphorylation occurs 
at Ser2.  A total of four phosphorylation sites were identified within the WOX5 sequence 
(Fig. 11A). Table 1 summarizes the site-discriminating ions for the four confirmed sites at 
Ser2, Ser4, Ser88, and Ser158 of the WOX5 protein. Intriguingly, phosphorylation at two Ser 
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residues occurs in a ‘GSFS’ motif within WOX5.  ACR4 also contains a ‘GSFS’ sequence 
located within the glycine-rich loop of the kinase structure and is autophosphorylated at the 
first Ser (19).  Furthermore, a third phosphorylation site in WOX5, Ser158, is found in a 
‘TSFS’ motif that is highly similar to the ‘GSFS’ sequence.  These data suggest a potential 
recognition motif for ACR4 substrate phosphorylation of WOX5 in vivo.  
Database mining of pJMD1 consensus binding motifs 
 In our phage-display screening of the pJMD1 peptide, two consensus peptide motifs 
LXSLL and FXPYEL, were identified.  In order to establish potential interacting proteins to 
the pJMD1 peptide sequence, we queried the consensus binding motifs against the 
Arabidopsis protein database using the Sequence Pattern search function in Scansite 2.0 
(MIT, http://scansite.mit.edu/).  Queries with the consensus motifs LXSLL, LLXLL and 
LLXXL yielded a multitude of protein hits.  Proteins that had an unknown function or did not 
have an apparent relevance to signal transduction were disregarded.   Our analysis included 
members of the RLK family, phosphatases, and transcription factors (Table 2).  The sequence 
of each RLK in our query was examined to ensure the consensus motif was located in the 
intracellular domain.  RLKs that contained the consensus motif in the presumed extracellular 
space were discarded.  As mentioned earlier, the AtCRRs were among the more significant 
RLKs identified in our search.  Additionally, some RLKs involved in plant growth and 
development were also identified including Brassinosteroid receptor kinase 1 (BRI1), 
somatic embryogenesis receptor kinases 4 and 5 (AtSERK), and ANXUR1 and 2 (14, 74, 
75).  Inasmuch as the significance and role of these RLKs in ACR4 signaling remains to be 
elucidated, there is increasing evidence of RLK crosstalk via heterodimer formation to 
activate differential signaling pathways in plant signaling behavior (14, 34, 74).   
197 
 
 A parallel query with the consensus motif FXPYEL, however, yielded no hits.  
Searching with the overlapping sub-sequences FXPY and PYEL returned a total of 295 
matches. The FXPY motif yielded the largest return of 280 proteins, with the PYEL only 
returning 15 proteins containing this motif. Identified proteins included those specifically 
involved in signal transduction processes such as protein phosphatases, transcription factors, 
F-box containing proteins, and ASYMMETRIC LEAVES2/LATERAL ORGAN 
BOUNDARY (AS2/LOB) domain containing proteins.  It is worth noting that 27 of the 
proteins were members of the AS2/LOB domain containing family.  AS2/LOB domain 
proteins comprise a 42 member family in Arabidopsis that have been shown to have 
influence functions in plant development, most notably lateral organ development in the 
meristem and cell fate specification in flower petals (76).  Interestingly, the WOX5 
transcription factor was among the proteins identified with a ‘FXPY’ motif.  WOX5 contains 
a ‘FSPY’ motif (residues 159-162) that is localized to the C-terminal end of the protein (Fig. 
11A).  Moreover, we have identified an in vitro ACR4 phosphorylation site at the Ser158 
positioned just upstream of this motif.  However, the functional significance of this motif and 
the role of phosphorylation at Ser158 have yet to be determined.    
 
Discussion 
 In higher animals and plants, directed cell proliferation, specification, and 
differentiation during growth and development are guided by a variety of external stimuli 
that are perceived and interpreted by a multitude of cell surface receptors primarily mediated 
through RTKs in animals and by RLKs in plants. The accepted paradigm of signal 
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transduction involves ligand perception/binding to the extracellular domain, activation of the 
intracellular kinase domain and subsequent activation of downstream signaling pathways 
through reversible phosphorylation events. Subsequently, downstream signaling components 
influence transcriptional activity in the nucleus allowing appropriate cellular responses to 
specific signaling cues. 
 In recent years, however, it has become apparent that the concept of a single receptor-
single ligand interaction is perhaps too simplistic. Thus, structural, biophysical, biochemical 
and functional studies of several RTKs such as the Epidermal Growth Factor Receptor 
(EGFR) family (10-12, 56), Somatostatin and Opioid receptors (77), Insulin-like Growth 
Factor Receptor (78), and Platelet-derived Growth Factor (PDGF) (79) have demonstrated 
the capacity of these RTKs to assemble as homo- or heterodimeric complexes with distinct 
ligand specificity/affinities and downstream signaling activity. Similar heteromeric 
interactions occur among RLKs such as FLS2 and BAK1 (80), CLAVATA2 (81), and BRI1 
(13, 14) and their impact on downstream signaling cascades is well established.  Among the 
five members of the ACR4 receptor family, limited genetic and cell biology analyses have 
suggested these receptors may act in the same genetic pathway through functional 
redundancy based upon gene duplication and/or through activation of signaling cascades via 
receptor heterodimerization (15, 17, 21).  Furthermore, RT-PCR studies of ACR4 and CRR 
transcript levels in varying tissues encompassing the entire Arabidopsis plant demonstrate all 
family members are expressed within all tissues examined, except for CRR2 and CRK1 
which are not expressed in the siliques (17).  Therefore, based upon their overlapping 
expression patterns in a variety of tissues, it is tempting to speculate that these proteins may 
also have the capacity to functionally interact in vivo.  
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 In this study we have analyzed the in vitro interactions between the ICDs of ACR4 
and the CRRs to elucidate the molecular aspects of protein-protein interactions within this 
receptor family.  Ideally, crystal structure determination of complexes between ACR4 and 
the CRRs would facilitate an atomistic level understanding of these interactions.  In the 
absence of structural information, we utilized hydrodynamic analyses, peptide binding 
studies, pull-down assays and phage display to demonstrate protein-protein interactions 
among members of the ACR4 family.  Our gel filtration studies and pull-downs show that, in 
the unphosphorylated state, the ICD of ACR4 can self-associate (Fig. 1A and Fig. 2D, lane 
1) and also bind to all four CRR ICDs (Fig. 1B and D and Fig. 2D), thus indicating that the 
intracellular regions of these receptors have the potential to form inactive, heteromeric 
complexes.   Indeed, examples exist in which RTKs are capable of preformed, inactive 
heterodimer complexes in a ligand independent manner. For instance, the EGFRs are able to 
form homo- or heterodimeric structures in the absence of external signaling molecules (82, 
83).  Furthermore, the intracellular kinase domains of the EGF receptor family also 
contribute to receptor oligomerization (83-86).  Among RLKs, an example of receptor 
homodimerization is seen for the BRI1 receptor in the absence of the brassinosteroid ligand 
(87) and the Arabidopsis Somatic Embroygenesis Receptor Kinase 1 (AtSERK1) is also able 
to form homodimers in protoplasts (88).  Interestingly, the ICDs of CRR2, CRR3, and CRK1 
do not show evidence of homodimerization (Fig. 1B, C, and D, right panels) although it is 
possible that they may have the capacity to form heteromers within the family. Indeed, 
precedent for such a heteromeric interaction exists in the five member AtSERK family, 
wherein AtSERK1 is able to heterodimerize with AtSERK2 in cowpea protoplasts (74).   
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 The effect of phosphorylation on the interactions between the ICD’s of ACR4 and the 
CRRs in the pull-down assays raises some intriguing questions about regulation of in vivo 
receptor activity. Thus, the inability of ACR4 to self-associate or even interact with CRR3 
after phosphorylation (Fig. 2A), suggests that pre-existing complexes may be activated upon 
ligand binding, allowing dissociation to monomeric receptors and subsequent engagement 
with other receptors/membrane bound proteins to induce a signaling cascade.  Alternatively, 
in the activated state, the heteromeric complex could still be maintained through interactions 
between the transmembrane domains as well as the extracytoplasmic domains, as has been 
reported for the EGFR family (89-93). In this model, it would be conformational changes in 
the cytoplasmic domain that would disrupt the protein-protein interactions. On the other 
hand, the interaction between ACR4 and CRK1 is attenuated but not completely eliminated 
in the phosphorylated state, indicating that active kinase domains may transduce signal via an 
active heterodimer complex.  Indeed, signaling from the BRI-BAK1 receptor complex is 
achieved through trans phosphorylation of receptor partners to fully activate the receptors 
(14).  Furthermore, it has recently been shown that fully active cytoplasmic domains of the 
FLS2 receptor and BAK1 (80) are required for immune responses in the plant (34, 94).  We 
have also demonstrated that the ICD of ACR4 is capable of binding to the kinase-dead CRR1 
and CRR2 ICDs regardless of the phosphorylation status (Fig. 2A and D).  This observation 
is particularly interesting in light of the fact that in animals there are atypical RTKs with 
kinase-inactive domains that signal through phosphorylation-independent mechanisms 
(Kroiher et al., 2001). A classic example is the ErbB3 receptor in the EGFR family that has a 
weakly active or non-functional kinase domain but is nevertheless a critical component of the 
EGFR signaling mechanism since it can form heterodimers with other members of the family 
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that phosphorylate it (12, 95). Atypical RLKs, functioning in an analogous manner, have also 
been reported in plants. Sequence analysis suggests that ~20% of the >600 RLKs  encoded in 
the Arabidopsis genome are inactive, atypical RLKs, and it is likely that activation of 
differential signaling pathways can occur through heterodimerization among this RLK 
subfamily (36, 96, 97). Therefore, it is quite possible for ACR4 to expand its signaling 
cascade through interactions with the kinase-dead homologs. Futhermore, the fact that ACR4 
kinase can phosphorylate both CRR1 and CRR2 ICDs (Fig. 3), parallels the mechanism 
described in kinase-defective ErbB3 signaling in complex with active members of the EGF 
receptor family (12, 95).   
 During ligand binding and receptor activation among the RTKs, the intracellular 
kinases are activated and autophosphorylated via a trans mechanism (1).  Our in vitro kinase 
assays demonstrate the active ACR4 kinase domain can phosphorylate the ICDs of all the 
CRR homologs, therefore indicating that ACR4 signaling can occur through 
heterodimerization with CRR family members.  Similar mechanisms have been determined 
in plant RLKs in which cytoplasmic domains in heterodimeric receptor complexes can 
undergo trans phosphorylation.  For instance, the BRI1 RLK can transphosphorylate 
members of the AtSERK family, AtSERK1 and AtSERK3 (BAK1) (33, 98).  Additionally, 
the FLS2, BIK1, and BAK1 require transphosphorylation for signaling during plant defense 
responses (99).  Importantly, binding of different ligands to the ACR4 extracellular domain 
may also promote preferred heterodimerization with CRR family members to initiate a 
diverse array of signaling pathways and alter the signaling output and duration.  For instance, 
members of the EGF receptor family can bind a variety of ligands which promotes homo- or 
heterodimerization that can activate multiple downstream signaling cascades (10, 12).  
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Indeed, an extra layer of complexity and dimension is conferred through cross-talk mediated 
by activation of EGFR signaling pathways by G-protein coupled receptor (GPCR) agonists 
(100, 101). Although one peptide, CLE40, has been proposed to be the ligand for ACR4 (22, 
23), it does not preclude the possibility that other ligands may act in ACR4 signaling. Indeed, 
there are 32 members of the CLE peptide family in Arabidopsis that affect developmental 
functions in the plant (102, 103).  However, the role of these presumed peptide ligands in 
ACR4 or CRR signaling has yet to be determined.  Our gel filtration and pull-down assays 
show that the ICD of ACR4 cannot interact with the ALE2 ICD regardless of 
phosphorylation status but it can phosphorylate ALE2 in vitro (Fig. 3, lane 5).  This may be 
attributed to an intrinsic low affinity between the ACR4 and ALE2 kinase domains but the 
apparent binding affinity may be increased by distal contacts found outside of the consensus 
phosphorylation sites harbored in the ALE2 substrate protein. This is illustrated in the low 
affinity, kinase-substrate complex formed between the yeast Sky1P kinase and its substrate, 
nuclear protein localization 3 (npl3).  Here, a fast phosphoryl transfer step due to efficient 
‘clamping’ of the npl3 substrate produces a decreased apparent Km of binding (104, 105).  
Thus, this may explain the observation of enhanced substrate phosphorylation without 
observing a stable protein-protein interaction. 
 Both intramolecular and intermolecular protein-protein interactions are driven by 
contacts between specific residues on the interfacial faces of the participating domains.  In 
contrast to stable complexes, biological signal transduction is regulated in large part by 
transiently formed states in which the proteins may switch between bound and unbound 
forms through modification-dependent conformational changes.  While it is not possible to 
accurately define the state of the ACR4/AtCRR interactions based on current data, 
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nevertheless our phage-display, peptide-binding and HD exchange experiments provide us a 
basis to propose a model for a molecular level understanding of the heteromeric interactions. 
In this model (Fig. 12), in the naïve heterodimeric state, the KDSAF sequence in the C-helix 
of CRK1/CRR3 (Fig. 8) contacts the LLSLL site in the β4 strand of the ACR4 kinase 
domain. Upon activation, phosphorylation of residues in ACR4, including Ser475 in the 
juxtamembrane region, induces a conformational change and dissociation of the complex. In 
this monomeric state, the phosphorylated KDSAF in the JM region of ACR4 now forms 
intramolecular contacts with the LLSLL site on the β4 strand within its N-lobe. This model is 
supported by the following facts: (i) the ICD of ACR4 exists as monomers in the 
phosphorylated state (19) (Chapter 2) (ii) in pull-down assays ACR4 is incapable of binding 
to sCRR3 and sALE2 in the fully autophosphorylated state (Fig. 2A, lanes 4 and 6) (iii) 
‘KDSAF’ motif containing peptides generated from the CRR3, CRK1, and ALE2 sequences 
are able to bind to the ACR4 kinase domain (Fig. 7B and C) and (iv) although our HDX 
results did not show a direct interaction between CRK1 and the ACR4 LLSLL region, the 
FRTELDL sequence is in close proximity to the ‘LLSLL’ region at the helix-C of ACR4 
(Fig. 5).  Taken together, these results point to the importance of the N-lobe region of ACR4 
in heteromeric interactions in general, and with CRK1 in particular. In fact, the N-lobe of 
some RTKs is implicated in the modulation of intermolecular interactions and kinase 
activity.  For example, the FKBP12 protein binds to the N-lobe of the TGFβ receptor-I kinase 
domain, holding it in an inactive conformation (106, 107).  However, additional mutational 
studies are needed to elucidate the function of the KDSAF motif in the ACR4 JMD and the 
helix-C regions of CRR3, CRK1, and ALE2 in protein-protein interactions. 
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 In planta investigations in the root tip have suggested a signaling module involving a 
putative peptide ligand, CLE40, the ACR4 RLK, and the WOX5 transcription factor [22-23].  
In this study, we provide evidence that, for the first time, establishes a link between ACR4 
and WOX5 in the proposed module.  The two proteins can not only interact with each other 
(Fig. 9) but the WOX5 transcription factor is phosphorylated by the ACR4 kinase (Fig. 10).  
This is similar to the example of the EGF receptor which can recruit and phosphorylate the 
Stat3 transcription factor, therefore modulating Stat3 activity inside the cell [72-73, 109].  
Furthermore, inactive G protein coupled receptors (GPCR) are able to bind the alpha subunit 
of G proteins through their intracellular GEF domains [71].  GPCR activation promotes the 
dissociation of G proteins in order to continue the signaling cascade inside the cell.  Thus, 
our data invokes a possible mechanism in which WOX5 and ACR4 may associate in a 
preformed complex at the cell surface.  WOX5 could presumably be activated by 
phosphorylation and move to the nucleus to influence transcriptional activity in an analogous 
manner.   
Phosphorylation sites within receptor molecules not only recruit substrate proteins but 
also create docking sites for downstream interaction partners (54-58). The identification of 
such cellular proteins will lend significant context to the potential involvement of diverse 
multi-protein complexes in the functions of ACR4. Phage display peptide screening affords a 
rapid tool for the identification of potential interaction partners through consensus peptide 
binding motifs (49, 50).  Our phage display studies identified two consensus peptide binding 
motifs for the phosphorylated JMD1 peptide, LXSLL and FXPYEL.  Database mining of 
these sites yielded numerous proteins containing Leu-rich consensus sequences (Table 2).  
Intriguingly, both the LXXLL motif and the FXPYEL submotifs, FXPY and PYEL, returned 
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proteins that can be classified into distinct signal transduction categories i.e. RLKs, 
phosphatases, transcription factors, and adapter proteins (F-box containing proteins).  It 
should of course be emphasized that, as with any high throughput screening procedures, 
while this data constitutes a significant collection of potential interacting proteins, their 
biological relevance need further confirmation and validation. Given this as it may, it is 
worth noting that the guidance to further study interactions with the AtCRRs was provided 
by the identification of the LXXLL motif by our phage display screening.  Interestingly, only 
ACR4 contains an LXSLL motif (LLSLL) in the N-lobe, whereas CRK1 contains a LVRLL 
motif at an analogous position. All members of the ACR4 family also contain an LLEL/IL 
motif in the C-lobes of their respective kinase domains.  However, this conserved motif is 
required for structural stabilization of the kinase domain (109) and is therefore unlikely to be 
important for protein-protein interactions.  The WOX5 transcription factor was also found in 
our database search and contained an FXPY motif.   
In summary, we have provided evidence for heteromeric interactions between the 
ICDs of ACR4 and CRR3, CRK1, and ALE2 and described a potential mechanism for these 
interactions. However, further in vivo and in vitro structure-function experiments, involving 
mutagenesis of binding site and phosphorylation site residues, are required to provide a more 
detailed view of the molecular aspects that modulate the interaction between these proteins.   
Importantly, to better understand heterologous signaling mechanisms and cross-talk, it will 
also be necessary to pursue the identification of key elements of the “ACR4 network” using 
complementary approaches such as yeast 2-hybrid screening, affinity pull-downs and phage 





1. Lemmon, M.A. and J. Schlessinger, Cell signaling by receptor tyrosine kinases. Cell, 
2010. 141(7): p. 1117-34. 
2. Ullrich, A. and J. Schlessinger, Signal Transduction by Receptors with Tyrosine 
Kinase-Activity. Cell, 1990. 61(2): p. 203-212. 
3. Jiang, G. and T. Hunter, Receptor signaling: When dimerization is not enough. 
Current Biology, 1999. 12(9): p. R568-71. 
4. Schlessinger, J., Cell signaling by receptor tyrosine kinases. Cell, 2000. 103(2): p. 
211-25. 
5. Scott, J.D. and T. Pawson, Cell signaling in space and time: where proteins come 
together and when they're apart. Science, 2009. 326(5957): p. 1220-4. 
6. Shiu, S.H. and A.B. Bleecker, Plant receptor-like kinase gene family: diversity, 
function, and signaling. Sci STKE, 2001. 2001(113): p. re22. 
7. Haffani, Y.Z., N.F. Silva, and D.R. Goring, Receptor kinase signalling in plants. 
Canadian Journal of Botany-Revue Canadienne De Botanique, 2004. 82(1): p. 1-15. 
8. Afzal, A.J., A.J. Wood, and D.A. Lightfoot, Plant receptor-like serine threonine 
kinases: roles in signaling and plant defense. Mol Plant Microbe Interact, 2008. 
21(5): p. 507-17. 
9. Kim, T.W., S. Guan, Y. Sun, Z. Deng, W. Tang, J.X. Shang, A.L. Burlingame, and 
Z.Y. Wang, Brassinosteroid signal transduction from cell-surface receptor kinases to 
nuclear transcription factors. Nat Cell Biol, 2009. 11(10): p. 1254-60. 
10. Olayioye, M.A., R.M. Neve, H.A. Lane, and N.E. Hynes, The ErbB signaling 
network: receptor heterodimerization in development and cancer. Embo Journal, 
2000. 19(13): p. 3159-67. 
11. Prenzel, N., O.M. Fischer, S. Streit, S. Hart, and A. Ullrich, The epidermal growth 
factor receptor family as a central element for cellular signal transduction and 
diversification. Endocrine-Related Cancer, 2001. 8(1): p. 11-31. 
12. Wieduwilt, M.J. and M.M. Moasser, The epidermal growth factor receptor family: 
biology driving targeted therapeutics. Cell Mol Life Sci, 2008. 65(10): p. 1566-84. 
13. Clouse, S.D., Brassinosteroid signal transduction: from receptor kinase activation to 
transcriptional networks regulating plant development. Plant Cell, 2011. 23(4): p. 
1219-30. 
14. Ye, H.X., L. Li, and Y.H. Yin, Recent Advances in the Regulation of Brassinosteroid 
Signaling and Biosynthesis Pathways. Journal of Integrative Plant Biology, 2011. 
53(6): p. 455-468. 
15. Gifford, M.L., S. Dean, and G.C. Ingram, The Arabidopsis ACR4 gene plays a role in 
cell layer organisation during ovule integument and sepal margin development. 
Development, 2003. 130(18): p. 4249-58. 
16. Watanabe, M., H. Tanaka, D. Watanabe, C. Machida, and Y. Machida, The ACR4 
receptor-like kinase is required for surface formation of epidermis-related tissues in 
Arabidopsis thaliana. Plant Journal, 2004. 39(3): p. 298-308. 
17. Cao, X., K. Li, S.G. Suh, T. Guo, and P.W. Becraft, Molecular analysis of the 
CRINKLY4 gene family in Arabidopsis thaliana. Planta, 2005. 220(5): p. 645-57. 
207 
 
18. Tanaka, H., M. Watanabe, D. Watanabe, T. Tanaka, C. Machida, and Y. Machida, 
ACR4, a putative receptor kinase gene of Arabidopsis thaliana, that is expressed in 
the outer cell layers of embryos and plants, is involved in proper embryogenesis. 
Plant and Cell Physiology, 2002. 43(4): p. 419-428. 
19. Meyer, M.R., C.F. Lichti, R.R. Townsend, and A.G. Rao, Identification of in vitro 
autophosphorylation sites and effects of phosphorylation on the Arabidopsis 
CRINKLY4 (ACR4) receptor-like kinase intracellular domain: insights into 
conformation, oligomerization, and activity. Biochemistry, 2011. 50(12): p. 2170-86. 
20. Tanaka, H., M. Watanabe, M. Sasabe, T. Hiroe, T. Tanaka, H. Tsukaya, M. Ikezaki, 
C. Machida, and Y. Machida, Novel receptor-like kinase ALE2 controls shoot 
development by specifying epidermis in Arabidopsis. Development, 2007. 134(9): p. 
1643-1652. 
21. De Smet, I., V. Vassileva, B. De Rybel, M.P. Levesque, W. Grunewald, D. Van 
Damme, G. Van Noorden, M. Naudts, G. Van Isterdael, R. De Clercq, J.Y. Wang, N. 
Meuli, S. Vanneste, J. Friml, P. Hilson, G. Jurgens, G.C. Ingram, D. Inze, P.N. 
Benfey, and T. Beeckman, Receptor-like kinase ACR4 restricts formative cell 
divisions in the Arabidopsis root. Science, 2008. 322(5901): p. 594-7. 
22. Stahl, Y., R.H. Wink, G.C. Ingram, and R. Simon, A signaling module controlling the 
stem cell niche in Arabidopsis root meristems. Curr Biol, 2009. 19(11): p. 909-14. 
23. Stahl, Y. and R. Simon, Is the Arabidopsis root niche protected by sequestration of 
the CLE40 signal by its putative receptor ACR4? Plant Signal Behav, 2009. 4(7): p. 
634-5. 
24. Miwa, H., A. Kinoshita, H. Fukuda, and S. Sawa, Plant meristems: CLAVATA3/ESR-
related signaling in the shoot apical meristem and the root apical meristem. J Plant 
Res, 2009. 122(1): p. 31-9. 
25. Nolen, B., S. Taylor, and G. Ghosh, Regulation of protein kinases: Controlling 
activity through activation segment conformation. Molecular Cell, 2004. 15(5): p. 
661-675. 
26. Pascal, B.D., M.J. Chalmers, S.A. Busby, and P.R. Griffin, HD desktop: an 
integrated platform for the analysis and visualization of H/D exchange data. J Am 
Soc Mass Spectrom, 2009. 20(4): p. 601-10. 
27. Zhang, Z. and D.L. Smith, Determination of amide hydrogen exchange by mass 
spectrometry: a new tool for protein structure elucidation. Protein Science, 1993. 
2(4): p. 522-31. 
28. Sali, A., L. Potterton, F. Yuan, H. van Vlijmen, and M. Karplus, Evaluation of 
comparative protein modeling by MODELLER. Proteins, 1995. 23(3): p. 318-26. 
29. Berenstein, D., J.F. Christensen, T. Kristensen, R. Hofbauer, and B. Munch-Petersen, 
Valine, not methionine, is amino acid 106 in human cytosolic thymidine kinase (TK1) 
- Impact on oligomerization, stability, and kinetic properties. Journal of Biological 
Chemistry, 2000. 275(41): p. 32187-32192. 
30. Hansson, H., M.P. Okoh, C.I.E. Smith, M. Vihinen, and T. Hard, Intermolecular 
interactions between the SH3 domain and the proline-rich TH region of Bruton's 
tyrosine kinase. Febs Letters, 2001. 489(1): p. 67-70. 
31. Levinson, N.M., P.R. Visperas, and J. Kuriyan, The Tyrosine Kinase Csk Dimerizes 
through Its SH3 Domain. PLoS One, 2009. 4(11). 
208 
 
32. Stone, J.M., A.E. Trotochaud, J.C. Walker, and S.E. Clark, Control of meristem 
development by CLAVATA1 receptor kinase and kinase-associated protein 
phosphatase interactions. Plant Physiology, 1998. 117(4): p. 1217-1225. 
33. Wang, X., U. Kota, K. He, K. Blackburn, J. Li, M.B. Goshe, S.C. Huber, and S.D. 
Clouse, Sequential transphosphorylation of the BRI1/BAK1 receptor kinase complex 
impacts early events in brassinosteroid signaling. Dev Cell, 2008. 15(2): p. 220-35. 
34. Schulze, B., T. Mentzel, A.K. Jehle, K. Mueller, S. Beeler, T. Boller, G. Felix, and D. 
Chinchilla, Rapid Heteromerization and Phosphorylation of Ligand-activated Plant 
Transmembrane Receptors and Their Associated Kinase BAK1. Journal of Biological 
Chemistry, 2010. 285(13): p. 9444-9451. 
35. Kim, H.H., U. Vijapurkar, N.J. Hellyer, D. Bravo, and J.G. Koland, Signal 
transduction by epidermal growth factor and heregulin via the kinase-deficient ErbB3 
protein. Biochemical Journal, 1998. 334: p. 189-195. 
36. Castells, E. and J.M. Casacuberta, Signalling through kinase-defective domains: the 
prevalence of atypical receptor-like kinases in plants. Journal of Experimental 
Botany, 2007. 58(13): p. 3503-3511. 
37. Hanks, S.K. and T. Hunter, Protein kinases 6. The eukaryotic protein kinase 
superfamily: kinase (catalytic) domain structure and classification. FASEB J, 1995. 
9(8): p. 576-96. 
38. Yan, X. and C.S. Maier, Hydrogen/Deuterium Exchange Mass Spectrometry, in Mass 
Spectrometry of Proteins and Peptides, M. Lipton and L. Pasa-Tolic, Editors. 2009, 
Humana Press. p. 255-271. 
39. Konermann, L., J.X. Pan, and Y.H. Liu, Hydrogen exchange mass spectrometry for 
studying protein structure and dynamics. Chemical Society Reviews, 2011. 40(3): p. 
1224-1234. 
40. Busenlehner, L.S. and R.N. Armstrong, Insights into enzyme structure and dynamics 
elucidated by amide H/D exchange mass spectrometry. Archives of Biochemistry and 
Biophysics, 2005. 433(1): p. 34-46. 
41. Zhou, B., J.L. Zhang, S.J. Liu, S. Reddy, F. Wang, and Z.Y. Zhang, Mapping ERK2-
MKP3 binding interfaces by hydrogen/deuterium exchange mass spectrometry. 
Journal of Biological Chemistry, 2006. 281(50): p. 38834-38844. 
42. Zhou, B. and Z.Y. Zhang, Application of hydrogen/deuterium exchange mass 
spectrometry to study protein tyrosine phosphatase dynamics, ligand binding, and 
substrate specificity. Methods, 2007. 42(3): p. 227-233. 
43. Pawson, T. and P. Nash, Assembly of cell regulatory systems through protein 
interaction domains. Science, 2003. 300(5618): p. 445-452. 
44. Cesareni, G., M. Gimona, M. Sudol, and M. Yaffe, Modular Protein Domains. 2005: 
Wiley-VCH. 
45. Ren, S., V.N. Uversky, Z.J. Chen, A.K. Dunker, and Z. Obradovic, Short Linear 
Motifs recognized by SH2, SH3 and Ser/Thr Kinase domains are conserved in 
disordered protein regions. Bmc Genomics, 2007. 9. 
46. Sidhu, S.S., W.J. Fairbrother, and K. Deshayes, Exploring protein-protein 
interactions with phage display. Chembiochem, 2003. 4(1): p. 14-25. 
209 
 
47. Tonikian, R., Y. Zhang, C. Boone, and S.S. Sidhu, Identifying specificity profiles for 
peptide recognition modules from phage-displayed peptide libraries. Nat Protoc, 
2007. 2(6): p. 1368-86. 
48. Molek, P., B. Strukelj, and T. Bratkovic, Peptide Phage Display as a Tool for Drug 
Discovery: Targeting Membrane Receptors. Molecules, 2011. 16(1): p. 857-887. 
49. Kay, B.K., J. Kasanov, S. Knight, and A. Kurakin, Convergent evolution with 
combinatorial peptides. Febs Letters, 2000. 480(1): p. 55-62. 
50. Smothers, J.F. and S. Henikoff, The HP1 chromo shadow domain binds a consensus 
peptide pentamer. Current Biology, 2000. 10(1): p. 27-30. 
51. Yaffe, M.B. and A.E.H. Elia, Phosphoserine/threonine-binding domains. Current 
Opinion in Cell Biology, 2001. 13(2): p. 131-138. 
52. Joughin, B.A., B. Tidor, and M.B. Yaffe, A computational method for the analysis 
and prediction of protein: phosphopeptide-binding sites. Protein Science, 2005. 
14(1): p. 131-139. 
53. Yaffe, M.B. and S.J. Smerdon, The use of in vitro peptide-library screens in the 
analysis of phosphoserine/threonine-binding domain structure and function. Annual 
Review of Biophysics and Biomolecular Structure, 2004. 33: p. 225-244. 
54. He, W., A. Craparo, Y. Zhu, T.J. O'Neill, L.M. Wang, J.H. Pierce, and T.A. 
Gustafson, Interaction of insulin receptor substrate-2 (IRS-2) with the insulin and 
insulin-like growth factor I receptors. Evidence for two distinct phosphotyrosine-
dependent interaction domains within IRS-2. J Biol Chem, 1996. 271(20): p. 11641-5. 
55. Holland, S.J., N.W. Gale, G.D. Gish, R.A. Roth, Z. Songyang, L.C. Cantley, M. 
Henkemeyer, G.D. Yancopoulos, and T. Pawson, Juxtamembrane tyrosine residues 
couple the Eph family receptor EphB2/Nuk to specific SH2 domain proteins in 
neuronal cells. Embo Journal, 1997. 16(13): p. 3877-88. 
56. Schulze, W.X., L. Deng, and M. Mann, Phosphotyrosine interactome of the ErbB-
receptor kinase family. Molecular Systems Biology, 2005. 1. 
57. Park, C.J., Y. Peng, X. Chen, C. Dardick, D. Ruan, R. Bart, P.E. Canlas, and P.C. 
Ronald, Rice XB15, a protein phosphatase 2C, negatively regulates cell death and 
XA21-mediated innate immunity. Plos Biology, 2008. 6(9): p. e231. 
58. Deheuninck, J., G. Goormachtigh, B. Foveau, Z. Ji, C. Leroy, F. Ancot, V. Villeret, 
D. Tulasne, and V. Fafeur, Phosphorylation of the MET receptor on juxtamembrane 
tyrosine residue 1001 inhibits its caspase-dependent cleavage. Cell Signal, 2009. 
21(9): p. 1455-63. 
59. Cubas, P., N. Lauter, J. Doebley, and E. Coen, The TCP domain: a motif found in 
proteins regulating plant growth and development. Plant Journal, 1999. 18(2): p. 215-
222. 
60. Savkur, R.S. and T.P. Burris, The coactivator LXXLL nuclear receptor recognition 
motif. Journal of Peptide Research, 2004. 63(3): p. 207-212. 
61. Plevin, M.J., M.M. Mills, and M. Ikura, The LxxLL motif: a multifunctional binding 
sequence in transcriptional regulation. Trends in Biochemical Sciences, 2005. 30(2): 
p. 66-69. 
62. Kim, J.G., X.Y. Li, J.A. Roden, K.W. Taylor, C.D. Aakre, B. Su, S. Lalonde, A. 
Kirik, Y.H. Chen, G. Baranage, H. McLane, G.B. Martin, and M.B. Mudgett, 
Xanthomonas T3S Effector XopN Suppresses PAMP-Triggered Immunity and 
210 
 
Interacts with a Tomato Atypical Receptor-Like Kinase and TFT1. Plant Cell, 2009. 
21(4): p. 1305-1323. 
63. Mol, C.D., D.R. Dougan, T.R. Schneider, R.J. Skene, M.L. Kraus, D.N. Scheibe, G.P. 
Snell, H. Zou, B.C. Sang, and K.P. Wilson, Structural basis for the autoinhibition 
and STI-571 inhibition of c-Kit tyrosine kinase. J Biol Chem, 2004. 279(30): p. 
31655-63. 
64. Griffith, J., J. Black, C. Faerman, L. Swenson, M. Wynn, F. Lu, J. Lippke, and K. 
Saxena, The structural basis for autoinhibition of FLT3 by the juxtamembrane 
domain. Mol Cell, 2004. 13(2): p. 169-78. 
65. Schubert, C., C. Schalk-Hihi, G.T. Struble, H.C. Ma, I.P. Petrounia, B. Brandt, I.C. 
Deckman, R.J. Patch, M.R. Player, J.C. Spurlino, and B.A. Springer, Crystal 
structure of the tyrosine kinase domain of colony-stimulating factor-1 receptor 
(cFMS) in complex with two inhibitors. J Biol Chem, 2007. 282(6): p. 4094-101. 
66. Li, S., N.D. Covino, E.G. Stein, J.H. Till, and S.R. Hubbard, Structural and 
biochemical evidence for an autoinhibitory role for tyrosine 984 in the 
juxtamembrane region of the insulin receptor. J Biol Chem, 2003. 278(28): p. 26007-
14. 
67. Hubbard, S.R., Juxtamembrane autoinhibition in receptor tyrosine kinases. Nat Rev 
Mol Cell Biol, 2004. 5(6): p. 464-71. 
68. Roskoski, R., Jr., Structure and regulation of Kit protein-tyrosine kinase--the stem 
cell factor receptor. Biochem Biophys Res Commun, 2005. 338(3): p. 1307-15. 
69. Wiesner, S., L.E. Wybenga-Groot, N. Warner, H. Lin, T. Pawson, J.D. Forman-Kay, 
and F. Sicheri, A change in conformational dynamics underlies the activation of Eph 
receptor tyrosine kinases. Embo Journal, 2006. 25(19): p. 4686-96. 
70. Sarkar, A.K., M. Luijten, S. Miyashima, M. Lenhard, T. Hashimoto, K. Nakajima, B. 
Scheres, R. Heidstra, and T. Laux, Conserved factors regulate signalling in 
Arabidopsis thaliana shoot and root stem cell organizers. Nature, 2007. 446(7137): p. 
811-4. 
71. Dorsam, R.T. and J.S. Gutkind, G-protein-coupled receptors and cancer. Nature 
Reviews Cancer, 2007. 7(2): p. 79-94. 
72. Park, O.K., T.S. Schaefer, and D. Nathans, In vitro activation of Stat3 by epidermal 
growth factor receptor kinase. Proc Natl Acad Sci U S A, 1996. 93(24): p. 13704-8. 
73. Quesnelle, K.M., A.L. Boehm, and J.R. Grandis, STAT-mediated EGFR signaling in 
cancer. J Cell Biochem, 2007. 102(2): p. 311-9. 
74. Albrecht, C., E. Russinova, B. Kemmerling, M. Kwaaitaal, and S.C. de Vries, 
Arabidopsis SOMATIC EMBRYOGENESIS RECEPTOR KINASE proteins serve 
brassinosteroid-dependent and -independent signaling pathways. Plant Physiol, 2008. 
148(1): p. 611-9. 
75. Boisson-Dernier, A., S. Roy, K. Kritsas, M.A. Grobei, M. Jaciubek, J.I. Schroeder, 
and U. Grossniklaus, Disruption of the pollen-expressed FERONIA homologs 
ANXUR1 and ANXUR2 triggers pollen tube discharge. Development, 2009. 136(19): 
p. 3279-88. 
76. Matsumura, Y., H. Iwakawa, Y. Machida, and C. Machida, Characterization of genes 
in the ASYMMETRIC LEAVES2/LATERAL ORGAN BOUNDARIES (AS2/LOB) 
211 
 
family in Arabidopsis thaliana, and functional and molecular comparisons between 
AS2 and other family members. Plant Journal, 2009. 58(3): p. 525-37. 
77. Pfeiffer, M., T. Koch, H. Schroder, M. Laugsch, V. Hollt, and S. Schulz, 
Heterodimerization of somatostatin and opioid receptors cross-modulates 
phosphorylation, internalization, and desensitization. J Biol Chem, 2002. 277(22): p. 
19762-72. 
78. Morgillo, F., J.K. Woo, E.S. Kim, W.K. Hong, and H.Y. Lee, Heterodimerization of 
insulin-like growth factor receptor/epidermal growth factor receptor and induction of 
survivin expression counteract the antitumor action of erlotinib. Cancer Res, 2006. 
66(20): p. 10100-11. 
79. Saito, Y., J. Haendeler, Y. Hojo, K. Yamamoto, and B.C. Berk, Receptor 
heterodimerization: essential mechanism for platelet-derived growth factor-induced 
epidermal growth factor receptor transactivation. Mol Cell Biol, 2001. 21(19): p. 
6387-94. 
80. Chinchilla, D., C. Zipfel, S. Robatzek, B. Kemmerling, T. Nurnberger, J.D. Jones, G. 
Felix, and T. Boller, A flagellin-induced complex of the receptor FLS2 and BAK1 
initiates plant defence. Nature, 2007. 448(7152): p. 497-500. 
81. Guo, Y., L. Han, M. Hymes, R. Denver, and S.E. Clark, CLAVATA2 forms a distinct 
CLE-binding receptor complex regulating Arabidopsis stem cell specification. Plant 
Journal, 2010. 63(6): p. 889-900. 
82. Liu, P., T. Sudhaharan, R.M. Koh, L.C. Hwang, S. Ahmed, I.N. Maruyama, and T. 
Wohland, Investigation of the dimerization of proteins from the epidermal growth 
factor receptor family by single wavelength fluorescence cross-correlation 
spectroscopy. Biophys J, 2007. 93(2): p. 684-98. 
83. Tao, R.H. and I.N. Maruyama, All EGF(ErbB) receptors have preformed homo- and 
heterodimeric structures in living cells. Journal of Cell Science, 2008. 121(19): p. 
3207-3217. 
84. Chantry, A., The Kinase Domain and Membrane Localization Determine 
Intracellular Interactions between Epidermal Growth-Factor Receptors. Journal of 
Biological Chemistry, 1995. 270(7): p. 3068-3073. 
85. Yu, X.C., K.D. Sharma, T. Takahashi, R. Iwamoto, and E. Mekada, Ligand-
independent dimer formation of epidermal growth factor receptor (EGFR) is a step 
separable from ligand-induced EGFR signaling. Molecular Biology of the Cell, 2002. 
13(7): p. 2547-2557. 
86. Monsey, J., W. Shen, P. Schlesinger, and R. Bose, Her4 and Her2/neu tyrosine kinase 
domains dimerize and activate in a reconstituted in vitro system. J Biol Chem, 2010. 
285(10): p. 7035-44. 
87. Wang, X., X. Li, J. Meisenhelder, T. Hunter, S. Yoshida, T. Asami, and J. Chory, 
Autoregulation and homodimerization are involved in the activation of the plant 
steroid receptor BRI1. Dev Cell, 2005. 8(6): p. 855-65. 
88. Shah, K., T.W. Gadella, Jr., H. van Erp, V. Hecht, and S.C. de Vries, Subcellular 
localization and oligomerization of the Arabidopsis thaliana somatic embryogenesis 
receptor kinase 1 protein. J Mol Biol, 2001. 309(3): p. 641-55. 
89. Spivak-Kroizman, T., D. Rotin, D. Pinchasi, A. Ullrich, J. Schlessinger, and I. Lax, 
Heterodimerization of c-erbB2 with different epidermal growth factor receptor 
212 
 
mutants elicits stimulatory or inhibitory responses. J Biol Chem, 1992. 267(12): p. 
8056-63. 
90. Ferguson, K.M., P.J. Darling, M.J. Mohan, T.L. Macatee, and M.A. Lemmon, 
Extracellular domains drive homo- but not hetero-dimerization of erbB receptors. 
Embo Journal, 2000. 19(17): p. 4632-43. 
91. Gerber, D., N. Sal-Man, and Y. Shai, Two motifs within a transmembrane domain, 
one for homodimerization and the other for heterodimerization. Journal of Biological 
Chemistry, 2004. 279(20): p. 21177-21182. 
92. Ferguson, K.M., Structure-based view of epidermal growth factor receptor 
regulation. Annu Rev Biophys, 2008. 37: p. 353-73. 
93. Mineev, K.S., E.V. Bocharov, Y.E. Pustovalova, O.V. Bocharova, V.V. Chupin, and 
A.S. Arseniev, Spatial Structure of the Transmembrane Domain Heterodimer of 
ErbB1 and ErbB2 Receptor Tyrosine Kinases. Journal of Molecular Biology, 2010. 
400(2): p. 231-243. 
94. Gomez-Gomez, L., Z. Bauer, and T. Boller, Both the extracellular leucine-rich repeat 
domain and the kinase activity of FLS2 are required for flagellin binding and 
signaling in arabidopsis. Plant Cell, 2001. 13(5): p. 1155-1163. 
95. Hynes, N.E. and G. MacDonald, ErbB receptors and signaling pathways in cancer. 
Current Opinion in Cell Biology, 2009. 21(2): p. 177-184. 
96. Shiu, S.H. and A.B. Bleecker, Expansion of the receptor-like kinase/Pelle gene family 
and receptor-like proteins in Arabidopsis. Plant Physiol, 2003. 132(2): p. 530-43. 
97. Llompart, B., E. Castells, A. Rio, R. Roca, A. Ferrando, V. Stiefel, P. Puigdomenech, 
and J.M. Casacuberta, The direct activation of MIK, a germinal center kinase (GCK)-
like kinase, by MARK, a maize atypical receptor kinase, suggests a new mechanism 
for signaling through kinase-dead receptors. J Biol Chem, 2003. 278(48): p. 48105-
11. 
98. Karlova, R., S. Boeren, W. van Dongen, M. Kwaaitaal, J. Aker, J. Vervoort, and S. de 
Vries, Identification of in vitro phosphorylation sites in the Arabidopsis thaliana 
somatic embryogenesis receptor-like kinases. Proteomics, 2009. 9(2): p. 368-79. 
99. Lu, D., S. Wu, X. Gao, Y. Zhang, L. Shan, and P. He, A receptor-like cytoplasmic 
kinase, BIK1, associates with a flagellin receptor complex to initiate plant innate 
immunity. Proc Natl Acad Sci U S A, 2010. 107(1): p. 496-501. 
100. Gschwind, A., E. Zwick, N. Prenzel, M. Leserer, and A. Ullrich, Cell communication 
networks: epidermal growth factor receptor transactivation as the paradigm for 
interreceptor signal transmission. Oncogene, 2001. 20(13): p. 1594-1600. 
101. Filardo, E.J., Epidermal growth factor receptor (EGFR) transactivation by estrogen 
via the G-protein-coupled receptor, GPR30: a novel signaling pathway with potential 
significance for breast cancer. Journal of Steroid Biochemistry and Molecular 
Biology, 2002. 80(2): p. 231-238. 
102. Fiers, M., K.L. Ku, and C.M. Liu, CLE peptide ligands and their roles in establishing 
meristems. Current Opinion in Plant Biology, 2007. 10(1): p. 39-43. 
103. Wang, G. and M. Fiers, CLE peptide signaling during plant development. 
Protoplasma, 2010. 240(1-4): p. 33-43. 
213 
 
104. Aubol, B.E., L. Ungs, R. Lukasiewicz, G. Ghosh, and J.A. Adams, Chemical 
clamping allows for efficient phosphorylation of the RNA carrier protein Npl3. 
Journal of Biological Chemistry, 2004. 279(29): p. 30182-30188. 
105. Lieser, S.A., B.E. Aubol, L. Wong, P.A. Jennings, and J.A. Adams, Coupling 
phosphoryl transfer and substrate interactions in protein kinases. Biochim Biophys 
Acta, 2005. 1754(1-2): p. 191-9. 
106. Huse, M., Y.G. Chen, J. Massague, and J. Kuriyan, Crystal structure of the 
cytoplasmic domain of the type I TGF beta receptor in complex with FKBP12. Cell, 
1999. 96(3): p. 425-36. 
107. Huse, M., T.W. Muir, L. Xu, Y.G. Chen, J. Kuriyan, and J. Massague, The TGF beta 
receptor activation process: an inhibitor- to substrate-binding switch. Mol Cell, 
2001. 8(3): p. 671-82. 
108. Shao, H., H.Y. Cheng, R.G. Cook, and D.J. Tweardy, Identification and 
characterization of signal transducer and activator of transcription 3 recruitment 
sites within the epidermal growth factor receptor. Cancer Res, 2003. 63(14): p. 3923-
30. 
109. Kornev, A.P., S.S. Taylor, and L.F. Ten Eyck, A helix scaffold for the assembly of 
































































































































e 1.  Gel 
en the ICD
ion on a Sup
rily elutes a
lution profil





es of the C
epict 12% S
nalysis of 
 and  the C
0 column.  






















































e 2.  Effec
rmed to det












 protein.  In
-), (C) m

















































































e 3.  ACR4
ncubated w
s an autorad

























e ICDs of 











.  Lower pa
UMO prote
of the sCR




ase assay.  (
e the ICDs 
nel shows th




h protein.  
 Active mA
































e 4.  HDX-
4 peptides, 
nge rates b







































































tocol.  The m
nt HDX are
























 Studio v 3
was validat


















 (gray).  Pep










































e.  Phage p
.  After four 
nts the pep





















ed in the 
uccessive b
lected for D
 to JMD1 p
































































es bind to t
 the sACR
)  Peptide a
ved ‘KDSA
showing tha






















 the ACR4 J
d).  In ALE
sphorylated 
C (upper pa






































































ht to be inv
.  Orientatio
).  





















icted is a cl
























 is a key re
 at the ‘LL



































rn blots of 
ins in each 
4; lane 3, m
4 ICD inte
termined by















4 cannot  in
n of interac
action (midd
ls).   Lane 
ane 4, MBP
  The inter



















































e 10.  ACR
5, sACR4 w
adiogram d
 is shown i
nts, 2, 5, an
t be phosph




n lane 1.  P






















ively.   A co
 loaded at i
: Correspon
e ACR4 ph































































f in vitro W
in is shown
2aa WOX5 




l end of the
ted b9 (theo
served m/z
rved m/z of 





ures of the W
 and the 
 and Ser158
ectrum of th

















 sites.  (A)  
usion tag an
, the N-term






















































e 12.  Pote








ighted:  the 
e CRR3/CR
 coded to ma
ntial interm
potential 

























on in the AC
e ‘GLSLL’
e conform
 in the JMD
ction betwe
ding of the 
domain.  
ation loops 





 region at th
ation.  D




(red),  the A
he labels fo
R4 or the C
 among th
 the KDS




































CHAPTER 6: CONCLUSIONS AND FUTURE WORK 
 
General Conclusion 
 Since the discovery of the CRINKLY4 gene in maize over 15 years ago (1), salient 
advancements have been made in understanding the function of the CRINKLY4 gene in both 
maize and Arabidopsis.  Genetic and cell biology studies have shed light on the function of 
maize CR4 pertaining to the morphogenesis of epidermal tissues in the plant (1-3).  The 
identification of an ortholog of maize CR4 in Arabidopsis (ACR4) has facilitated the 
examination of CRINKLY4 function in this model organism (4).  Phenotypic analyses of 
acr4 knockout plants have provided a large amount of information about receptor function in 
both the aerial and underground organs of the plant (5-8).  Additionally, molecular and cell 
biology studies of truncation mutants have revealed information on receptor localization and 
internalization that have led to a basic understanding of domains within the ACR4 receptor 
that are critical for cellular functions (6, 9, 10).  Recent biochemical studies have started to 
elucidate the role of the transmembrane domains of the CR4, ACR4, and AtCRR receptors in 
protein function (11, 12).   However, the molecular basis for ligand binding, activation of the 
receptor and concomitant activation of the intracellular kinase domain, and the components 
of the downstream signaling pathway remains largely a mystery. 
 In this dissertation we provide the first fundamental biochemical analysis of the 
intracellular domain of the ACR4 receptor and its interaction with homologs. In concert with 
concurrent genetic and biological investigations from other laboratories, this study lays the 
foundation for a more comprehensive exploration of the central role of this important 
receptor in plant growth and development. Significant new information includes: 
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 The ACR4 kinase domain was recombinantly expressed in a bacterial system and its 
biochemical properties including autophosphorylation mechanism, oligomerization, and 
conformational dynamics were studied in detail (13) (Chapter 2).   
 To study the interactions between members of the ACR4 receptor family, we have 
recombinantly expressed and purified milligram quantities of the ICDs of ACR4, the 
AtCRRs, and ALE2 as C-terminal fusions to the Small Ubiquitin like MOdifier (SUMO) 
protein (Chapter 3). 
 We provide evidence for an intramolecular interaction between the ACR4 JMD and the 
amino-terminal region of the KD and its potential role in the regulation of kinase activity. 
Phage display and peptide binding studies demonstrate that the ‘KDSAF’ motif harbored in 
the ACR4 JMD can make intramolecular contacts with the N-lobe of the kinase via a 
‘LLSLL’ motif.  Furthermore, we also show that autophosphorylation of the JMD may be 
important for efficient substrate phosphorylation (Chapter 4). 
 We demonstrate that ACR4 can interact with all four CRRs in a phosphorylation independent 
manner. Sequence comparison, phage display, and peptide binding studies are indicative of 
an intermolecular interaction mechanism between a highly conserved ‘KDSAF’ region in 
CRR3, CRK1, and ALE2 and the ‘LLSLL’ motif in the ACR4 kinase N-lobe (Chapter 5).    
 Phage display panning of a phosphorylated peptide in the juxtamembrane domain has 
allowed us to compile a significant list of potential interacting proteins that can be classified 
into distinct signal transduction categories i.e. RLKs, phosphatases, transcription factors, and 
other adapter proteins that will have to await further confirmation and establishment of 
biological relevance.   
 Lastly, we demonstrate, for the first time, that the intracellular domain of ACR4 can interact 
with the WOX5 transcription factor and phosphorylate it in vitro.  Thus, signifying a potential 
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interaction between the ACR4 RLK and a putative downstream signaling component within 
the ACR4 signaling pathway. 
 
Future Work 
The role of subdomains on kinase activity 
 The studies in this dissertation provide evidence for a mechanism of ACR4 
juxtamembrane autoinhibition of the kinase domain (KD) but the intriguing question is how 
the kinase is retained in a basal, inactive state at the cell surface.  Our studies indicate that 
phosphorylation at Ser475 and Thr478 are necessary for maximal kinase activity (Chapter 4, 
Fig. 3).  However, the exact roles of individual autophosphorylation sites in JMD 
autoregulation remain to be ascertained. Furthermore, there is an additional phosphorylation 
site at Thr501 that shows a significant effect on kinase autophosphorylation when mutated to 
Ala (Chapter 3, Fig. 7).  Although this site is outside our defined region of the JMD, it lies 
immediately N-terminal to the kinase subdomain.     
Thus far, little is known about the role of the C-terminal domain (CTD) in kinase 
autoregulation and activation.  Individual Ala mutations of autophosphorylation sites within 
the CTD have been shown to be inhibitory to maximal kinase activity (Chapter 3, Fig. 7), 
suggesting that the CTD performs a similar role to JMD.  Future studies must emphasize 
detailed biochemical and biophysical analysis that includes kinetic analyses of CTD 
autophosphorylation site mutants and substrate phosphorylation.  These studies will provide 
the mechanistic details of CTD autoregulation and aid in the development of an overall 
mechanism of intracellular subdomain autoinhibition of the ACR4 kinase.  
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Ultimately, the three-dimensional structure of the ACR4 kinase domain, in the 
phosphorylated and unphosphorylated state, will provide a better understanding of the finer 
aspects of kinase activity and its regulation.  
Intermolecular interactions in the ACR4 family  
 Our studies have shown that the ACR4 ICD can interact with all four of the CRR 
ICDs in the absence of phosphorylation (Chapter 5, Fig. 1 and 2).  A potential mechanism for 
these interactions involves the conserved ‘KDSAF’ motif in the CRRs and ‘LLSLL’ region 
in ACR4.  Yet, we do not know the precise role of these residues/regions in protein-protein 
interactions within the family.  Mutational studies of these interaction sites in ACR4 and the 
CRRs will need to be assessed in vitro.  Concomitant phenotypic analysis of mutant plants 
will provide valuable clues regarding the relationship between heteromeric interactions and 
potential activation of differential signaling events.  It may be possible to tailor specific 
combinations of heteromers to influence new signaling pathways and produces novel 
phenotypes.  It is also enticing to speculate that an entirely different mechanism regulates the 
interactions of ACR4 with the dead kinases, CRR1 and CRR2.  Interestingly, both of these 
proteins contain an ‘IVNLL’motif in the analogous position to the ‘LLSLL’ motif in ACR4.  
Our HDX data with CRK1 shows other regions that may also be involved in protein-protein 
contacts between the ICDs (Chapter 5, Fig. 5).  Further HDX analysis of these protein-
protein interactions, especially with membrane bound ICDs, can be utilized to characterize 
the interaction interface on both the ACR4 and CRRs in more detail.    
Other members of the “ACR4 network”  
   Phage display screening of phosphorylated JMD peptides has yielded consensus 
sequences that preferentially bind to these linear peptides.  Subsequently, database mining for 
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proteins that harbor these consensus motifs revealed a multitude of hits to proteins (Chapter 
5, Table 2) that are potentially involved in signal transduction.  However, the relevance of 
these proteins in the ACR4 signaling network remains to be clarified.  With at least 18 
autophosphorylation sites in ACR4 (13) (Chapter 2), it is a daunting challenge to delineate 
the function of each phosphorylation site during ACR4 signaling. For instance, one site may 
be involved in activation of the kinase domain by driving conformational changes in the 
protein versus a phosphorylation site that acts as a recruitment point for downstream targets 
in the ACR4 signaling pathway.  Further increasing this complexity, are the potential for the 
CRRs and ALE2 to transphosphorylate the ACR4 intracellular domain (Chapter 3, Fig. 4) 
and the ability of ACR4 to phosphorylate all of the CRRs and ALE2 (Chapter 5, Fig. 3).  
Thus, increasing the number of potential phosphorylation sites correspondingly increases the 
complexity and the challenge of delineating their specific roles.  Phage display screening of 
phosphorylated peptides and/or domains corresponding to ACR4 phosphorylation sites 
coupled to yeast 2-hybrid screening would provide an excellent means to overcome this 
obstacle.   
 As of yet, there are no known proteins that interact with the C-terminal domain 
(CTD).  It is common among RTKs to have their CTDs phosphorylated at tyrosine residues 
in response to receptor activation.  These sites can then recruit SH2 or PTB domain 
containing target proteins.  As exemplified in the four-member EGF receptor family, multiple 
sites within their respective CTDs are phosphorylated and act to attract downstream targets 
(14, 15).  Therefore, we can invoke the likelihood that some of the six autophosphorylation 
sites in the ACR4 receptor can serve to recruit downstream signaling targets. Therefore, 
phage display screening of phosphorylated peptide targets would be advantageous in 
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identifying consensus binding motifs that potentially signify 14-3-3, WW, FHA, or WD40 
domain containing proteins that recognize phosphoserine or phosphothreonine residues (16). 
 It appears that ACR4 is involved in at least two distinct signaling pathways with 
overlapping themes.  In one pathway, ACR4 has been proposed to be the mediator of stem 
cell differentiation in the root tip (8, 17).  Here, ACR4 is described to perceive the 
extracellular CLE40 peptide ligand which promotes stem cell differentiation.  Presumed 
activation of ACR4 then influences the expression domain of the WOX5 transcription factor, 
a protein that promotes stem cell proliferation (described in Chapter 1).  Our experiments 
have demonstrated that the ACR4 kinase can interact with and phosphorylate WOX5 in vitro. 
At this time, the relevance of these phosphorylation sites is not known. Complementary in 
vivo experiments knocking out the potential phosphorylation sites in the WOX5 protein may 
drive phenotypic effects in transformed wox5 mutant plants aiding in the characterization of 
the functional significance of these phosphorylated residues. In the second pathway, ACR4 is 
described to be involved in the proper differentiation of epidermis in vegetative and 
reproductive tissues (described in Chapter 1). Currently, the list of proteins known to be 
involved in epidermal development is rather limited.  The major players such as AtDEK1, 
ALE1, ALE2, ACR4, and SAL1 are all known to affect different aspects of epidermal 
specification, differentiation, and maintenance (described in Chapter 1). Recently, maize 
Thk1 has been identified as a negative regulator of aluerone cell identity and has been 
proposed to function downstream of maize DEK1 (18).  However, little is known about the 
interplay among these proteins (Fig. 1) and how they network together to regulate epidermis 
formation. One of our long term goals is to understand the relationship between ACR4 and 
other members of epidermal cell fate, namely, signaling components that can directly interact 
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with ACR4 in the intracellular or extracellular region.  In vitro biochemical and biophysical 
studies of recombinant proteins can often provide valuable clues towards an understanding of 
in vivo physiological functions. However, this is not a trivial task and characterization of 
proteins involved in epidermal cell fate will require large amounts of soluble protein.  For 
example, we have attempted to clone and express the extracellular domain of the ACR4 
receptor in eukaryotic and prokaryotic systems with no success thus far.  This is likely due to 
the overall complexity of the extracellular ‘crinkly’ repeats and the 26 cysteine residues 
found in the extracellular domain (Chapter 1, Fig. 1).  Cloning and expressing other proteins 
classified to be involved in epidermal formation may be a task within itself.  Indeed, the 
production of milligram quantities of the ACR4 intracellular domain itself was quite 
challenging.   
 The grand challenges of the 21st century are health, food, water and energy. The 
world population is growing at an annual rate of 80 million per year and, at this rate, will 
increase from the current 6 billion to >10 billion people by the 2030’s (19).  Simultaneous 
decline of arable agricultural land continues to challenge our ability to meet increasing 
demands for food, feed and fuel.  To meet these demands, it is necessary to achieve a 
comprehensive understanding of plant function to enable knowledge-driven manipulation of 
pathways and regulatory networks for crop improvement.  Towards this goal, Arabidopsis 
has served as a model for identifying genes and discovering their function in plant growth 
and development for application to crop species (20).  Therefore, on a broader basis, given 
the existence of ACR4 equivalents in both maize and rice, there is high probability of the 
conservation of signaling components in these agriculturally important crops.  The potential 
therefore exists to advantageously regulate plant development for improved agronomic value 
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